British Columbia, Canada |
7372 |
Not applicable | ||
(State or Other Jurisdiction of Incorporation or Organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification Number) |
Marc J. Ross Avital Perlman Sichenzia Ross Ference LLP 1185 Avenue of the Americas, 31st Floor New York, NY 10036 Tel: (212) 930-9700 |
Brett Hanson Emily Humbert Fox Rothschild LLP 222 South Ninth Street, Suite 2000 Minneapolis, MN 55402 Tel: (612) 607-7000 |
Emerging growth company |
PRELIMINARY PROSPECTUS |
SUBJECT TO COMPLETION |
DATED AUGUST 9, 2022 |
Per Share |
Per Related Nine Warrants |
Total Without Over-Allotment Option |
Total With Over-Allotment Option |
|||||||||||||
Public offering price |
$ |
24.91 |
$ |
0.09 |
$ |
25,000,000 |
$ |
28,750,000 |
||||||||
Underwriting discounts (1) |
$ |
1.9928 |
$ |
0.0072 |
$ |
2,000,000 |
$ |
2,300,000 |
||||||||
Proceeds, before expenses, to us |
$ |
22.9172 |
$ |
0.0828 |
$ |
23,000,000 |
$ |
26,450,000 |
(1) |
See “Underwriting” on page 113 of this prospectus for a description of all underwriting compensation payable in connection with this offering. |
(2) |
The amount of offering proceeds to us presented in this table does not give effect to any exercise of the over-allotment option we have granted to the underwriter as described below. |
1 |
||||
13 |
||||
33 |
||||
34 |
||||
34 |
||||
34 |
||||
35 |
||||
36 |
||||
74 |
||||
86 |
||||
102 |
||||
103 |
||||
103 |
||||
109 |
||||
113 |
||||
113 |
||||
113 |
||||
118 |
||||
118 |
||||
118 |
||||
F-1 |
• | HVAC units and refrigerators in commercial buildings; |
• | control systems, heat exchangers, and compressors at process industry facilities; and |
• | wind turbines generating renewable energy at onshore wind farms. |
• | curbing wasted energy while improving occupant comfort in commercial facilities through AI-powered adaptive control; |
• | maximizing asset availability and production yields of renewable energy sources through continuous performance assessment and predictive maintenance; and |
• | optimizing the uptime and manage the operational risk of industrial process plants, including oil and gas facilities, through continuous AI-powered advisory and assistance to process operators in the field. |
• | not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, |
• | reduced disclosure obligations regarding executive compensation in periodic reports, proxy statements and registration statements, and |
• | exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. |
• | Quorum Requirement |
• | Shareholder Approval Requirements |
• | Depending on the context, the terms “we,” “us,” “our company,” and “our” refer to mCloud Technologies Corp., and its consolidated subsidiaries: |
• | “preferred shares” refer to our Series A Preferred Shares, no par value. |
• | all references to “CAD”, “CAD$” and “Canadian dollar” are to the legal currency of Canada, and all references to “USD,” “$”, “US$” and “U.S. dollars” are to the legal currency of the United States. |
Series A Preferred Shares |
1,000,000 Series A Preferred Shares on a firm commitment basis | |
Offering Price basis |
$25.00 per Series A Preferred Share and Warrant on a combined basis | |
Warrants |
Warrants to purchase up to 9,000,000 Common Shares, which are exercisable on the date of issuance and expire on November 29, 2026, at an exercise price per Common Share equal to $4.75. | |
Over-allotment Option to purchase additional Common Shares from us |
We have granted the underwriters an option to purchase an additional 150,000 Series A Preferred Shares and/or 1,350,000 Warrants to purchase additional Common Shares from us (being up to 15% of the Series A Preferred Shares, and/or up to 15% of the Warrants sold in this offering), in any combination thereof, at the public offering price per Series A Preferred Share and public offering price per Warrant, respectively, less the underwriting discounts and commissions, for 45 days from the date of this prospectus. | |
Number of Series A Preferred Shares issued and outstanding before this offering |
0 | |
Number of Series A Preferred Shares outstanding after this offering |
1,000,000 shares. | |
Number of Common Shares outstanding prior to offering |
16,155,654 shares. |
Liquidation Preference |
The liquidation preference of each Series A Preferred Share is $25.00 per share. Upon liquidation, holders of Series A Preferred Shares will be entitled to receive the liquidation preference with respect to their Series A Preferred Shares plus an amount equal to accumulated but unpaid dividends with respect to such shares. | |
Conversion |
The Series A Preferred Shares will be convertible into common Shares based on a conversion ratio of (i) the $25.00 per share liquidation preference divided by (ii) $2.75. Therefore, each Series A Preferred Share is convertible into nine Common Shares. Upon such a conversion, any declared but unpaid dividends shall be paid to the holder of Series A Preferred Shares in cash. In the event that the conversion would result in the issuance of fractional Common Shares, we will pay the holder the cash value of such fractional shares in lieu of such fractional shares based on a price of $2.75 per Common Share. | |
Dividends |
Subject to the preferential rights, if any, of the holders of any class or series of capital stock of the Company ranking senior to the Series A Preferred Shares as to dividends, the holders of the Series A Preferred Shares will be entitled to receive, when, as and if declared by the Board (or a duly authorized committee of the Board), only out of funds legally available for the payment of dividends, cumulative cash dividends at the annual rate of 9.0% of the $25.00 liquidation preference per year (equivalent to $2.25 per year) until the beginning of the fifth year, at which time the annual rate will increases 4.0% per calendar quarter until it reaches a maximum of 25.0%. Dividends on the Series A Preferred Shares will accumulate and be cumulative from, and including, the date of original issue by us of the Series A Preferred Shares. However, the Company will be entitled to defer the payment of any declared dividends on the Series A Preferred Shares until the occurrence of a liquidation or Board approved Change of Control of the Company. | |
Ranking |
The Series A Preferred Shares will rank, as to dividend rights and rights upon our liquidation, dissolution or winding up: (1) Senior to all classes or series of our common shares and to all other equity securities issued by us other than any equity securities issued with terms specifically providing that those equity securities rank on a parity with the Series A Preferred Shares; (2) Junior to any future equity securities issued by us with terms specifically providing that those equity securities rank senior to the Series A Preferred Shares with respect to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up; and (3) Effectively junior to all our existing and future indebtedness (including indebtedness convertible into our common shares or preferred shares) and to the indebtedness and other liabilities of (as well as any preferred equity interests held by others in) our existing or future subsidiaries. | |
No Maturity Date |
The Series A Preferred Shares are perpetual and have no maturity date, and we are not required to redeem the Series A Preferred Shares. Accordingly, all Series A Preferred Shares will remain outstanding indefinitely, unless and until they are redeemed or converted in accordance with their terms. | |
Preemptive Rights |
Holders of Series A Preferred Shares will have no preemptive rights. |
Voting Rights |
In any matter in which the Series A Preferred Shares may vote, as described below, each Series A Preferred Share shall be entitled to one vote per $25.00 of liquidation preference; provided that if the Series A Preferred Shares and any other stock ranking on parity to the Series A Preferred Shares as to dividend rights and rights as to the distribution of assets upon the Corporation’s liquidation, dissolution or winding up are entitled to vote together as a single class on any matter, the holders of each will vote in proportion to their respective liquidation preferences. So long as any Series A Preferred Shares remain outstanding, the Company will not, without the consent or the affirmative vote of the holders of at least two-thirds of the outstanding Series A Preferred Shares and each other class or series of preferred stock entitled to vote thereon (voting together as a single class), given in person or by proxy, either in writing without a meeting or by vote at any meeting called by the Company for the purpose:(i) authorize, create or issue, or increase the number of authorized or issued number of shares of, any class or series of capital stock ranking senior to the Series A Preferred Shares with respect to payment of dividends or the distribution of assets upon the liquidation, dissolution or winding up of the Company or reclassify any authorized capital stock of the Company into any such shares, or create, authorize or issue any obligation or security convertible into or evidencing the right to purchase any such shares; or (ii) amend, alter or repeal the provisions of the Articles of Incorporation, as amended, including the terms of the Series A Preferred Shares, whether by merger, consolidation, transfer or conveyance of all or substantially all of the Company’s assets or otherwise, so as to materially and adversely affect the rights, preferences, privileges or voting powers of the Series A Preferred Shares, taken as a whole. If any event described in paragraph (ii) above would materially and adversely affect the rights, preferences, privileges or voting powers of the Series A Preferred Shares, taken as a whole, disproportionately relative to any other class or series of voting preferred stock (as defined below), the affirmative vote of the holders of at least two-thirds of the outstanding shares of the Series A Preferred Shares, voting as a separate class, will also be required. Furthermore, if holders of shares of the Series A Preferred Shares receive the $25.00 per share of the Series A Preferred Shares liquidation preference plus all declared and unpaid dividends thereon or greater amounts pursuant to the occurrence of any of the events described in paragraph (ii) above, then such holders shall not have any voting rights with respect to the events described in such paragraph. As used herein, “voting preferred stock” means any other class or series of the Company’s preferred stock ranking equally with the Series A Preferred Shares as to dividends (whether cumulative or non-cumulative) and the distribution of the Company’s assets upon liquidation, dissolution or winding up and upon which like voting rights to the Series A Preferred Shares have been conferred and are exercisable. | |
Use of Proceeds |
We intend to use the proceeds from this offering for working capital and general corporate purposes, including retiring convertible debenture debt that was due June 30, 2022. See “Use of Proceeds” for more information. |
Restrictions on Dividends, Redemption and Repurchases |
So long as any Series A Preferred Share remains outstanding, unless we also have either paid or declared and set apart for payment full cumulative dividends on the Series A Preferred Shares for all past completed dividend periods, we will not during any dividend period: (1) pay or declare and set apart for payment any dividends or declare or make any distribution of cash or other property on Common Shares or other capital stock that ranks junior to or on parity with the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up (other than, in each case, (a) a dividend paid in Common Shares or other stock ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up or (b) any declaration of a Common Share dividend in connection with any stockholders’ rights plan, or the issuance of rights, stock or other property under any stockholders’ rights plan, or the redemption or repurchase of rights pursuant to such plan); (2) redeem, purchase or otherwise acquire Common Shares or other capital stock that ranks junior to or on parity with the Series A Preferred Shares (other than the Series A Preferred Shares) with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up (other than (a) by conversion into or exchange for Common Shares or other capital stock ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up, (b) the redemption of shares of capital stock pursuant to the provisions of our memorandum of articles, as amended, relating to the restrictions upon ownership and transfer of our capital stock, (c) a purchase or exchange offer made on the same terms to holders of all outstanding A Preferred Shares and any other capital stock that ranks on parity with the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up, (d) purchases, redemptions or other acquisitions of shares of our capital stock ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up pursuant to any employment contract, dividend reinvestment and stock purchase plan, benefit plan or other similar arrangement with or for the benefit of employees, officers, directors, consultants or advisors, (e) through the use of the proceeds of a substantially contemporaneous sale of stock ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up, or (f) purchases or other acquisitions of shares of our capital stock pursuant to a contractually binding stock repurchase plan existing prior to the preceding Dividend Payment Date on which dividends were not paid in full); or (3) redeem, purchase or otherwise acquire Series A Preferred Shares (other than (a) by conversion into or exchange for Common Shares or other capital stock ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon our voluntary or involuntary liquidation, dissolution or winding up, (b) a purchase or exchange offer made on the same terms to holders of all outstanding Series A Preferred Shares or (c) with respect to redemptions, a redemption pursuant to which all Series A Preferred Shares are redeemed). |
Optional Redemption |
The Series A Preferred Shares are not redeemable prior to [ ], which is the first anniversary of the closing date of this offering, except for the circumstances described under “Special Optional Redemption.” On or after [ ], the Series A Preferred Shares may be redeemed at our option, in whole or in part, from time to time, at a redemption price of $25.00 per Series A Preferred Share, plus all dividends accumulated and unpaid (whether or not declared) on the Series A Preferred Shares up to, but not including, the date of such redemption, upon the giving of notice. | |
Special Optional Redemption |
Upon the occurrence of any Delisting Event, Change of Control, or $8 VWAP Event, whether before or after [ ], we may, at our option, redeem the Series A Preferred Stock, in whole or in part and within 90 days after the date of the Delisting Event, Change of Control or $8 VWAP Event, by paying $25.00 per share of Series A Preferred Stock, plus all dividends accumulated and unpaid (whether or not declared) on the Series A Preferred Stock up to, but not including, the date of such redemption. | |
A “Delisting Event” occurs when, after the original issuance of Series A Preferred Stock, both (i) the shares of Series A Preferred Stock are no longer listed on Nasdaq, the New York Stock Exchange (the “NYSE”) or the NYSE American LLC (“NYSE AMER”), or listed or quoted on an exchange or quotation system that is a successor to Nasdaq, the NYSE or the NYSE AMER, and (ii) the Company not subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), but any Series A Preferred Stock is still outstanding. | ||
A “Change of Control” occurs when, after the original issuance of the Series A Preferred Stock, the following have occurred and are continuing: (a) any person or persons acting together which would constitute a “group” for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), (other than the Company or any subsidiary of the Company) shall beneficially own (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, at least 25% of the total voting power of all classes of capital stock of the Company entitled to vote generally in the election of the Board; (b) Current Directors (as herein defined) shall cease for any reason to constitute at least a majority of the members of the Board (for this purpose, a “Current Director” shall mean any member of the Board as of the date hereof and any successor of a Current Director whose election, or nomination for election by the Company’s shareholders, was approved by at least a majority of the Current Directors then on the Board); (c) (i) the complete liquidation of the Company or (ii) the merger or consolidation of the Company, other than a merger or consolidation in which (x) the holders of the common stock of the Company immediately prior to the consolidation or merger have, directly or indirectly, at least a majority of the common stock of the continuing or surviving corporation immediately after such consolidation or merger or (y) the Board immediately prior to the merger or consolidation would, immediately after the merger or consolidation, constitute a majority of the board of directors of the continuing or surviving corporation, which liquidation, merger or consolidation has been approved by the shareholders of the Company; or (d) the sale or other disposition (in one transaction or a series of transactions) of all or substantially all of the assets of the Company pursuant to an agreement (or agreements) which has (have) been approved by the shareholders of the Company. |
An “$8 VWAP Event” occurs when, after the original issuance of Series A Preferred Stock, the volume weighted average price of the Common Shares on the Nasdaq Capital Market for five consecutive trading days (as reported by Bloomberg L.P. based on a trading day from 9:30 a.m. to 4:02 p.m. (New York City time)) is at least $8.00. | ||
Redemption Upon Request of Holder in Connection with Change of Control: |
Upon the occurrence of a Board Approved Change of Control, holders of our Series A Preferred Shares may (i) require us to redeem their shares of our Series A Preferred Shares at a per share redemption price of $25.00, plus declared and unpaid dividends to, but excluding, the effective date of the Change of Control, or (ii) continue to hold our Series A Preferred Shares (subject to the Company’s option to redeem the Series A Preferred Shares as set forth above). | |
Segregated Dividend Payment Account |
The Company shall establish a segregated account that will be funded at closing of the offering with proceeds in an amount equal to nine (9) months of dividends on the maximum number of Series A Preferred Shares. The segregated account may only be used to pay dividends declared on the Series A Preferred Shares, when legally permitted, and may not be used for other corporate purposes. | |
Listing |
We are in the process of applying to have the Series A Preferred Shares listed on Nasdaq under the symbol “MCLDP.” There is no assurance that our listing application will be approved. Our Warrants will trade on the Nasdaq along with the Listed Warrants under the symbol “MCLDW.” Our Common Shares are listed on Nasdaq under the symbol “MCLD” and our Listed Warrants are listed under the symbol “MCLDW.” Our Common Shares are also listed on the TSXV under the symbol “MCLD”. | |
Risk Factors |
Investing in these securities involves a high degree of risk. |
Year ended December 31, |
||||||||||||||||
Three months ended March 31, 2022 |
2021 |
2020 |
2019 |
|||||||||||||
Revenue |
$ | 4,429,603 | $ | 25,596,972 | $ | 26,928,439 | $ | 18,340,249 | ||||||||
Cost of sales |
(1,932,356 | ) | (9,683,748 | ) | (10,281,922 | ) | (7,583,127 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit |
$ | 2,497,247 | $ | 15,913,224 | $ | 16,646,517 | $ | 10,757,122 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Expenses |
||||||||||||||||
Salaries, wages and benefits |
5,314,330 | 21,691,774 | 20,885,044 | 10,313,803 | ||||||||||||
Sales and marketing |
762,231 | 1,377,255 | 1,536,420 | 3,166,788 | ||||||||||||
Research and development |
531,950 | 3,179,353 | 1,078,164 | 498,099 | ||||||||||||
General and administration |
2,552,013 | 8,538,854 | 5,741,872 | 3,294,550 | ||||||||||||
Professional and consulting fees |
3,176,043 | 9,085,436 | 8,886,341 | 4,351,812 | ||||||||||||
Share-based compensation |
252,933 | 1,867,915 | 1,454,235 | 1,468,361 | ||||||||||||
Depreciation and amortization |
1,943,213 | 8,924,812 | 6,778,100 | 4,044,143 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total expenses |
$ | 14,532,713 | $ | 54,665,399 | $ | 46,360,176 | $ | 27,137,556 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating loss |
$ | 12,035,466 | $ | 38,752,175 | $ | 29,713,659 | $ | 16,380,434 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Other expenses (income) |
||||||||||||||||
Finance costs |
1,858,637 | 8,618,794 | 6,033,510 | 3,217,500 | ||||||||||||
Foreign exchange loss (gain) |
622,509 | (267,294 | ) | 1,198,372 | 494,404 | |||||||||||
Business acquisition costs and other expenses |
— | 346,420 | 1,811,682 | 9,880,170 | ||||||||||||
Impairment |
— | — | — | 600,657 | ||||||||||||
Fair value loss on derivatives |
(2,493,270 | ) | 6,040,121 | — | — | |||||||||||
Other income |
(398,268 | ) | (7,126,097 | ) | (2,932,342 | ) | (167,913 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before tax |
$ | 11,625,074 | $ | 46,364,119 | $ | 35,824,881 | $ | 30,405,252 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Current tax expense (recovery) |
288,863 | 157,303 | (295,709 | ) | 181,895 | |||||||||||
Deferred tax (recovery) expense |
(890,816 | ) | (1,822,109 | ) | (668,209 | ) | (2,692,313 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss for the year |
11,023,121 |
$ |
44,699,313 |
$ |
34,860,963 |
$ |
27,894,834 |
|||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive (income) loss |
||||||||||||||||
Foreign subsidiary translation differences |
(649,089 | ) | 69,460 | (1,209,006 | ) | (607,302 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Comprehensive loss for the year |
$ |
10,374,032 |
$ |
44,768,773 |
$ |
33,651,957 |
$ |
27,287,532 |
||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss (income) for the year attributable to: |
||||||||||||||||
mCloud Technologies Corp. shareholders |
9,777,570 | 44,329,707 | 36,870,267 | 29,839,342 | ||||||||||||
Non-controlling interest |
1,245,551 | 369,606 | (2,009,304 | ) | (1,944,508 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
$11,023,121 |
$44,699,313 |
$ 34,860,963 |
$27,894,834 |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Comprehensive loss (income) for the year attributable to: |
||||||||||||||||
mCloud Technologies Corp. shareholders |
9,147,568 | 44,427,305 | 35,563,921 | 29,431,628 | ||||||||||||
Non-controlling interest |
1,226,464 | 341,468 | (1,911,964 | ) | (2,144,096 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
$10,374,032 |
$44,768,773 |
$ 33,651,957 |
$27,287,532 |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss per share attributable to mCloud shareholders – basic and diluted |
$ |
0.61 |
$ |
3.73 |
$ |
5.07 |
$ |
7.30 |
||||||||
Weighted average number of common shares outstanding basic and diluted |
16,147,560 |
11,898,183 |
7,272,464 |
4,085,322 |
||||||||||||
|
|
|
|
|
|
|
|
March 31, 2022 |
December 31, 2021 |
December 31, 2020 |
December 31, 2019 |
|||||||||||||
ASSETS |
||||||||||||||||
Current assets |
||||||||||||||||
Cash and cash equivalents |
$ | 1,873,021 | $ | 4,588,057 | $ | 1,110,889 | 529,190 | |||||||||
Trade and other receivables |
13,736,106 | 14,566,975 | 12,312,814 | 9,091,654 | ||||||||||||
Current portion of prepaid expenses and other assets |
2,287,443 | 2,355,350 | 1,326,319 | 839,012 | ||||||||||||
Current portion of long-term receivables |
471,909 | 397,060 | 445,213 | 378,221 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total current assets |
$ | 18,368,479 | $ | 21,907,442 | $ | 15,195,235 | $ | 10,838,077 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Non-current assets |
||||||||||||||||
Prepaid expenses and other assets |
165,698 | 622,577 | 1,011,847 | 86,913 | ||||||||||||
Long-term receivables |
992,732 | 343,371 | 2,091,059 | 1,586,429 | ||||||||||||
Right-of-use |
7,033,377 | 916,028 | 3,660,717 | 4,206,808 | ||||||||||||
Property and equipment |
564,253 | 649,403 | 506,387 | 710,552 | ||||||||||||
Intangible assets |
18,923,489 | 20,585,833 | 27,766,839 | 23,671,089 | ||||||||||||
Goodwill |
27,042,823 | 27,081,795 | 27,086,727 | 18,758,975 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total non-current assets |
54,722,372 | $ | 50,199,007 | $ | 62,123,576 | 49,020,766 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total assets |
73,090,851 |
$ |
72,106,449 |
$ |
77,318,811 |
59,858,843 |
||||||||||
|
|
|
|
|
|
|
|
|||||||||
LIABILITIES |
||||||||||||||||
Current liabilities |
||||||||||||||||
Bank indebtedness |
4,710,549 | $ | 3,460,109 | $ | 976,779 | 1,471,805 | ||||||||||
Trade payables and accrued liabilities |
17,079,919 | 12,421,309 | 12,924,256 | 9,636,405 | ||||||||||||
Deferred revenue |
4,694,450 | 2,811,408 | 1,771,120 | 1,138,281 | ||||||||||||
Current portion of loans and borrowings |
12,480,038 | 12,447,939 | 3,431,251 | 3,004,717 | ||||||||||||
Current portion of convertible debentures |
22,922,383 | 22,185,170 | — | — | ||||||||||||
Warrant liabilities |
6,060,782 | 8,880,038 | 710,924 | 725,086 | ||||||||||||
Current portion of lease liabilities |
453,855 | 410,674 | 835,472 | 720,457 | ||||||||||||
Current portion of other liabilities |
— | — | 6,003,838 | |||||||||||||
Current portion of business acquisition payable |
1,389,094 | 1,398,972 | 1,594,297 | 1,043,314 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total current liabilities |
69,791,070 | $ | 64,015,619 | $ | 28,247,937 | 17,740,065 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Non-current liabilities |
||||||||||||||||
Convertible debentures |
111,411 | 110,540 | 19,534,988 | 17,535,946 | ||||||||||||
Lease liabilities |
6,773,990 | 634,798 | 3,109,604 | 3,641,627 | ||||||||||||
Loans and borrowings |
646,137 | 767,662 | 9,721,049 | 10,968,338 | ||||||||||||
Deferred income tax liabilities |
1,407,503 | 2,291,057 | 4,168,905 | 3,854,614 | ||||||||||||
Other liabilities |
— | — | 232,577 | |||||||||||||
Business acquisition payable |
— | — | 845,232 | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities |
78,730,111 |
$ |
67,819,676 |
$ |
65,860,292 |
53,740,590 |
||||||||||
|
|
|
|
|
|
|
|
|||||||||
EQUITY |
||||||||||||||||
Share capital |
118,275,850 | 118,195,363 | 83,120,611 | 45,368,745 | ||||||||||||
Contributed surplus |
11,408,263 | 11,040,751 | 8,518,476 | 7,278,119 | ||||||||||||
Accumulative other comprehensive income |
2,202,000 | 1,571,998 | 1,669,596 | 363,250 | ||||||||||||
Deficit |
(139,793,643 | ) | (130,016,073 | ) | (85,686,366 | ) | (48,816,099 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total shareholders’ equity |
(7,907,530 | ) | $ | 792,039 | $ | 7,622,317 | 4,194,015 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Non-controlling interest |
2,268,270 | 3,494,734 | 3,836,202 | 1,924,238 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total equity |
$ |
(5,639,260 |
) |
$ |
4,286,773 |
$ |
11,458,519 |
6,118,253 |
||||||||
|
|
|
|
|
|
|
|
|||||||||
Total liabilities and equity |
$ |
73,090,851 |
$ |
72,106,449 |
$ |
77,318,811 |
59,858,843 |
|||||||||
|
|
|
|
|
|
|
|
• | As a company primarily based outside of the United States, our business is subject to economic, political, regulatory and other risks associated with international operations. |
• | mCloud may be unable to identify and complete suitable platform acquisitions and acquisitions in its existing vertical markets. |
• | Potential acquisitions could be difficult to consummate and integrate into mCloud’s operations, and they and investment transactions could disrupt mCloud’s business, dilute stockholder value or impair mCloud’s financial results. |
• | The loss of one or more of mCloud’s key personnel, or its failure to attract and retain other highly qualified personnel in the future, could harm its business. |
• | We may acquire contingent liabilities through acquisitions that could adversely affect mCloud’s operating results. |
• | Acquisitions, investments, joint ventures and other business ventures may negatively affect mCloud’s operating results. |
• | We may not be able to protect our intellectual property rights, which could make us less competitive and cause us to lose market share. The loss of our rights to use technology currently licensed by third parties could increase operating expenses by forcing us to seek alternative technology and adversely affect our ability to compete. |
• | If mCloud is not able to maintain and enhance the AssetCare brand, or if events occur that damage the AssetCare reputation and brand, mCloud’s ability to expand its base of users may be impaired, which could adversely affect mCloud’s business and financial results. |
• | Because we are a corporation incorporated in British Columbia and some of our directors and officers are resident in Canada, it may be difficult for investors in the United States to enforce civil liabilities against us based solely upon the federal securities laws of the United States. Similarly, it may be difficult for Canadian investors to enforce civil liabilities against our directors and officers residing outside of Canada. |
• | failure to realize anticipated returns on investment, cost savings and synergies; |
• | difficulty in assimilating the operations, policies, and personnel of the acquired company; |
• | unanticipated costs associated with acquisitions; |
• | challenges in combining product offerings and entering into new markets in which we may not have experience; |
• | distraction of management’s attention from normal business operations; |
• | potential loss of key employees of the acquired company; |
• | difficulty implementing effective internal controls over financial reporting and disclosure controls and procedures; |
• | impairment of relationships with customers or suppliers; |
• | possibility of incurring impairment losses related to goodwill and intangible assets; and |
• | other issues not discovered in due diligence, which may include product quality issues or legal or other contingencies. |
• | the usefulness, ease of use, performance, and reliability of mCloud’s products compared to its competitors; |
• | the size and composition of mCloud’s user base; |
• | the engagement of mCloud’s users with its products; |
• | the timing and market acceptance of mCloud’s products, including developments and enhancements, or similar improvements by its competitors; |
• | mCloud’s ability to monetize its products, including its ability to successfully monetize AssetCare; |
• | customer service and support efforts; |
• | marketing and selling efforts; |
• | mCloud’s financial condition and results of operations; |
• | changes mandated by legislation, regulatory authorities, or litigation, including settlements and consent decrees, some of which may have a disproportionate effect on mCloud; |
• | acquisitions or consolidation within mCloud’s industry, which may result in more formidable competitors; |
• | mCloud’s ability to attract, retain, and motivate talented employees, particularly computer engineers; |
• | mCloud’s ability to cost-effectively manage and grow its operations; and |
• | the mCloud reputation and brand strength relative to competitors. |
• | actual or anticipated quarterly fluctuations in its financial results and financial condition; |
• | changes in financial estimates or publication of research reports and recommendations by financial analysts with respect to it or other financial institutions; |
• | reports in the press or investment community generally or relating to mCloud’s reputation or the industry in which it operates; |
• | strategic actions by mCloud or its competitors, such as acquisitions, restructurings, dispositions, or financings; |
• | fluctuations in the stock price and financial results of mCloud’s competitors; |
• | future sales of mCloud’s equity or equity-related securities; |
• | proposed or adopted regulatory changes or developments; |
• | domestic and international economic factors unrelated to mCloud’s performance; and |
• | general market conditions and, in particular, developments related to market conditions for the remote asset management industry. |
• | the timing of the development of future services, |
• | projections of revenue, earnings, capital structure and other financial items, |
• | statements regarding the capabilities of our business operations, |
• | statements of expected future economic performance, |
• | statements regarding competition in our market, and |
• | assumptions underlying statements regarding us or our business. |
Year Ended |
Period End |
|||
December 31, 2019 |
$ | 1.2988 | ||
December 31, 2020 |
$ | 1.2732 | ||
December 31, 2021 |
$ | 1.2678 | ||
March 31, 2022 |
$ | 1.2482 |
• | On an actual basis, as determined in accordance with IFRS; and |
• | On an as adjusted basis to reflect the issuance and sale by us of 1,000,000 Series A Preferred Shares and warrants to purchase up to 9,000,000 Common Shares at an assumed combined public offering price of $25.00 per Series A Preferred Share and related Warrants, assuming no exercise of the Warrants and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us. |
As of March 31, 2022 |
||||||||||||
Actual | Pro forma Adjustments |
Pro Forma As Adjusted |
||||||||||
Cash and Cash Equivalents |
$ | 1,873,021 | 5,000,525 | (1) |
$ | 6,873,546 | ||||||
Current portion of loans and borrowings |
12,480,038 | |
— |
|
12,480,038 | |||||||
Current portion of convertible debentures |
22,922,383 | |
(22,922,383 |
) |
— | |||||||
Warrant Liabilities |
6,060,782 | — | (2) |
6,060,782 | ||||||||
Long term convertible debentures |
111,411 | — | 111,411 | |||||||||
Loans and borrowings |
646,137 | — | 646,137 | |||||||||
Equity |
||||||||||||
Common shares, no par value; unlimited number of shares authorized, shares issued and outstanding, actual; unlimited number of shares authorized, 16,151,500 shares issued and outstanding, 9.0% Series A Cumulative Perpetual Preferred Shares of the Company, without par value; 1,000,000 shares issued and outstanding (3) |
||||||||||||
Equity Share Capital |
$ | 118,275,850 | 28,740,800 | (2) |
147,016,650 | |||||||
Contributed Surplus |
$ | 11,408,263 | — | 11,408,263 | ||||||||
Accumulated Other Comprehensive Income |
$ | 2,202,000 | — | 2,202,000 | ||||||||
Deficit |
$ | (139,793,643 | ) | (535,117 | ) | (140,328,760 | ) | |||||
Total Shareholders Deficit |
$ | (7,907,530 | ) | $ | 28,205,683 | $ | 20,298,153 | |||||
Total Deficit |
$ | (5,639,260 | ) | $ | 28,205,683 | $ | 22,566,423 | |||||
(1) | The pro forma adjustment to Cash and Cash Equivalents reflects the increase in cash after payment of the principal value of the convertible debenture and the related accrued interest at March 31, 2022. |
(2) | The amount to be attributed to the warrants has not yet been determined, and has been included in the amount attributed to Equity Share Capital. Upon issuance of the Series A Preferred Shares and Warrants, the total net proceeds will be allocated to Equity Share Capital and Warrant Liabilities. |
(3) | Assumes adoption of the Rights and Restrictions for 9.0% Cumulative Series A Preferred Shares, which was adopted subsequent to March 31, 2022. |
The above discussion and table is based on 16,150,100 Common Shares outstanding as of March 31, 2022, and do not include, as of that date: |
• | 1,136,141 Common Shares issuable upon exercise of Listed Warrants; |
• | 7,529,274 Common Shares issuable upon exercise of Non-Listed Warrants; |
• | 806,734 Common Shares issuable upon exercise of Options |
• | 213,293 Common Shares issuable upon exercise of Restricted Share Units; |
• | 1,579,583 Common Shares issuable upon exercise of Convertible Debt; and |
• | An ineffective control environment resulting from an insufficient number of trained financial reporting and accounting, information technology (IT) and operational personnel with the appropriate skills and knowledge and with assigned responsibility and accountability related to the design, implementation and operating effectiveness of internal control over financial reporting. |
• | The insufficient number of personnel described above contributed to an ineffective risk assessment process necessary to identify all relevant risks of material misstatement and to evaluate the implications of relevant risks on its internal control over financial reporting. |
• | An ineffective information and communication process resulting from (i) insufficient communication of internal control information, including objectives and responsibilities, such as delegation of authority; and (ii) ineffective general IT controls and ineffective controls related to spreadsheets, resulting in insufficient controls to ensure the relevance, timeliness and quality of information used in control activities. |
• | As a consequence of the above and as a result of inadequate segregation of duties and secondary review, the Company had ineffective control activities related to the design, implementation and operating effectiveness of process level and financial reporting controls which had a pervasive impact on the Company’s internal control over financial reporting. |
• | An ineffective monitoring process resulting from the evaluation and communication of internal control deficiencies, including monitoring corrective actions, not being performed in a timely manner. |
• | Identifying key positions necessary to support the Company’s initiatives related to internal controls over financial reporting, and expanding its hiring efforts accordingly. |
• | Hiring consultants to assist with process improvements and control remediation efforts in targeted accounting, IT and operations processes. |
• | Formalizing its entity-wide risk assessment process, and documenting internal ownership of risk monitoring and mitigation efforts, with improved risk monitoring activities and regular reporting to those charged with governance at an appropriate frequency. |
• | Finalize a delegation of authority matrix to enforce desired limits of authority for key transactions, events, and commitments, and communicating these limits of authority to relevant personnel throughout the Company. |
• | Further simplify and streamline its spreadsheet models to reduce the risk of errors in mathematical formulas and improve the ability to verify the logic of spreadsheets. |
• | Hiring a consultant to assist management with process improvements and control remediation for general IT controls. |
• | Continuing to perform scoping exercises and planning for an ERP implementation to streamline the number of applications used for financial reporting activities. |
Years ended December 31 |
2021 |
2020 |
2019 |
|||||||||
Revenues |
$ | 25.597 | $ | 26.928 | $ | 18.340 | ||||||
Gross profit |
15.913 | 16.647 | $ | 10.757 | ||||||||
Total expenses |
54.665 | 46.360 | $ | 27.138 | ||||||||
Other expenses (income) |
5.947 | 5.148 | $ | 11.514 | ||||||||
Net loss |
44.699 | 34.861 | $ | 27.895 | ||||||||
Loss per share attributable to mCloud shareholders – basic and diluted |
3.73 | $ | 5.07 | $ | 2.43 | |||||||
Total assets |
72.106 | $ | 77.319 | $ | 59.859 | |||||||
Total non-current financial liabilities |
1.513 | $ | 33.443 | $ | 32.146 |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 Change % |
2020 vs 2019 Change $ |
2020 vs 2019 Change % |
||||||||||||||||||||||
Revenue |
$ | 25.597 | $ | 26.928 | $ | 18.340 | $ | (1.331 | ) | (5 | )% | $ | 8.588 | 47 | % | |||||||||||||
Cost of Sales |
(9.684 | ) | (10.282 | ) | (7.583 | ) | 0.598 | (6 | )% | (2.699 | ) | 36 | % | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Gross Profit |
$ |
15.913 |
$ |
16.647 |
$ |
10.757 |
$ |
(0.733 |
) |
(4 |
) % |
$ |
5.890 |
55 |
% | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Expenses |
||||||||||||||||||||||||||||
Salaries, wages and benefits |
$ | 21.692 | $ | 20.885 | $ | 10.314 | $ | 0.807 | 4 | % | $ | 10.571 | 102 | % | ||||||||||||||
Sales and marketing |
1.377 | 1.536 | 3.167 | (0.159 | ) | (10 | )% | (1.631 | ) | (51 | )% | |||||||||||||||||
Research and development |
3.179 | 1.078 | 0.498 | 2.101 | 195 | % | 0.580 | 116 | % | |||||||||||||||||||
General and administrative |
8.539 | 5.742 | 3.295 | 2.797 | 49 | % | 2.447 | 74 | % | |||||||||||||||||||
Professional and consulting fees |
9.085 | 8.886 | 4.352 | 0.199 | 2 | % | 4.534 | 104 | % | |||||||||||||||||||
Share-based compensation |
1.868 | 1.454 | 1.468 | 0.414 | 28 | % | (0.014 | ) | (1 | )% | ||||||||||||||||||
Depreciation and amortization |
8.925 | 6.778 | 4.044 | 2.147 | 32 | % | 2.734 | 68 | % | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total expenses |
$ | 54.665 | $ | 46.360 | $ | 27.138 | $ | 8.305 | 18 | % | $ | 19.222 | 71 | % | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Operating loss |
$ |
38.752 |
$ |
29.714 |
$ |
16.380 |
$ |
9.039 |
30 |
% |
$ |
13.334 |
81 |
% | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Other Expenses (income) |
||||||||||||||||||||||||||||
Finance costs |
$ | 8.619 | $ | 6.034 | $ | 3.218 | $ | 2.585 | 43 | % | $ | 2.816 | 88 | % | ||||||||||||||
Foreign exchange loss (gain) |
(0.267 | ) | 1.198 | 0.494 | (1.466 | ) | (122 | )% | 0.704 | 143 | % | |||||||||||||||||
Impairment |
— | — | 0.601 | (0.601 | ) | (100 | )% | |||||||||||||||||||||
Business acquisition costs and other expenses |
0.346 | 1.812 | 9.880 | (1.465 | ) | (81 | )% | (8.068 | ) | (82 | )% | |||||||||||||||||
Fair value loss on derivatives |
6.040 | — | — | 6.040 | 100 | % | — | — | % | |||||||||||||||||||
Other income |
(7.126 | ) | (2.932 | ) | (0.168 | ) | (4.194 | ) | 143 | % | (2.764 | ) | 1645 | % | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Loss before tax |
$ |
46.364 |
$ |
35.825 |
$ |
30.405 |
$ |
10.539 |
29 |
% |
$ |
5.420 |
18 |
% | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Current tax expense (recovery) |
$ | 0.157 | $ | (0.296 | ) | $ | (0.182 | ) | $ | 0.453 | (153 | )% | $ | (0.114 | ) | 63 | % | |||||||||||
Deferred tax (recovery) expense |
(1.822 | ) | (0.668 | ) | 2.692 | (1.154 | ) | 173 | % | (3.360 | ) | (125 | )% | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net loss for the period |
$ |
44.699 |
$ |
34.861 |
$ |
27.895 |
$ |
9.838 |
28 |
% |
$ |
6.966 |
25 |
% | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Major Service Line |
2021 |
2020 |
2019 |
2021 vs 2020 Chabrnge $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
|||||||||||||||||||||
AssetCare Initialization |
$ | 1.250 | $ | 7.689 | $ | 5.965 | $ | (6.439 | ) | (84 | )% | $ | 1.724 | 29 | % | |||||||||||||
AssetCare Over Time |
23.462 | 12.809 | 2.940 | 10.653 | 83 | % | 9.869 | 336 | % | |||||||||||||||||||
Engineering Services |
0.885 | 6.430 | 9.436 | (5.545 | ) | (86 | )% | (3.005 | ) | (32 | )% | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ |
25.597 |
$ |
26.928 |
$ |
18.340 |
$ |
(1.331 |
) |
(5 |
)% |
$ |
8.588 |
47 |
% | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Timing of revenue recognition |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
|||||||||||||||||||||
Revenue recognized over time |
$ | 24.423 | $ | 18.551 | $ | 12.375 | $ | 5.872 | 32 | % | $ | 6.176 | 50 | % | ||||||||||||||
Revenue recognized at point in time upon completion |
1.174 | 8.377 | 5.965 | (7.202 | ) | (86 | )% | 2.412 | 40 | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ |
25.597 |
$ |
26.928 |
$ |
18.340 |
$ |
(1.331 |
) |
(5 |
)% |
$ |
8.588 |
47 |
% | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, | ||||||||||||
2021 |
2020 |
2019 |
||||||||||
Canada |
$ | 10.734 | $ | 13.833 | $ | 10.890 | ||||||
United States |
6.564 | 5.691 | 7.451 | |||||||||
Japan |
5.850 | 6.447 | — | |||||||||
Australia |
0.994 | 0.152 | — | |||||||||
Other |
1.455 | 0.805 | — | |||||||||
|
|
|
|
|
|
|||||||
Total revenue |
$ |
25.597 |
$ |
26.928 |
$ |
18.341 |
||||||
|
|
|
|
|
|
2021 |
2020 |
2019 |
||||||||||
Customer A |
Less than 10 | % | 13.6 | % | n/a | |||||||
Customer B |
Less than 10 | % | 13.1 | % | 11.0 | % | ||||||
Customer C |
11.3 | % | Less than 10 | % | 20.0 | % | ||||||
Customer D |
10.7 | % | Less than 10 | % | n/a |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
||||||||||||||||||||||
Cost of Sales |
$ | 9.684 | $ | 10.282 | $ | 7.583 | $ | (0.598 | ) | (6 | )% | $ | 2.699 | 36 | % | |||||||||||||
Gross Profit |
15.913 | 16.647 | 10.757 | (0.733 | ) | (4 | )% | 5.890 | 55 | % | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Gross Margin % |
62.2 |
% |
61.8 |
% |
58.6 |
% |
1 |
% |
3 |
% | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
Expenses |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
|||||||||||||||||||||
Salaries, wages and benefits |
$ | 21.692 | $ | 20.885 | $ | 10.314 | $ | 0.807 | 4 | % | $ | 10.571 | 102 | % | ||||||||||||||
Sales and marketing |
1.377 | 1.536 | 3.167 | (0.159 | ) | (10 | )% | (1.631 | ) | (51 | )% | |||||||||||||||||
Research and development |
3.179 | 1.078 | 0.498 | 2.101 | 195 | % | 0.580 | 116 | % | |||||||||||||||||||
General and administration |
8.539 | 5.742 | 3.295 | 2.797 | 49 | % | 2.447 | 74 | % | |||||||||||||||||||
Professional and consulting fees |
9.085 | 8.886 | 4.352 | 0.199 | 2 | % | 4.534 | 104 | % | |||||||||||||||||||
Share-based compensation |
1.868 | 1.454 | 1.468 | 0.414 | 28 | % | (0.014 | ) | — | % | ||||||||||||||||||
Depreciation and amortization |
8.925 | 6.778 | 4.044 | 2.147 | 32 | % | 2.734 | 68 | % | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ |
54.665 |
$ |
46.360 |
$ |
27.138 |
$ |
8.305 |
18 |
% |
$ |
19.222 |
71 |
% | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
• | General and administration expenses, which typically consist of public company fees, bad debt expense, rent expense, and recruitment costs, increased by 49% or $2.797 million in 2021 compared to 2020, primarily due to an increase in the loss allowance of $1.162 million related to uncollectible receivables, and $1.000 million associated with the Company’s NASDAQ listing, combined with costs associated with a full year of the Company’s ownership of its kanepi subsidiary that were not present in the year ended December 31, 2020. General and administration expenses increased by 74% or $2.447 million for the year ended December 31, 2020 compared to the year ended December 31, 2019, primarily due to facilities and overhead costs associated with a full year of ownership of its subsidiaries including mCloud Technologies Services (“MTS”), acquired in Q3 2019, Construction Systems Associates, Inc. USA (“CSA”), acquired in Q1 2020, and kanepi, acquired in Q4 2020. |
• | Depreciation and amortization expenses increased by 32% or $2.147 million in 2021 compared to 2020, attributable to a full year of amortization of intangibles acquired through business and asset acquisitions in Fiscal 2020. Depreciation and amortization expenses increased by 68% or $2.734 million in 2020 compared to 2019, due to amortization of intangibles assets acquired through acquisitions of Agnity, MTS and CSA. |
• | The Company’s customers use its software to monitor their assets and rely on the Company to provide updates and releases as part of its software maintenance and support services. While the Company has not developed a formal research and development policy, the Company is and has been engaged with a number of research and development initiatives as a part of its ongoing effort to continually update its software and develop new products. Research and development expenses increased by $2.101 million in 2021 compared to 2020, due to ongoing development and investments in AssetCare Mobile, IAQ Badge and 3D technologies. Research and development expenses increased by $0.580 million in 2020 compared to 2019, due to the development of AssetCare project investments. |
• | Professional and consulting expenses increased by $0.199 million in 2021 compared to 2020, due to the Company retaining more consultants for various accounting and professional service functions that were previously performed by employees in 2020, combined with the costs associated with a full year of the Company’s ownership of its kanepi subsidiary. Professional and consulting expenses increased by $4.534 million in 2020 compared to 2019, attributable to professional legal and advisory, as well as accounting and valuation services related to business acquisitions and financings completed during the year. |
• | For the year ended December 31, 2021, salaries, wages and benefits were flat year over year, compared to the same period in 2020. Salaries, wages and benefits increased by 102% or $10.571 million in 2020 compared to 2019, due to higher headcount attributable to acquisitions of CSA and kanepi, combined with added personnel in the asset purchase of AirFusion. |
• | The above noted increases were partially offset by a decrease in the Company’s sales and marketing costs by 10% or $0.159 million due to lower marketing spending early in 2021, as the pandemic curtailed industry activity and the Company elected to spend less. This decrease in spending was partially offset by the mCloud Connect event that took place in 2021. For the year ended December 31, 2020, sales and marketing decreased by 51% or $1.631 million compared to the same period in 2019, due to the curtailment of activities attributable to ongoing COVID-19 restrictions. |
Expenses |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
|||||||||||||||||||||
Salaries, wages and benefits |
$ | 21.692 | $ | 20.885 | $ | 10.314 | $ | 0.807 | 4 | % | $ | 10.571 | 102 | % | ||||||||||||||
Sales and marketing |
1.377 | 1.536 | 3.167 | (0.159 | ) | (10) | % | (1.631 | ) | (51) | % | |||||||||||||||||
Research and development |
3.179 | 1.078 | 0.498 | 2.101 | 195 | % | 0.580 | 116 | % | |||||||||||||||||||
General and administration |
8.539 | 5.742 | 3.295 | 2.797 | 49 | % | 2.447 | 74 | % | |||||||||||||||||||
Professional and consulting fees |
9.085 | 8.886 | 4.352 | 0.199 | 2 | % | 4.534 | 104 | % | |||||||||||||||||||
Share-based compensation |
1.868 | 1.454 | 1.468 | 0.414 | 28 | % | (0.014 | ) | — | % | ||||||||||||||||||
Depreciation and amortization |
8.925 | 6.778 | 4.044 | 2.147 | 32 | % | 2.734 | 68 | % | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ |
54.665 |
$ |
46.360 |
$ |
27.138 |
$ |
8.305 |
18 |
% |
$ |
19.222 |
71 |
% | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
• | Depreciation and amortization expenses increased by 32% or $2.147 million in 2021 compared to 2020, attributable to a full year of amortization of intangibles acquired through business and asset acquisitions in Fiscal 2020. Depreciation and amortization expenses increased by 68% or $2.734 million in 2020 compared to 2019, due to amortization of intangibles assets acquired through acquisitions of Agnity, MTS and CSA. |
• | The Company’s customers use its software to monitor their assets and rely on the Company to provide updates and releases as part of its software maintenance and support services. While the Company has not developed a formal research and development policy, the Company is and has been engaged with a number of research and development initiatives as a part of its ongoing effort to continually update its software and develop new products. Research and development expenses increased by $2.101 million in 2021 compared to 2020, due to ongoing development and investments in AssetCare Mobile, IAQ Badge and 3D technologies. Research and development expenses increased by $0.580 million in 2020 compared to 2019, due to the development of AssetCare project investments. |
• | Professional and consulting expenses increased by $0.199 million in 2021 compared to 2020, due to the Company retaining more consultants for various accounting and professional service functions that were previously performed by employees in 2020, combined with the costs associated with a full year of the Company’s ownership of its kanepi subsidiary. Professional and consulting expenses increased by $4.534 million in 2020 compared to 2019, attributable to professional legal and advisory, as well as accounting and valuation services related to business acquisitions and financings completed during the year. |
• | For the year ended December 31, 2021, salaries, wages and benefits were flat year over year, compared to the same period in 2020. Salaries, wages and benefits increased by 102% or $10.571 million in 2020 compared to 2019, due to higher headcount attributable to acquisitions of CSA and kanepi, combined with added personnel in the asset purchase of AirFusion. |
• | The above noted increases were partially offset by a decrease in the Company’s sales and marketing costs by 10% or $0.159 million due to lower marketing spending early in 2021, as the pandemic curtailed industry activity and the Company elected to spend less. This decrease in spending was partially offset by the mCloud Connect event that took place in 2021. For the year ended December 31, 2020, sales and marketing decreased by 51% or $1.631 million compared to the same period in 2019, due to the curtailment of activities attributable to ongoing COVID-19 restrictions. |
Other expenses (income) |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
|||||||||||||||||||||
Finance costs |
$ | 8.619 | $ | 6.034 | $ | 3.218 | $ | 2.585 | 43 | % | $ | 2.816 | 88 | % | ||||||||||||||
Foreign exchange loss (gain) |
(0.267 | ) | 1.198 | 0.494 | (1.465 | ) | (122 | )% | $ | 0.704 | 143 | % | ||||||||||||||||
Impairment of intangible asset |
— | — | 0.601 | — | — | % | $ | (0.601 | ) | (100 | )% | |||||||||||||||||
Business acquisition costs and other expenses |
0.346 | 1.812 | 9.880 | (1.466 | ) | (81 | )% | $ | (8.068 | ) | (82 | )% | ||||||||||||||||
Fair value loss on derivatives |
6.040 | — | — | 6.040 | — | % | $ | — | — | % | ||||||||||||||||||
Other income |
(7.126 | ) | (2.932 | ) | (0.168 | ) | (4.194 | ) | 143 | % | $ | (2.764 | ) | 1645 | % | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ | 7.612 | $ | 6.111 | $ | 14.025 | $ | 1.500 | 25 | % | $ | (7.914 | ) | 4713 | % | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
• | Finance costs increased by $2.585 million during the year ended December 31, 2021, compared to the same period in 2020, due to increased interest and transaction costs associated with the 2021 Convertible Debentures, which were converted in Q3 2021, along with interest and fees on new borrowings, partially offset by lower interest on repaid borrowings. Finance costs increased by $2.816 million for the year ended December 31, 2020, compared with the same period in 2019, due to higher interest expense on the 2019 Convertible Debentures, with the funds used for business acquisitions. |
• | Foreign exchange was a gain of $0.267 million for the year ended December 31, 2021, compared to a loss of $1.198 million for the same period in 2020, due to an increase in US denominated financings in 2021. For the year ended December 31, 2020, the foreign exchange loss increased by $0.704 million to $1.198 million from $0.494 million for the same period in 2019, as a result of the timing of cash receipts and payments. |
• | During the year ended December 31, 2021, the Company determined that the amount of the contingent consideration recognized at the date of acquisition of CSA would not be payable as the operational performance metrics were not achieved. In addition, the fair value of the contingent consideration recognized at the date of acquisition for kanepi remeasured based on management’s estimate of the likelihood the performance metrics would be met by October 2022, resulting in a decrease in fair value and an offsetting amount recognized as other income, presented as business acquisition costs and other expenses, . For the year ended December 31, 2019, business acquisition costs included $9.870 million incurred as transaction costs in connection with acquisitions including consulting fees, legal and professional fees and fair value of $8.880 million for 800,000 common shares issued for brokering and due diligence services. |
• | Fair value changes in derivatives were a loss of $6.040 million for the year ended December 31, 2021. These are non-cash losses as a result of the conversion of the 2021 Convertible Debenture into common shares and warrants. The initial fair value loss on the convertible debentures along with losses on modification and remeasurement of the financial liability, partially offset by gains on the remeasurement of the warrant liability from date of issuance on August 13, 2021 to December 31, 2021 are the primary drivers of this amount. The additional element of these fair value changes in derivatives relates to the remeasurement of warrant liabilities issued in November 2021, at December 31, 2021. |
• | Other Income increased by $4.194 million for the year ended December 31, 2021, to $7.126 million from $2.932 million for the same period in 2020. The majority of Other Income includes wage and rent subsidies received from the Canadian government and low-interest loans from the US government, which were partially forgiven in 2021 and 2020. Also during the year ended December 31, 2021, contingent consideration associated with the acquisition of CSA and kanepi was determined not to be payable and as such, $1.010 million was recognized in Other Income. For the year ended December 31, 2020, Other Income increase by $2.764 million compared to the same period in 2019, primarily due to wage subsidies and benefits from low-interest loans received from US and Canadian government COVID-19 relief programs. |
Expenses |
2021 |
2020 |
2019 |
2021 vs 2020 Change $ |
2021 vs 2020 % |
2020 vs 2019 Change $ |
2020 vs 2019 % |
|||||||||||||||||||||
Current tax expense (recovery) |
$ | 0.157 | $ | (0.296 | ) | $ | 0.182 | $ | 0.453 | (153 | )% | $ | (0.478 | ) | (262 | )% | ||||||||||||
Deferred tax expense (recovery) |
$ | (1.822 | ) | $ | (0.668 | ) | $ | (2.692 | ) | $ | (1.154 | ) | 173 | % | $ | 2.024 | (75 | )% |
Major Service Line |
2021 |
2020 |
Change $ |
Change % |
||||||||||||
AssetCare Initialization |
$ | 0.173 | $ | 2.672 | $ | (2.499 | ) | (94 | )% | |||||||
AssetCare Over Time |
3.886 | 5.546 | (1.660 | ) | (30 | )% | ||||||||||
Engineering Services |
0.111 | 1.005 | (0.894 | ) | (89 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
4.170 |
$ |
9.223 |
$ |
(5.053 |
) |
(55 |
)% | |||||||
|
|
|
|
|
|
|
|
Timing of revenue recognition |
2021 |
2020 |
Change $ |
Change % |
||||||||||||
Revenue recognized over time |
$ | 4.073 | $ | 4.757 | $ | (0.684 | ) | (14 | )% | |||||||
Revenue recognized at point in time upon completion |
0.097 | 4.466 | (4.369 | ) | (98 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
4.170 |
$ |
9.223 |
$ |
(5.053 |
) |
(55 |
)% | |||||||
|
|
|
|
|
|
|
|
2021 |
2020 |
Change $ |
Change % |
|||||||||||||
Cost of Sales |
$ | 1.507 | $ | 3.579 | $ | (2.072 | ) | (58 | )% | |||||||
Gross Profit |
2.664 | 5.644 | (2.981 | ) | (53 | )% | ||||||||||
|
|
|
|
|
|
|||||||||||
Gross margin % |
63.9 |
% |
61.2 |
% |
4 |
% | ||||||||||
|
|
|
|
|
|
Expenses |
2021 |
2020 |
Change $ |
Change % |
||||||||||||
Salaries, wages and benefits |
$ | 5.608 | $ | 4.486 | $ | 1.122 | 25 | % | ||||||||
Sales and marketing |
0.400 | 0.304 | 0.096 | 32 | % | |||||||||||
Research and development |
1.105 | 0.323 | 0.782 | 242 | % | |||||||||||
General and administration |
4.187 | 1.924 | 2.263 | 118 | % | |||||||||||
Professional and consulting fees |
2.446 | 2.090 | 0.356 | 17 | % | |||||||||||
Share-based compensation |
0.684 | 0.427 | 0.257 | 60 | % | |||||||||||
Depreciation and amortization |
2.146 | 1.917 | 0.229 | 12 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
16.576 |
$ |
11.471 |
$ |
5.105 |
45 |
% | ||||||||
|
|
|
|
|
|
|
|
• | General and administration expenses increased by 118% or $2.263 million primarily as the result of costs associated with the Company’s NASDAQ listing, which occurred in November 2021, combined with a bad debts provision. |
• | Research and development expenses increased by $0.782 million in Q4 2021 compared with 2020, related specifically to the ongoing development of AssetCare Mobile, “IAQ” Badge and 3D technologies. Spending in prior year was curtailed as a means of conserving cash. |
• | Professional and consulting expenses increased by 17% or $0.356 million, primarily related to increased costs for professional services associated with the general efforts to raise capital to explore current and future acquisition opportunities, perform technical accounting and advisory fees and prepare and file the Company’s prospectus supplements. Consultants filled positions in 2021 that were previously held by employees in 2020. |
• | Salaries, wages and benefits costs increased by 25% or $1.122 million, primarily due to a full year of the costs associated with a full year of the Company’s ownership of its kanepi subsidiary, as compared with the prior year when kanepi was acquired in October 2020. This was partially offset by the use of consultants in 2021 for tasks previously performed by employees in 2020. |
• | Depreciation and amortization non-cash costs increased by 12% or $0.229 million for Q4 2021. These changes were related to intangible assets which were acquired as part of business and assets acquisitions completed throughout Fiscal 2020 acquired from CSA, and the intangible assets acquired as part of the Company’s acquisition of kanepi. |
• | Sales and marketing costs increased by 32% mainly as a result of investments by the Company to explore opportunities in the AssetCare solutions across all industries and in particular, in the IAQ space. |
Other expenses (income) |
2021 |
2020 |
Change $ |
Change % |
||||||||||||
Finance costs |
$ | 2.724 | $ | 1.694 | $ | 1.030 | 61 | % | ||||||||
Foreign exchange loss (gain) |
(0.041 | ) | 1.583 | (1.624 | ) | (103 | )% | |||||||||
Business acquisition costs and other expenses |
0.023 | 0.501 | (0.478 | ) | (95 | )% | ||||||||||
Fair value gain on derivatives |
(3.075 | ) | — | (3.075 | ) | — | % | |||||||||
Other income |
(1.654 | ) | (0.971 | ) | (0.683 | ) | 70 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
(2.023 |
) |
$ |
2.807 |
$ |
(4.830 |
) |
(172 |
)% | ||||||
|
|
|
|
|
|
|
|
• | Finance costs increased by $1.030 million for the three months ended December 31, 2021, due to higher interest and fees on new borrowings. |
• | Foreign exchange changed from a loss of $1.583 million for the comparative period in 2020 to a gain of $0.041 million in Q4 2021. These movements were the result of the timing of cash receipts and payments, combined with the USD public offering that closed in the last quarter of 2021. |
• | Fair value changes in derivatives constituted a gain of $3.075 million for the three months ended December 31, 2021. These non-cash changes relate to the fair value adjustment for the warrants and was partially offset by the remeasurement of warrant liabilities, issued in November 2021, being revalued at December 31, 2021. |
• | Other Income increased by $0.683 million for the three months ended December 31, 2021. The majority of Other Income includes wage and rent subsidies received from the Canadian government and low-interest loans from the US government which have been partially forgiven in the periods. |
Expenses |
2021 |
2020 |
Change $ |
Change % |
||||||||||||
Current tax expense (recovery) |
$ | (0.704 | ) | $ | (0.397 | ) | $ | (0.307 | ) | 77 | % | |||||
Deferred tax expense (recovery) |
$ | (0.854 | ) | $ | 0.682 | $ | (1.535 | ) | (225 | )% |
For the quarter ended: |
Q4 2021 |
Q3 2021 (1) |
Q2 2021 (1) |
Q1 2021 (1) |
Q4 2020 |
Q3 2020 |
Q2 2020 |
Q1 2020 |
||||||||||||||||||||||||
Total revenue |
$ | 4.171 | $ | 7.434 | $ | 6.556 | $ | 7.436 | $ | 9.223 | $ | 6.137 | $ | 5.010 | $ | 6.558 | ||||||||||||||||
Net loss |
10.331 | 15.616 | 9.000 | 9.752 | 8.918 | 8.713 | 9.353 | 7.878 | ||||||||||||||||||||||||
Net loss - mCloud shareholders |
9.662 | 15.466 | 8.930 | 10.271 | 9.725 | 9.417 | 9.707 | 8.021 | ||||||||||||||||||||||||
Basic and diluted loss per share |
$ | 0.70 | $ | 1.22 | $ | 0.88 | $ | 1.12 | $ | 1.07 | $ | 1.15 | $ | 1.53 | $ | 1.47 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total assets |
$ |
72.106 |
$ |
73.818 |
$ |
79.868 |
$ |
75.803 |
$ |
77.319 |
$ |
68.113 |
$ |
64.349 |
$ |
67.869 |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total non- current financial liabilities |
$ |
1.513 |
$ |
12.978 |
$ |
24.565 |
$ |
43.440 |
$ |
33.443 |
$ |
33.319 |
$ |
37.223 |
$ |
32.795 |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
• | March 31, 2021, decreased revenue and increased net loss, net loss attributable to mCloud shareholders and loss per share attributable to mCloud shareholders - basic and diluted by $0.945 million ($0.10 per share); |
• | June 30, 2021, decreased revenue and increased net loss, net loss attributable to mCloud shareholders and loss per share attributable to mCloud shareholders - basic and diluted by $0.652 million ($0.13 per share); |
• | September 30, 2021, increased revenue and decreased net loss, net loss attributable to mCloud shareholders and loss per share attributable to mCloud shareholders - basic and diluted by $0.098 million ($0.01 per share). |
Cash provided by (used in): |
2021 |
2020 |
2019 |
|||||||||
Operating activities |
$ | (28.330 | ) | $ | (24.856 | ) | $ | (14.516 | ) | |||
Investing activities |
(1.064 | ) | (6.395 | ) | (20.732 | ) | ||||||
Financing activities |
32.927 | 31.857 | 34.465 | |||||||||
|
|
|
|
|
|
|||||||
Increase in cash, before effect of exchange rate fluctuation |
$ |
3.533 |
$ |
0.606 |
$ |
(0.784 |
) | |||||
|
|
|
|
|
|
At December 31, 2021 |
Undiscounted Contractual Cash Flows |
|||||||||||||||
Contractual Obligations |
< 1 year |
1 – 2 years |
> 2 years |
Total |
||||||||||||
Bank indebtedness 1 |
$ | 3.460 | $ | — | $ | — | $ | 3.460 | ||||||||
Trade payables and accrued liabilities |
12.421 | — | — | 12.421 | ||||||||||||
Loans and borrowings 2 |
11.764 | 0.786 | — | 12.550 | ||||||||||||
Lease liabilities 3 |
0.522 | 0.534 | 0.179 | 1.235 | ||||||||||||
2019 Convertible Debentures |
24.630 | — | — | 24.630 | ||||||||||||
2021 Convertible Debentures |
0.008 | 0.103 | — | 0.111 | ||||||||||||
Warrant liabilities 5 |
0.710 | — | — | 0.710 | ||||||||||||
Business acquisition payable |
1.399 | — | — | 1.399 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Contractual obligations |
$ |
54.913 |
$ |
1.423 |
$ |
0.179 |
$ |
56.516 |
||||||||
|
|
|
|
|
|
|
|
|||||||||
At December 31, 2021 |
Undiscounted Contractual Cash Flows |
|||||||||||||||||||
Commitments |
< 1 year |
2 – 3 years |
4 – 5 years |
More than 5 years |
Total |
|||||||||||||||
Variable lease payments 5 |
0.397 | 0.478 | 0.125 | 0.013 | 1.013 | |||||||||||||||
Lease payments related to leases which have not yet commenced 6 |
0.105 | 2.589 | 2.763 | 12.636 | 18.093 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Commitments |
$ |
0.501 |
$ |
3.067 |
$ |
2.888 |
$ |
12.649 |
$ |
19.106 |
||||||||||
|
|
|
|
|
|
|
|
|
|
1 |
No contractual maturity, due on demand. Excludes interest charged on facility. |
2 |
Includes term loan with a carrying value of $9.276 classified as current due to covenant breach. Assuming term loan is repaid in accordance with agreement to maturity, the undiscounted contractual cash flows for loans and borrowings would be $2.934 million, $5.472 million, and $4.144 million, respectively for the periods presented above. |
3 |
Variable costs payable under lease agreements are not included in this amount. Minimum payment related to leases which have not yet commenced are not included in this amount. |
4 |
Majority of liability will be settled by issuing common shares when warrants are exercised during the year. The remaining amount may be settled in cash or common shares of Agnity. |
5 |
Variable lease payments associated with lease liabilities. |
6 |
In October 2021, the Company executed a 12-year lease for office space in Calgary, Alberta. Base rent and estimated common expense payments commence in December 2022, preceded by a fixturing period which the Company will use to build out the space. The Company will receive a tenant improvement allowance which is expected to cover the majority of the costs. |
For the quarter ended: |
Q1 2022 |
Q4 2021 |
Q3 2021 (1) |
Q2 2021 (1) |
Q1 2021 (1) |
Q4 2020 |
Q3 2020 |
Q2 2020 |
||||||||||||||||||||||||
Total Revenue |
4.430 | 4.171 | 7.434 | 6.556 | 7.436 | 9.223 | 6.137 | 5.010 | ||||||||||||||||||||||||
Net loss |
11.023 | 10.331 | 15.616 | 9.000 | 9.752 | 8.918 | 8.713 | 9.353 | ||||||||||||||||||||||||
Net Loss - mCloud shareholders |
9.778 | 9.662 | 15.466 | 8.930 | 10.271 | 9.725 | 9.417 | 9.707 | ||||||||||||||||||||||||
Basic and diluted loss per share |
$ | 0.61 | $ | 0.70 | $ | 1.22 | $ | 0.88 | $ | 1.12 | $ | 1.07 | $ | 1.15 | $ | 1.53 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total assets |
73.091 |
72.106 |
73.818 |
79.868 |
75.803 |
77.319 |
68.113 |
64.349 |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total non- current financial liabilities |
7.532 |
1.513 |
12.978 |
24.565 |
43.440 |
33.443 |
33.319 |
37.223 |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
The results for each of the quarters ended March 31, June 30 and September 30, 2021 have been adjusted for an immaterial error correction which impacted revenue, current and non-current long-term accounts receivables; deferred revenue, and correspondingly, impacted net loss and net loss attributable to mCloud shareholders and related loss per share attributable to mCloud shareholders - basic and diluted. During the quarters ended: |
• |
March 31, 2021, decreased revenue and increased net loss, net loss attributable to mCloud shareholders and loss per share attributable to mCloud shareholders - basic and diluted by $0.945 million ($0.10 per share); |
• |
June 30, 2021, decreased revenue and increased net loss, net loss attributable to mCloud shareholders and loss per share attributable to mCloud shareholders - basic and diluted by $0.652 million ($0.13 per share); |
• |
September 30, 2021, increased revenue and decreased net loss, net loss attributable to mCloud shareholders and loss per share attributable to mCloud shareholders - basic and diluted by $0.098 million ($0.01 per share). |
2022 |
2021 |
Change $ |
Change % |
|||||||||||||
Revenue Cost of Sales |
$ |
4.430 (1.932 |
) |
$ |
7.436 (3.259 |
) |
$ |
(3.006 1.327 |
) |
|
(40 (41 |
)% )% | ||||
|
|
|
|
|
|
|
|
|||||||||
Gross Profit |
$ |
2.497 |
$ |
4.177 |
$ |
(1.680 |
) |
(40 |
)% | |||||||
|
|
|
|
|
|
|
|
|||||||||
Expenses |
||||||||||||||||
Salaries, wages and benefits |
$ | 5.314 | $ | 4.870 | $ | 0.444 | 9 | % | ||||||||
Sales and marketing |
0.762 | 0.185 | 0.577 | 312 | % | |||||||||||
Research and development |
0.532 | 0.749 | (0.217 | ) | (29 | )% | ||||||||||
General and administrative |
2.552 | 1.337 | 1.215 | 91 | % | |||||||||||
Professional and consulting fees |
3.176 | 1.739 | 1.437 | 83 | % | |||||||||||
Share-based compensation |
0.253 | 0.375 | (0.122 | ) | (33 | )% | ||||||||||
Depreciation and amortization |
1.943 | 1.971 | (0.028 | ) | (1 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total expenses |
$ | 14.533 | $ | 11.227 | $ | 3.306 | 29 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating loss |
$ |
12.035 |
$ |
7.050 |
$ |
4.985 |
71 |
% | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Other Expenses (income) |
||||||||||||||||
Finance costs |
$ | 1.859 | $ | 2.236 | $ | (0.377 | ) | (17 | )% | |||||||
Foreign exchange loss |
0.623 | 0.367 | 0.256 | 70 | % | |||||||||||
Business acquisition costs and other expenses |
— | 0.324 | (0.324 | ) | (100 | )% | ||||||||||
Fair value (gain) loss on derivatives |
(2.493 | ) | 1.564 | (4.057 | ) | (259 | )% | |||||||||
Other income |
(0.398 | ) | (1.910 | ) | 1.512 | (79 | )% | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before tax |
$ |
11.625 |
$ |
9.632 |
$ |
1.993 |
21 |
% | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Current tax expense |
$ | 0.289 | $ | 0.239 | $ | 0.050 | 21 | % | ||||||||
Deferred tax recovery |
(0.891 | ) | (0.119 | ) | (0.772 | ) | 647 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss for the period |
$ |
11.023 |
$ |
9.752 |
$ |
1.271 |
13 |
% | ||||||||
|
|
|
|
|
|
|
|
Major Service Line |
2022 |
2021 |
Change $ |
Change % |
||||||||||||
AssetCare initialization |
$ | 0.415 | $ | 0.515 | $ | (0.100 | ) | (20 | )% | |||||||
AssetCare over time |
3.989 | 6.435 | (2.446 | ) | (38 | )% | ||||||||||
Engineering services |
0.026 | 0.486 | (0.460 | ) | (95 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
4.430 |
$ |
7.436 |
$ |
(3.006 |
) |
(40 |
)% | |||||||
|
|
|
|
|
|
|
|
Timing of revenue recognition |
2022 |
2021 |
Change $ |
Change % |
||||||||||||
Revenue recognized over time |
$ | 3.862 | $ | 5.449 | $ | (1.587 | ) | (29 | )% | |||||||
Revenue recognized at point in time upon completion |
$ | 0.568 | 1.987 | (1.419 | ) | (71 | )% | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
4.430 |
$ |
7.436 |
$ |
(3.006 |
) |
(40 |
)% | |||||||
|
|
|
|
|
|
|
|
2022 |
2021 |
Change $ |
Change % |
|||||||||||||
Cost of Sales |
$ | 1.932 | $ | 3.259 | $ | (1.326 | ) | (41 | )% | |||||||
Gross Profit |
2.497 | 4.177 | (1.680 | ) | (40 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross margin % |
56.4 |
% |
56.2 |
% |
— |
% | ||||||||||
|
|
|
|
|
|
|
|
Expenses |
2022 |
2021 |
Change $ |
Change % |
||||||||||||
Salaries, wages and benefits |
$ | 5.314 | $ | 4.870 | $ | 0.444 | 9 | % | ||||||||
Sales and marketing |
0.762 | 0.185 | 0.577 | 312 | % | |||||||||||
Research and development |
0.532 | 0.749 | (0.217 | ) | (29 | )% | ||||||||||
General and administration |
2.552 | 1.337 | 1.215 | 91 | % | |||||||||||
Professional and consulting fees |
3.176 | 1.739 | 1.437 | 83 | % | |||||||||||
Share-based compensation |
0.253 | 0.375 | (0.122 | ) | (33 | )% | ||||||||||
Depreciation and amortization |
1.943 | 1.971 | (0.028 | ) | (1 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
14.533 |
$ |
11.227 |
$ |
3.306 |
29 |
% | ||||||||
|
|
|
|
|
|
|
|
• | Professional and consulting expenses increased by 83% or $1.437 million, primarily related to increased costs for professional services in Q1 2022. Consultants also filled positions in Q2 2021 that were previously held by employees. |
• | General and administration expenses increased by 91% or $1.215 million primarily due to increased insurance premiums following the Company’s NASDAQ listing in Q4 2021, combined with increased IT subscriptions as the Company ramps up to return its resources to pre-COVID 19 levels. |
• | Sales and marketing costs increased by 312% or $0.577 million, due to sponsorships with the Mercedes-Benz Formula E Limited racing team and increased marketing initiatives in Q1 2022. |
• | Salaries, wages and benefits costs increased by 9% or $0.444 million, primarily attributable to increased headcount related to the Company’s post COVID-19 expansion, ramping up for expected growth later in 2022. |
• | Research and development expenses decreased by $0.217 million in Q1 2022 compared with the same period in 2021, as a means of conserving cash in Q1 2022. Research and development specifically relates to the ongoing development of AssetCare Mobile, “IAQ” Badge and 3D technologies. |
• | Depreciation and amortization non-cash costs decreased by 1% or $0.028 million for Q1 2022, due to a decrease in new assets for property and equipment, combined with fully depreciated assets at or nearing the end of their useful life. |
Other expenses (income) |
2022 |
2021 |
Change $ |
Change % |
||||||||||||
Finance costs |
$ | 1.859 | $ | 2.236 | $ | (0.377 | ) | (17 | )% | |||||||
Foreign exchange loss (gain) |
0.623 | 0.367 | 0.256 | 70 | % | |||||||||||
Business acquisition costs and other expenses |
— | 0.324 | (0.324 | ) | (100 | )% | ||||||||||
Fair value (gain) loss on derivatives |
(2.493 | ) | 1.564 | (4.057 | ) | (259 | )% | |||||||||
Other income |
(0.398 | ) | (1.910 | ) | 1.512 | (79 | )% | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
(0.410 |
) |
$ |
2.582 |
$ |
(2.990 |
) |
(116 |
)% | ||||||
|
|
|
|
|
|
|
|
• | Fair value changes in derivatives were a gain of $2.493 million for the three months ended March 31, 2022. These are non-cash gains as a result of the remeasurement of the warrant liabilities at March 31, 2022. The warrant liabilities include the warrants issued on conversion of the 2021 Convertible Debenture and the warrant liabilities issued in November 2021. |
• | Finance costs decreased by $0.377 million during the three months ended March 31, 2022, compared to the same period in 2021, primarily due to transaction costs on the issuance of convertible debentures expensed in Q1 2021. |
• | There were no business acquisition costs in either Q1 2022 or Q1 2021. Other expenses vary depending on activity. |
• | Other Income decreased by $1.512 million for the three months ended March 31, 2022, to $0.398 million from $1.910 million for the same period in 2021. The majority of Other Income includes wage and rent subsidies for COVID-19 programs received from the Canadian government and low-interest loans from the US government. The majority of these programs have now ended. |
• | Foreign exchange was a loss of $0.623 million for the three months ended March 31, 2022, compared to a loss of $0.367 million for the same period in 2021, due to a stronger Canadian dollar. |
Cash provided by (used in): |
2022 |
2021 |
||||||
Operating activities |
$ | (3.771 | ) | $ | (4.930 | ) | ||
Investing activities |
(0.011 | ) | (0.461 | ) | ||||
Financing activities |
1.090 | 4.608 | ||||||
|
|
|
|
|||||
Increase in cash, before effect of exchange rate fluctuation |
$ |
(2.692 |
) |
$ |
(0.783 |
) | ||
|
|
|
|
• | the plans for the repayment of the 2019 Convertible Debentures; |
• | the repayment of a portion of the term loan on May 6, 2022 and the agreement executed whereby the term loan will be repaid in full on or before October 31, 2022; |
• | the likelihood that undrawn funds under the revolving operating facility will be available and will not be required to be repaid; |
• | the required cash principal and interest payments on indebtedness; |
• | the likelihood of payments required under contingent consideration arrangements; |
• | the available funding of US$15 million under a promissory note executed on March 28, 2022; |
• | cash inflows from current operations, expected government assistance in the form of wage and rent subsidies, and expected increases in revenues and cash flows resulting from new revenue contracts expected over the next 12 months due to the anticipated reduction of COVID-19 related restrictions; and |
• | future debt and equity raises. |
Three months ended March 31, |
2022 |
2021 |
Change % |
|||||||||
Salaries, fees and short-term benefits |
$ | 0.399 | $ | 0.374 | 7 | % | ||||||
Share-based compensation |
0.121 | 0.057 | 112 | % | ||||||||
|
|
|
|
|
|
|||||||
$ |
0.520 |
$ |
0.431 |
21 |
% | |||||||
|
|
|
|
|
|
• | An ineffective control environment resulting from an insufficient number of trained financial reporting and accounting, information technology (IT) and operational personnel with the appropriate skills and knowledge and with assigned responsibility and accountability related to the design, implementation and operating effectiveness of internal control over financial reporting. |
• | The insufficient number of personnel described above contributed to an ineffective risk assessment process necessary to identify all relevant risks of material misstatement and to evaluate the implications of relevant risks on its internal control over financial reporting. |
• | An ineffective information and communication process resulting from (i) insufficient communication of internal control information, including objectives and responsibilities, such as delegation of authority; and (ii) ineffective general IT controls and ineffective controls related to spreadsheets, resulting in insufficient controls to ensure the relevance, timeliness and quality of information used in control activities. |
• | As a consequence of the above and as a result of inadequate segregation of duties and secondary review, the Company had ineffective control activities related to the design, implementation and operating effectiveness of process level and financial reporting controls which had a pervasive impact on the Company’s internal control over financial reporting. |
• | An ineffective monitoring process resulting from the evaluation and communication of internal control deficiencies, including monitoring corrective actions, not being performed in a timely manner. |
• | Identifying key positions necessary to support the Company’s initiatives related to internal controls over financial reporting, and expanding its hiring efforts accordingly. |
• | Hiring consultants to assist with process improvements and control remediation efforts in targeted accounting, IT and operations processes. |
• | Formalizing its entity-wide risk assessment process, and documenting internal ownership of risk monitoring and mitigation efforts, with improved risk monitoring activities and regular reporting to those charged with governance at an appropriate frequency. |
• | Finalize a delegation of authority matrix to enforce desired limits of authority for key transactions, events, and commitments, and communicating these limits of authority to relevant personnel throughout the Company. |
• | Further simplify and streamline its spreadsheet models to reduce the risk of errors in mathematical formulas and improve the ability to verify the logic of spreadsheets. |
• | Hiring a consultant to assist management with process improvements and control remediation for general IT controls. |
• | Continuing to perform scoping exercises and planning for an ERP implementation to streamline the number of applications used for financial reporting activities. |
Securities Outstanding |
||||
Shares issued and outstanding |
16,155,654 |
|||
Share purchase warrants (1) |
8,665,406 |
|||
Stock options |
870,146 |
|||
Restricted share units |
251,265 |
|||
2019 Convertible Debentures (2) |
1,563,833 |
|||
2021 Convertible Debentures (3) |
15,750 |
|||
|
|
|||
Total |
27,522,054 |
|||
|
|
(1) |
Share purchase warrants offer the holder the right to purchase a common share of the Company at a specified price by a specific date. Share purchase warrants outstanding have exercise prices ranging from Canadian dollar equivalent at date of issuance between $4.12 - $22.50 and a weighted average remaining contractual life of 2.6 years. |
(2) |
Debentures are convertible at the option of the holder and have a conversion price of $15.00 and mature June 30, 2022. |
(3) |
Debentures are convertible at the option of the holder and have a conversion price of $5.98 which has been converted to Canadian dollars at May 12, 2022. The Debentures have a remaining life to maturity of 1.6 years. |
* | Despite owning no shares, or having any voting rights, the Company determined that it exercises control over Agnity Global, Inc. (“Agnity”) as the Company has the right to nominate a majority of the members of Agnity’s Operations Committee and therefore the right and ability to direct the relevant activities of Agnity and to significantly affect its returns through the use of its rights. As a result, the financial results of Agnity have been consolidated into the Company’s financial statements. |
• | HVAC units and refrigerators in commercial buildings; |
• | control systems, heat exchangers, and compressors at process industry facilities; and |
• | wind turbines generating renewable energy at onshore wind farms. |
• | curbing wasted energy while improving occupant comfort in commercial facilities through AI-powered adaptive control; |
• | maximizing asset availability and production yields of renewable energy sources through continuous performance assessment and predictive maintenance; and |
• | optimizing the uptime and manage the operational risk of industrial process plants, including oil and gas facilities, through continuous AI-powered advisory and assistance to process operators in the field. |
1) | Connected Buildings |
2) | Connected Workers AI-powered “digital assistant”; |
3) | Connected Energy AI-powered computer vision and the deployment of analytics to improve wind farm energy production yield and availability; |
4) | Connected Industry |
5) | Connected Health in-person visits, including at elder care facilities, age-in-place |
Patent |
Patent No. / App. Serial No. |
Jurisdiction |
Date Issued / Date Filed |
Status |
Registered Owner | |||||
Apparatus and method for detecting faults and providing diagnostics in vapor compression cycle equipment |
6,658,373 | US Patent | 12/2/2003 | Live | Field Diagnostic Services, Inc. | |||||
Estimating operating parameters of vapor compression cycle equipment |
6,701,725 | US Patent | 3/9/2004 | Live | Field Diagnostic Services, Inc. | |||||
Estimating evaporator airflow in vapor compression cycle cooling equipment |
6,973,793 | US Patent | 12/13/2005 | Live | Field Diagnostic Services, Inc. | |||||
Apparatus and method for detecting faults and providing diagnostics in vapor compression cycle equipment |
7,079,967 | US Patent | 7/18/2006 | Live | Field Diagnostic Services, Inc. | |||||
Method for Determining Evaporator Airflow Verification |
8,024,938 | US Patent | 9/27/2011 | Live | Field Diagnostic Services, Inc. | |||||
Method and Apparatus for Transforming Polygon Data to Voxel Data for General Purpose Applications |
6,867,774 | US Patent | 3/15/2005 | Live | NGRAIN (Canada) Corporation | |||||
Method and System for Rendering Voxel Data while Addressing Multiple Voxel Set Interpenetration |
7,218,323 | US Patent | 5/15/2007 | Live | NGRAIN (Canada) Corporation | |||||
Method and Apparatus for Transforming Point Cloud Data to Volumetric Data |
7,317,456 | US Patent | 1/8/2008 | Live | NGRAIN (Canada) Corporation | |||||
Method, System and Data Structure for Progressive Loading and Processing of a 3D Dataset |
7,965,290 | US Patent | 6/21/2011 | Live | NGRAIN (Canada) Corporation |
Method and System for Calculating Visually Improved Edge Voxel Normals when Converting Polygon Data to Voxel Data |
8,217,939 | US Patent | 7/16/2012 | Live | NGRAIN (Canada) Corporation | |||||
System and Method for Optimal Geometry Configuration Based on Parts Exclusion | 9,159,170 | US Patent | 10/13/2015 | Live | NGRAIN (Canada) Corporation | |||||
Method and System for Emulating Kinematics | 9,342,913 | US Patent | 5/17/2016 | Live | NGRAIN (Canada) Corporation | |||||
System, Computer- Readable Medium and Method for 3D Differencing of 3D Voxel Models | 9,600,929 | US Patent | 3/21/2017 | Live | NGRAIN (Canada) Corporation | |||||
System, Method and Computer-Readable Medium for Organizing and Rendering 3D Voxel Models in a Tree Structure |
9,754,405 | US Patent | 9/10/2015 | Live | NGRAIN (Canada) Corporation | |||||
Portable apparatus and method for decision support for real time automated multisensor data fusion and analysis | 10,346,725 072239.0004 / BR BR 11 2017 024598 1 072239.0005 / MX MX/a/2017/014648 072239.0006 / EU EP16797087.0 072239.0007 / IN 201747045184 072239.0008 / CN 2016800413571 072239.0009 / CA 072239.0010 / ZA 2018/01638 |
US Patent National Stage Filings in BR / MX / EU / IN / CN / CA / ZA |
7/9/2019 | Live | mCloud Corp. |
Trademark |
App. Serial No. / Reg. No. |
Date Issued / Date Filed |
Status |
Registered Owner | ||||
ACRx | 75281276/ 2492872 |
9/25/2001 |
Live | Field Diagnostic Services, Inc. | ||||
MCLOUD CORP (standard mark) | 87327278/ 5333557 |
14/11/2017 |
Live | mCloud Corp. | ||||
mCloud Corp (design mark) |
87327435/ 5333558 |
14/11/2017 |
Live | mCloud Corp. | ||||
Asset Circle of Care (standard mark) | 87327483/ 5333559 |
14/11/2017 |
Live | mCloud Corp. | ||||
AssetCare (standard mark) | 87327512/ 5333560 |
11/14/2017 |
Live | mCloud Corp. | ||||
3KO | 77398780/ 3796217 |
11/11/2008 |
Live | NGRAIN (Canada) Corporation | ||||
NGRAIN (design mark) |
77912373/ 3840652 |
6/15/2010 |
Live | NGRAIN (Canada) Corporation | ||||
NGRAIN (design mark) |
009245101 (EU) | 12/27/2010 |
Live | NGRAIN (Canada) Corporation | ||||
PRODUCER | 009327412 (EU) | 2/3/2011 |
Live | NGRAIN (Canada) Corporation | ||||
NGRAIN (standard mark) | 78199527/ 2881383 |
9/7/2004 |
Live | NGRAIN (Canada) Corporation | ||||
mCloud Connect (standard mark) |
5756945 | 5/21/2019 |
Live | mCloud Corp. | ||||
mCloud (design mark) |
88/907693 | In Application (Approved) | ||||||
mCloud (design mark) |
88/907606 | In Application (Approved) | ||||||
AssetCare (design mark) | 88/907679 | In Application (Approved) | ||||||
PanoMap (standard mark) | 88/916707 6,444,185 |
8/10/2021 |
Live | mCloud Corp. | ||||
Newton Engine (standard mark) | 88/907682 | In Application (Approved) | ||||||
Kanepi | 40201608870Y / SG | June 1 2016 | Live | Kanepi Pte Ltd | ||||
40201608871T / SG | June 1 2016 | Live | Kanepi Pte Ltd | |||||
SEE YOUR BUSINESS | 2024268 / AUS | March 11 2020 | Live | Kanepi Pte Ltd | ||||
MY LDAR (standard mark) | 97264404 | February 11, 2020 |
In Application | mCloud Corp. | ||||
97264407 | February 11, 2020 |
In Application | mCloud Corp. |
Name |
Age |
Position |
Appointed | |||||
Russel H. McMeekin |
56 | Chief Executive Officer, President, Director | October 2017 | |||||
Michael Allman |
61 | Director | October 2017 | |||||
Costantino Lanza |
68 | Chief Growth Officer, Corporate Secretary, Director | October 2017 | |||||
Elizabeth MacLean |
57 | Director | October 2018 | |||||
Ian Russell |
73 | Director | September 2019 | |||||
Chantal Schutz |
48 | Chief Financial Officer | May 2019 |
• | an understanding of the accounting principles used by the Company to prepare the Company’s financial statements; |
• | the ability to assess the general application of the above-noted principles in connection with estimates, accruals and reserves; |
• | experience preparing, auditing, analyzing or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by the Company’s financial statements, or experience actively supervising individuals engaged in such activities; and |
• | an understanding of internal controls and procedures for financial reporting. |
Fees billed for the fiscal year ended December 31, |
||||||||
Service Retained |
2021 |
2020 |
||||||
Audit fees (1) |
CAD$ | 1,799,383 | CAD$ | 769,826 | ||||
Audit-related fees (2) |
CAD$ | 6,420 | CAD$ | — | ||||
Tax fees (3) |
CAD$ | 339,624 | CAD$ | 321,050 | ||||
All other fees (4) |
CAD$ | 102,720 | CAD$ | 38,873 | ||||
|
|
|
|
|||||
Total |
CAD$ | 2,248,147 | CAD$ | 1,129,749 |
1. | Includes fees necessary to perform the annual audit of our consolidated financial statements, reviews of the interim financial statements, and services related to prospectus filings. |
2. | Includes other audit related services that are performed by the auditor. |
3. | Includes fees for tax compliance, tax planning and tax advice. These services include preparing tax returns and corresponding with government tax authorities. |
4. | Includes French translation services related to prospectus filings and historical financial statements and management’s discussion and analysis. |
• | to attract, retain and motivate talented executives who create and sustain the Corporation’s continued success; |
• | to align the interests of the Corporation’s executives with the interests of the Corporation’s shareholders; and |
• | to provide total compensation to executives that is competitive with that paid by other companies of comparable size engaged in similar businesses in appropriate regions. |
(a) | base salaries; |
(b) | performance bonuses; and |
(b) | equity incentive grants. |
• | developing and recommending to the Board criteria for selecting board and committee members; |
• | establishing procedures for identifying and evaluating director candidates, including nominees recommended by shareholders; |
• | identifying individuals qualified to become board members; |
• | recommending to the Board the persons to be nominated for election as directors and to each of the Board’s committees; |
• | reviewing and making recommendations to the Board regarding the appointment and succession of our directors and officers; |
• | developing and recommending to the Board a code of business conduct and ethics and a set of corporate governance guidelines; and |
• | overseeing the evaluation of the Board, its committees and our management. |
• | meeting with our technical management team at least once per calendar quarter; |
• | assessing whether the product delivery schedule is being met and whether it needs to be adjusted; |
• | ensuring that all third-party software we use is properly licensed; |
• | making recommendations to the Board concerning our technology strategy, roadmap and investment plans; |
• | assessing the health and oversight of the execution of our technology strategies; including architecture, use of open source software, development best practices and third-party dependencies; |
• | ensuring that best practice Q&A policies and procedures are in place and are adhered to; |
• | assessing the scope and quality of our intellectual property, including its support of our approved business plan; |
• | providing guidance on technology as it may pertain to market entry and exit, investments, mergers, acquisitions and divestitures, research and development investments, and key competitor and partnership strategies; |
• | performing such other duties and responsibilities as are enumerated in and consistent with its charter |
Name and Principal Position |
Year |
Salary ($) |
Bonus ($) |
Committee or meeting fees ($) |
Value of perquisites ($) |
All other compensation ($) |
Total compensation ($) |
|||||||||||||||||||||
Russel H. McMeekin (1) Director, President and Chief Executive Officer |
2021 | $ | 249,999.84 USD | Nil | Nil | Nil | $ | 93,500 USD | $ | 343,499.84 USD | ||||||||||||||||||
Costantino Lanza (2) Director and Chief Growth Officer |
2021 | $ | 249,999.84 USD | Nil | Nil | Nil | $ | 42,358 USD | $ | 292,357 USD | ||||||||||||||||||
Chantal Schutz Chief Financial Officer |
2021 | $ | 262,000 CAD | Nil | Nil | Nil | Nil | $ | 262,000 CAD | |||||||||||||||||||
Michael Allman Director |
2021 | Nil | Nil | $ | 48,000 USD | Nil | Nil | $ | 48,000 USD | |||||||||||||||||||
Elizabeth MacLean Director |
2021 | Nil | Nil | $ | 48,000 USD | Nil | Nil | $ | 48,000 USD | |||||||||||||||||||
Ian Russell Director |
2021 | Nil | Nil | $ | 48,000 USD | Nil | Nil | $ | 48,000 USD | |||||||||||||||||||
Michael A. Sicuro (3) |
2021 | Nil | Nil | $ | 20,000 USD | Nil | Nil | $ | 20,000 USD |
(1) | Inclusive of the total compensation, Mr. McMeekin received no compensation for his role as director of the Company. |
(2) | Inclusive of the total compensation, Mr. Lanza received no compensation for his role as director of the Company. |
(3) | Mr. Sicuro resigned effective as of May 31, 2021. |
Name and Principal Position |
Type of Security |
Number of Compensation Securities, Number of Underlying Securities, and Percentage of Class(1) |
Date of Issue or Grant |
Issue, Conversion or Exercise Price ($) |
Closing Price of Security or Underlying Security on Date of Grant ($) |
Closing Price of Security or Underlying Security at Year End ($) |
Expiry Date | |||||||||||||
Russel H. McMeekin |
Stock Options | 25,000 | October 24, 2019 | Exercise price $12.90 |
$ | 12.30 CAD | $ | 6.10 CAD | October 24, 2029 | |||||||||||
Russel H. McMeekin |
RSU’s | 50,000 | April 12, 2018 | $9.75 CAD | $ | 9.75 CAD | $ | 6.10 CAD | No expiry | |||||||||||
Russel H. McMeekin |
RSU’s | 25,000 | October 24, 2019 | $12.30 CAD | $ | 12.30 CAD | $ | 6.10 CAD | No expiry | |||||||||||
Costantino Lanza |
Stock Option | 12,500 | October 24, 2019 | Exercise price $12.90 |
$ | 12.30 CAD | $ | 6.10 CAD | October 24, 2029 | |||||||||||
Costantino Lanza |
RSU’s | 3,333 | April 12, 2018 | $9.75 CAD | $ | 9.75 CAD | $ | 6.10 CAD | No expiry | |||||||||||
Costantino Lanza |
RSU’s | 12,500 | October 24, 2019 | $12.30 CAD | $ | 12.30 CAD | $ | 6.10 CAD | No expiry | |||||||||||
Michael A. Sicuro |
RSU’s | 6,667 | April 12, 2018 | $9.75 CAD | $ | 9.75 CAD | $ | 6.10 CAD | No expiry | |||||||||||
Ian Russel |
Stock Option | 5,000 | October 24, 2019 | Exercise price $11.85 |
$ | 12.30 CAD | $ | 6.10 CAD | October 24, 2029 | |||||||||||
Chantal Schutz |
Stock Option | 8,333 | October 24, 2019 | Exercise Price $11.70 |
$ | 12.30 CAD | $ | 6.10 CAD | October 24, 2029 | |||||||||||
Chantal Schutz |
Stock Option | 8,333 | July 31, 2021 | Exercise Price $7.65 |
$ | 7.65 CAD | $ | 6.10 CAD | July 31, 2031 | |||||||||||
Chantal Schutz |
Stock Option | 28,800 | October 22, 2021 | Exercise Price $6.99 |
$ | 6.99 CAD | $ | 6.10 CAD | October 22, 2031 | |||||||||||
Chantal Schutz |
Stock Option | 733 | Jan 1, 2022 | Exercise Price $6.99 |
$ | 6.32 CAD | $ | 6.10 CAD | Jan 1, 2032 | |||||||||||
Chantal Schutz |
RSU’s | 8,333 | October 24, 2019 | $12.30 CAD | $ | 12.30 CAD | $ | 6.10 CAD | No Expiry | |||||||||||
Chantal Schutz |
RSU’s | 8,333 | July 31, 2021 | $7.65 CAD | $ | 7.65 CAD | $ | 6.10 CAD | No Expiry |
• | to attract, retain and motivate talented executives who create and sustain our continued success; |
• | to align our interests with the interests of our shareholders; and |
• | to provide total compensation to executives that is competitive with that paid by other companies of comparable size engaged in similar businesses in appropriate regions. |
a) | base salaries; |
b) | performance bonuses; and |
c) | equity incentive grants. |
Name |
Position | |
Russel H. McMeekin |
Chief Executive Officer, President, Director | |
Michael Allman |
Director | |
Costantino Lanza |
Chief Growth Officer, Corporate Secretary, Director | |
Elizabeth MacLean |
Director | |
Ian Russell |
Director | |
Chantal Schutz |
Chief Financial Officer |
• | each shareholder known by us to be the beneficial owner of more than 5% of our outstanding Common Shares, |
• | each of our directors, |
• | each of our named executive officers, and |
• | all of our directors and executive officers as a group. |
Beneficial Ownership |
||||||||||||||||
Prior to Offering |
Following Offering(1) |
|||||||||||||||
Name of Beneficial Owner |
Common Shares |
Percentage |
Common Shares |
Percentage |
||||||||||||
Russel H. McMeekin |
229,538 | 1.42 | % | 229,538 | * | % | ||||||||||
Michael Allman |
135,157 | * | % | 135,157 | * | % | ||||||||||
Costantino Lanza |
182,845 | 1.13 | % | 182,845 | * | % | ||||||||||
Elizabeth MacLean |
0 | 0 | % | 0 | 0 | % | ||||||||||
Ian Russell |
18,702 | * | % | 18,702 | * | % | ||||||||||
Chantal Schutz |
8,808 | * | % | 8.808 | * | % | ||||||||||
All officers and directors as a group |
|
|
|
|
|
|
|
|
|
|
|
|
* | Less than 1% |
(1) | Calculated assuming full conversion of all Series A Preferred Shares into Common Shares |
Underwriter |
Series A Preferred Shares |
Warrants |
||||||
Maxim Group LLC |
||||||||
American Trust Investment Services Inc. |
||||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
• | receipt and acceptance of the Units by the Underwriter; |
• | the Underwriter’s right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part; and |
• | other conditions contained in the Underwriting Agreement, such as the receipt by the Underwriter of officers’ certificates and legal opinions. |
Underwriter |
Per Series A Preferred Share |
Per Warrant |
Without Over- Allotment Option |
With Over- Allotment Option |
||||||||||||
Public offering price: |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Underwriting discounts and commissions payable by us: |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Proceeds, before expenses, to us: |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
||||||||||||||||
|
|
|
|
|
|
|
|
• | a passive market maker may not effect transactions or display bids for our shares in excess of the highest independent bid price by persons who are not passive market makers; |
• | net purchases by a passive market maker on each day are generally limited to 30% of the passive market maker’s average daily trading volume in our shares during a specified two-month prior period or 200 shares, whichever is greater, and must be discontinued when that limit is reached; and |
• | passive market making bids must be identified as such. |
U.S. Securities and Exchange Commission registration fee |
$ | 5,829.97 | ||
FINRA filing fee |
9,933.59 | |||
Nasdaq listing fee |
5,000 | |||
Legal fees and expenses |
264,000 | |||
Accounting fees and expenses |
150,000 | |||
Transfer agent fees and expenses |
5,000 | |||
Printing fees and expenses |
70,000 | |||
Miscellaneous |
50,000 | |||
|
|
|||
Total |
$ | 553,933.59 | ||
|
|
Notes |
December 31, 2021 |
December 31, 2020 |
||||||||||
ASSETS |
||||||||||||
Current assets |
||||||||||||
Cash and cash equivalents |
$ | $ | ||||||||||
Trade and other receivables |
6 | |||||||||||
Current portion of prepaid expenses and other assets |
7 | |||||||||||
Current portion of long-term receivables |
6 | |||||||||||
Total current assets |
$ | $ | ||||||||||
Non-current assets |
||||||||||||
Prepaid expenses and other assets |
7 | |||||||||||
Long-term receivables |
6 | |||||||||||
Right-of-use assets |
8 | |||||||||||
Property and equipment |
9 | |||||||||||
Intangible assets |
10 | |||||||||||
Goodwill |
10 | |||||||||||
Total non-current assets |
$ | $ | ||||||||||
Total assets |
$ |
$ |
||||||||||
LIABILITIES |
||||||||||||
Current liabilities |
||||||||||||
Bank indebtedness |
13 | $ | $ | |||||||||
Trade payables and accrued liabilities |
11 | |||||||||||
Deferred revenue |
5 | |||||||||||
Current portion of loans and borrowings |
12 | |||||||||||
Current portion of convertible debentures |
14 | |||||||||||
Warrant liabilities |
15 | |||||||||||
Current portion of lease liabilities |
8 | |||||||||||
Current portion of other liabilities |
16 | |||||||||||
Current portion of business acquisition payable |
18 | |||||||||||
Total current liabilities |
$ | $ | ||||||||||
Non-current liabilities |
||||||||||||
Convertible debentures |
14 | |||||||||||
Lease liabilities |
8 | |||||||||||
Loans and borrowings |
12 | |||||||||||
Deferred income tax liabilities |
25 | |||||||||||
Other liabilities |
16 | |||||||||||
Business acquisition payable |
18 | |||||||||||
Total liabilities |
$ |
$ |
||||||||||
EQUITY |
||||||||||||
Share capital |
19 | |||||||||||
Contributed surplus |
||||||||||||
Accumulative other comprehensive income |
||||||||||||
Deficit |
( |
) | ( |
) | ||||||||
Total shareholders’ equity |
$ | $ | ||||||||||
Non-controlling interest |
21 | |||||||||||
Total equity |
$ |
$ |
||||||||||
Total liabilities and equity |
$ |
$ |
“Russ McMeekin” |
“Michael Allman” |
| ||||
Director |
Director |
Year ended December 31, |
||||||||||||||||
Notes |
2021 |
2020 |
2019 |
|||||||||||||
Revenue |
4, 5 | $ | |
$ | |
$ | |
|||||||||
Cost of sales |
( |
) | ( |
) | ( |
) | ||||||||||
Gross profit |
$ | $ | $ | |||||||||||||
Expenses |
||||||||||||||||
Salaries, wages and benefits |
||||||||||||||||
Sales and marketing |
||||||||||||||||
Research and development |
||||||||||||||||
General and administration |
||||||||||||||||
Professional and consulting fees |
||||||||||||||||
Share-based compensation |
20 | |||||||||||||||
Depreciation and amortization |
8-10 | |||||||||||||||
Total expenses |
$ | $ | $ | |||||||||||||
Operating loss |
$ | $ | $ | |||||||||||||
Other expenses (income) |
||||||||||||||||
Finance costs |
22 | |||||||||||||||
Foreign exchange loss (gain) |
( |
) | ||||||||||||||
Business acquisition costs and other expenses |
17 | |||||||||||||||
Impairment |
9,10(a) | – | – | |||||||||||||
Fair value loss on derivatives |
23 | – | – | |||||||||||||
Other income |
24 | ( |
) | ( |
) | ( |
) | |||||||||
Loss before tax |
$ | $ | $ | |||||||||||||
Current tax expense (recovery) |
25 | ( |
) | |||||||||||||
Deferred tax (recovery) expense |
25 | ( |
) | ( |
) | ( |
) | |||||||||
Net loss for the year |
$ | $ | $ | |||||||||||||
Other comprehensive (income) loss |
||||||||||||||||
Foreign subsidiary translation differences |
( |
) | ( |
) | ||||||||||||
Comprehensive loss for the year |
$ |
$ |
$ |
|||||||||||||
Net loss (income) for the year attributable to: |
||||||||||||||||
mCloud Technologies Corp. shareholders |
||||||||||||||||
Non-controlling interest |
( |
) | ( |
) | ||||||||||||
$ |
$ |
$ |
||||||||||||||
Comprehensive loss (income) for the year attributable to: |
||||||||||||||||
mCloud Technologies Corp. shareholders |
||||||||||||||||
Non-controlling interest |
( |
) | ( |
) | ||||||||||||
$ |
$ |
$ |
||||||||||||||
Loss per share attributable to mCloud shareholders – basic and diluted |
$ |
$ |
$ |
|||||||||||||
Weighted average number of common shares outstanding - basic and diluted |
Notes |
Number of Shares |
Share Capital |
Contributed Surplus |
Accumulated Other Comprehensive Income |
Deficit |
Total Shareholder’s Equity |
Non- controlling Interest |
Total Equity |
||||||||||||||||||||||||||||
Balance, December 31, 2020 |
$ | $ | $ | $ | ( |
) | $ | $ | $ | |||||||||||||||||||||||||||
Share-based payments |
20 | – | – | – | – | – | ||||||||||||||||||||||||||||||
RSUs exercised |
20 | ( |
) | – | – | ( |
) | – | ( |
|||||||||||||||||||||||||||
Broker warrants issued |
19(b) | – | – | – | – | – | ||||||||||||||||||||||||||||||
Shares issued in public offering, net of costs |
19(a) | – | – | – | – | |||||||||||||||||||||||||||||||
Warrants issued in public offering, net of costs |
19(a) | – | – | – | – | – | ||||||||||||||||||||||||||||||
Shares issued in private placement |
19(a) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued on 2021 Debentures conversion, net |
19(a) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued in USD public offering, net of costs |
19(a) | – | – | – | – | |||||||||||||||||||||||||||||||
Underwriter warrants issued in USD public offering |
19(a) | – | – | – | – | – | ||||||||||||||||||||||||||||||
Net loss for the year |
– | – | – | – | ( |
) | ( |
) | ( |
( |
||||||||||||||||||||||||||
Other comprehensive (loss) income for the year |
– | – | – | ( |
) | – | ( |
) | ( |
|||||||||||||||||||||||||||
Balance, December 31, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
Notes |
Number of Shares |
Share Capital |
Contributed Surplus |
Accumulated Other Comprehensive Income |
Deficit |
Total Shareholder’s Equity |
Non- controlling Interest |
Total Equity |
||||||||||||||||||||||||||||
Balance, December 31, 2019 |
$ | $ | $ | $ | ( |
) | $ | $ | $ | |||||||||||||||||||||||||||
Share-based payments |
20 | – | – | – | – | – | ||||||||||||||||||||||||||||||
RSUs exercised |
20(b) | ( |
) | – | – | ( |
) | – | ( |
|||||||||||||||||||||||||||
Stock options exercised |
20(a) | ( |
) | – | – | – | ||||||||||||||||||||||||||||||
Warrants exercised |
( |
) | – | – | – | |||||||||||||||||||||||||||||||
Shares issued in business combination - CSA |
17(d) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued in business combination - kanepi |
17(e) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued for transaction costs - kanepi |
17(e) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued for asset acquisition - AirFusion |
– | – | – | – | ||||||||||||||||||||||||||||||||
Shares issued on conversion of 2019 debentures |
19(b) | – | – | – | ||||||||||||||||||||||||||||||||
Issue of special warrants, net |
– | – | – | – | – | |||||||||||||||||||||||||||||||
Conversion of special warrants |
( |
) | – | – | – | – | – | |||||||||||||||||||||||||||||
Settlement of debt with RSUs |
– | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued in public offering, net of costs |
– | – | – | |||||||||||||||||||||||||||||||||
Net (loss) income for the year |
– | – | – | – | ( |
) | ( |
) | ( |
|||||||||||||||||||||||||||
Other comprehensive (loss) income for the year |
– | – | – | – | ( |
) | ||||||||||||||||||||||||||||||
Balance, December 31, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
Notes |
Number of Shares |
Share Capital |
Contributed Surplus |
Accumulated Other Comprehensive Income |
Deficit |
Total Shareholder’s Equity |
Non- controlling Interest |
Total Equity |
||||||||||||||||||||||||||||
Balance, December 31, 2018 |
$ | |
$ | |
$ ( |
) | $ ( |
) | $ | $ | – | $ | ||||||||||||||||||||||||
Share-based payments |
20 | – | – | – | – | – | ||||||||||||||||||||||||||||||
RSUs exercised |
20(b) | ( |
) | – | – | – | – | – | ||||||||||||||||||||||||||||
Stock options exercised |
20(a) | ( |
) | – | – | – | ||||||||||||||||||||||||||||||
Share purchase warrants exercised |
18(b) | ( |
) | – | – | – | ||||||||||||||||||||||||||||||
Shares issued on business combination |
17(c) | – | – | – | – | |||||||||||||||||||||||||||||||
Transaction costs on business combination |
17(c) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued to extinguish the loan from Flow Capital |
17(a) | – | – | – | – | |||||||||||||||||||||||||||||||
Shares issued to settle liabilities |
19(a) | – | – | – | – | |||||||||||||||||||||||||||||||
Share issuance costs |
– | ( |
) | – | – | ( |
) | – | ( |
|||||||||||||||||||||||||||
Warrants issued |
– | – | – | – | – | |||||||||||||||||||||||||||||||
Equity component of convertible debentures |
– | – | – | – | – | |||||||||||||||||||||||||||||||
Contingent shares issuable to Flow Capital |
17(a) | – | – | – | – | – | ||||||||||||||||||||||||||||||
Non-controlling interest recognized in business combination |
– | – | – | – | – | – | ( |
) | ( |
|||||||||||||||||||||||||||
Net (loss) income for the year |
– | – | – | – | ( |
) | ( |
) | ( |
|||||||||||||||||||||||||||
Other comprehensive income for the year |
– | – | – | – | ||||||||||||||||||||||||||||||||
Balance, December 31, 2019 |
$ |
$ |
$ |
$ ( |
$ |
$ |
$ |
Year ended December 31, |
||||||||||||||||
Notes |
2021 |
2020 |
2019 |
|||||||||||||
Operating activities |
||||||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||||||
Items not affecting cash: |
||||||||||||||||
Depreciation and amortization |
8-10 | |||||||||||||||
Share-based compensation |
20 | |||||||||||||||
Finance costs |
22 | |||||||||||||||
Fair value loss on derivatives |
23 | – | – | |||||||||||||
Impairment |
– | – | ||||||||||||||
Other income |
24 | ( |
) | ( |
) | ( |
) | |||||||||
Provision for expected credit loss |
26 | |||||||||||||||
Unrealized foreign currency exchange gain |
( |
) | ||||||||||||||
Business acquisition costs |
– | |||||||||||||||
Current tax expense (recovery) |
25 | ( |
) | |||||||||||||
Deferred income tax recovery |
25 | ( |
) | ( |
) | ( |
) | |||||||||
Gain on settlement of lease liability |
– | – | ( |
) | ||||||||||||
Decrease in working capital |
30 | ( |
) | ( |
) | ( |
) | |||||||||
Interest paid |
( |
) | ( |
) | ( |
) | ||||||||||
Taxes paid |
– | ( |
) | ( |
) | |||||||||||
Net cash used in operating activities |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||||||
Investing activities |
||||||||||||||||
Acquisition of property and equipment |
9 | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||
Acquisition of and expenditure on intangible assets |
10 | ( |
) | ( |
) | – | ||||||||||
Acquisition of royalty agreement |
17(a) | – | – | ( |
) | |||||||||||
Acquisition of assets of AirFusion |
– | ( |
) | – | ||||||||||||
Acquisition of business, net of cash acquired |
17 | – | ( |
) | ( |
) | ||||||||||
Net cash used in investing activities |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||||||
Financing activities |
||||||||||||||||
Payment of lease liabilities |
8 | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||
Repayment of loans |
12 | ( |
) | ( |
) | ( |
) | |||||||||
Proceeds from loans and bank indebtedness, net of transaction costs |
12, 13 | |
|
|||||||||||||
Net (repayments) advances of bank indebtedness |
13 | ( |
) | ( |
) | |||||||||||
Proceeds from issuance of shares, net of issuance costs |
19(a) | |
– | |||||||||||||
Proceeds from issuance of convertible debentures, net of costs |
14 | |||||||||||||||
Proceeds from issuance of warrants, net of issuance costs |
19(a) | |||||||||||||||
Proceeds from the exercise of stock options, net of issuance costs |
||||||||||||||||
Proceeds from exercise of warrants, net |
– | – | ||||||||||||||
Income tax withholding on RSUs |
( |
) | ( |
) | – | |||||||||||
Net cash provided by financing activities |
$ | $ | $ | |||||||||||||
Increase in cash and cash equivalents |
$ | $ | $ | ( |
) | |||||||||||
Effect of exchange rate fluctuations on cash held |
( |
) | ( |
) | ( |
) | ||||||||||
Cash and cash equivalents, beginning of year |
||||||||||||||||
Cash and cash equivalents, end of year |
$ |
$ |
$ |
(a) |
Critical judgements in applying accounting policies |
(b) |
Key sources of estimation uncertainty |
(b) |
Key sources of estimation uncertainty (continued) |
Year ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Canada |
$ | $ | $ | |||||||||
United States |
||||||||||||
Japan |
– | |||||||||||
Australia |
– | |||||||||||
Other |
– | |||||||||||
Total revenue |
$ |
$ |
$ |
For the years ended December 31, |
2021 |
2020 |
2019 | |||
Customer A |
Less than |
n/a | ||||
Customer B |
Less than |
|||||
Customer C |
Less than |
|||||
Customer D |
Less than |
n/a |
December 31, 2021 |
December 31, 2020 |
|||||||
Canada |
$ | $ | ||||||
Australia |
||||||||
United States |
||||||||
Total non-current assets |
$ |
$ |
Year ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
AssetCare initialization 1 |
$ | $ | $ | |||||||||
AssetCare over time 2 |
||||||||||||
Engineering services 3 |
||||||||||||
$ |
$ |
$ |
1 |
Revenues from initial implementation and activation of AssetCare projects, including the sale of hardware. |
2 |
Revenues include sales of subscriptions to AssetCare, other subscriptions, post contract support and maintenance, perpetual software licenses, and installation and engineering services. |
3 |
Revenues includes consulting, implementation and integration services entered into on a time and materials basis or fixed fee basis without the use of AssetCare. |
Year ended December 31, |
||||||||||||
Timing of revenue recognition | 2021 |
2020 |
2019 |
|||||||||
Over time |
$ | $ | $ | |||||||||
At a point in time upon completion |
||||||||||||
$ |
$ |
$ |
Unbilled revenue |
Deferred revenue |
|||||||||
Balance at January 1, 2019 |
$ |
— |
$ |
|||||||
Acquired in business combination (Note 17(c)) |
||||||||||
Acquired in business combination (Note 17(b)) |
— |
|||||||||
Additions |
||||||||||
Less: transferred to trade and other receivables |
( |
) |
— |
|||||||
Less: recognized in revenue |
— |
( |
) | |||||||
Less: Loss allowance |
( |
) |
— |
|||||||
Effect of movement in exchange rates |
— |
( |
) | |||||||
Balance at December 31, 2019 |
$ | $ | ||||||||
Acquired in business combination |
– | |||||||||
Additions |
||||||||||
Less: transferred to trade and other receivables |
( |
) | – | |||||||
Less: write-offs |
( |
) | – | |||||||
Less: recognized in revenue |
– | ( |
) | |||||||
Less: applied to outstanding trade receivables |
– | ( |
) | |||||||
Effect of movement in exchange rates |
( |
) | ||||||||
Balance at December 31, 2020 |
$ |
$ |
||||||||
Additions |
|
|||||||||
Less: transferred to trade and other receivables |
( |
) | – | |||||||
Less: recognized in revenue |
– | ( |
) | |||||||
Effect of movement in exchange rates |
– | |||||||||
Balance at December 31, 2021 1 |
$ |
$ |
1 |
Unbilled revenue is included in trade and other receivables (Note 6) and relates to the Company’s right to consideration for work completed but not billed at the reporting date. Unbilled revenue is transferred to trade and other receivables when services are billed to customers. |
December 31, 2021 |
December 31, 2020 |
|||||||
Trade receivables from contracts with customers |
$ | $ | ||||||
Unbilled revenue (Note 5) |
||||||||
Indirect taxes receivable |
||||||||
Income taxes receivable |
||||||||
Other receivables |
||||||||
Contract asset 1 |
||||||||
Loss allowance (Note 26(b)) |
( |
) | ( |
) | ||||
Total trade and other receivables - current |
$ |
$ |
1 |
At December 31, 2021, the total contract assets were $ |
December 31, 2021 |
December 31, 2020 |
|||||||
Current portion of long-term receivables 1 |
$ | $ | ||||||
Non-current portion of long-term receivables 2 |
||||||||
Total long-term receivables |
$ |
$ |
1 |
Net of expected credit loss allowance of $ $ |
2 |
Net of expected credit loss allowance of $ |
December 31, 2021 |
December 31, 2020 |
|||||||
Prepaid insurance |
$ | $ | ||||||
Advances |
||||||||
Deposits |
||||||||
Prepaid licenses |
||||||||
Prepaid services |
||||||||
Other prepaid costs |
||||||||
Other assets |
||||||||
Prepaid expenses and other assets |
$ |
$ |
||||||
Current portion |
$ |
$ |
||||||
Non-current portion |
||||||||
$ |
$ |
Office |
Equipment and Vehicles |
Total |
||||||||||
Balance at January 1, 2019 |
$ | $ | – | $ | ||||||||
Acquired right-of-use assets (Note 17) |
||||||||||||
Additions to right-of-use assets |
– | |||||||||||
Depreciation charge for the year |
( |
) | ( |
) | ( |
) | ||||||
Impairment charge for the year |
( |
) | – | ( |
) | |||||||
Effect of movement in exchange rates |
( |
) | – | ( |
) | |||||||
Balance at January 1, 2020 |
$ |
$ |
$ |
|||||||||
Acquired right-of-use assets (Note 17) |
– | |||||||||||
Additions to right-of-use assets |
||||||||||||
Depreciation charge for the year |
( |
) | ( |
) | ( |
) | ||||||
Impact of lease modification |
( |
) | – | ( |
) | |||||||
Effect of movement in exchange rates |
( |
) | ||||||||||
Balance at December 31, 2020 |
$ |
$ |
$ |
|||||||||
Depreciation charge for the year |
( |
) | ( |
) | ( |
) | ||||||
Impact of lease modification |
( |
) | – | ( |
) | |||||||
Effect of movement in exchange rates |
( |
) | ||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
Year ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Accretion of lease liabilities included in finance costs |
$ | $ | $ | |||||||||
Depreciation of right-of-use assets 1 |
||||||||||||
Expense related to variable lease payments 2 |
– | |||||||||||
Expense related to short-term leases 2 |
– | – | ||||||||||
$ |
$ |
$ |
1 |
Included in depreciation and amortization expense. |
2 |
Included in rent expense within general and administrative expense. |
Year ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Total cash outflows included in operating activities |
$ | $ | $ | |||||||||
Total cash outflows included in financing activities |
$ | |
$ | |
$ | |
Office Furniture and Equipment |
Leasehold Improvements |
Computer Equipment |
Total |
|||||||||||||||||||
Cost: |
||||||||||||||||||||||
At January 1, 2019 |
$ | $ | $ | $ | ||||||||||||||||||
Additions |
||||||||||||||||||||||
Acquisitions |
||||||||||||||||||||||
Impairment |
– | – | ( |
) | ( |
) | ||||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
At December 31, 2019 |
$ |
$ |
$ |
$ |
||||||||||||||||||
Additions |
– | |||||||||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Balance at December 31, 2020 |
$ |
$ |
$ |
$ |
||||||||||||||||||
Additions |
– | – | ||||||||||||||||||||
Disposals |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
$ |
||||||||||||||||||
Accumulated depreciation: |
||||||||||||||||||||||
At January 1, 2019 |
$ | $ | $ | $ | ||||||||||||||||||
Depreciation |
||||||||||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
At December 31, 2019 |
$ |
$ |
$ |
$ |
||||||||||||||||||
Depreciation |
||||||||||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Balance at December 31, 2020 |
$ |
$ |
$ |
$ |
||||||||||||||||||
Depreciation |
||||||||||||||||||||||
Disposals |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Other movements |
– | ( |
) | – | ||||||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
$ |
||||||||||||||||||
Carrying amounts: |
||||||||||||||||||||||
Balance at December 31, 2020 |
$ | $ | $ | $ | ||||||||||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
$ |
Patents and trademarks |
Customer relationships |
Technology |
Total |
|||||||||||||
Cost: |
||||||||||||||||
At January 1, 2019 |
$ | |
$ | $ | $ | |||||||||||
Additions |
– | – | – | – | ||||||||||||
Acquisitions |
– | |||||||||||||||
Effect of movements in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Balance at December 31, 2019 |
$ |
$ |
$ |
$ |
||||||||||||
Additions |
– | – | ||||||||||||||
Acquisitions |
– | |||||||||||||||
Effect of movements in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Balance at December 31, 2020 |
$ |
$ |
$ |
$ |
||||||||||||
Additions |
– | – | ||||||||||||||
Effect of movement in exchange rates |
( |
) | ( |
) | ( |
) | ||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
$ |
||||||||||||
Accumulated amortization and impairments: |
||||||||||||||||
At January 1, 2019 |
$ | $ | $ | $ | ||||||||||||
Amortization 1 |
||||||||||||||||
Impairment |
– | – | ||||||||||||||
Effect of movements in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Balance at December 31, 2019 |
$ | $ | $ | $ | ||||||||||||
Amortization 1 |
||||||||||||||||
Effect of movements in exchange rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Balance at December 31, 2020 |
$ |
$ |
$ |
$ |
||||||||||||
Amortization 1 |
||||||||||||||||
Effect of movement in exchange rates |
||||||||||||||||
Balance at December 31, 2021 |
$ |
$ |
$ |
$ |
||||||||||||
Carrying amounts: |
||||||||||||||||
Balance at December 31, 2020 |
$ | $ | $ | $ | ||||||||||||
Balance at December 31, 2021 |
$ | $ | $ | $ |
1 |
Amortization charges are included in depreciation and amortization in the consolidated statements of loss and comprehensive loss. |
December 31, 2021 |
December 31, 2020 |
|||||||
Opening balance |
$ | |
$ | |||||
Acquisitions, business combinations (Note 18) |
– | |||||||
Effect of movements in exchange rates |
( |
( |
||||||
Total goodwill |
$ |
$ |
December 31, 2021 |
December 31, 2020 |
|||||||
Trade payables |
$ | $ | ||||||
Accrued liabilities |
||||||||
Interest payable |
||||||||
Mastercard facility (Note 13) |
||||||||
Due to related parties (Note 28) |
||||||||
Income taxes payable |
||||||||
Indirect taxes payable |
||||||||
Other |
||||||||
Total trade payables and accrued liabilities |
$ |
$ |
December 31, 2021 |
December 31, 2020 |
|||||||
Term loan |
$ | $ | ||||||
Nations Interbanc facility |
||||||||
Debenture payable to Industry Canada |
||||||||
Loan payable to related party 1 |
||||||||
Oracle financing 2 |
||||||||
Other loans and financing |
||||||||
Total 3 |
$ |
$ |
||||||
Current |
||||||||
Non-current |
||||||||
$ |
$ |
1 |
Loan assumed as part of CSA Acquisition (Note 17(d)) which bears interest at |
2 |
Financing arrangements provided by Oracle Credit Corporation (“Oracle”) bearing interest between |
3 |
Note 30(b) includes the reconciliation of movements of liabilities to cash flows arising from financing activities. |
December 31, 2021 |
December 31, 2020 |
|||||||
ATB Financial revolving operating facility |
$ | |
$ | – | ||||
Operating loan facility 1 |
– | |||||||
Bank overdraft 1 |
– | |||||||
Total |
$ |
$ |
1 |
At December 31, 2020, the Company had access to an operating loan facility and Mastercard facility. On April 15, 2021, the operating loan facility was repaid and closed. The Mastercard facility remains in place and at December 31, 2021, $ |
December 31, 2021 |
December 31, 2020 |
|||||||
2019 Convertible debentures liability (a) |
$ | $ | |
|||||
2021 Convertible debentures liability (b) |
– | |||||||
2021 Convertible debentures embedded derivative (b) |
– | |||||||
Total |
$ |
$ |
Current debentures |
$ | |
$ | – | ||||
Non-current debentures |
||||||||
$ |
$ |
a) |
2019 Convertible debentures |
December 31, 2021 |
December 31, 2020 |
|||||||
Opening balance |
$ | |
$ | |
||||
Conversion of debentures into common shares |
– | ( |
||||||
Interest paid |
( |
( |
||||||
Accreted interest at effective interest rate |
||||||||
Carrying amount of liability component |
$ | $ | ||||||
Less: interest payable |
( |
( |
||||||
Total |
$ |
$ |
a) |
2019 Convertible debentures (continued) |
b) |
2021 Convertible debentures |
b) |
2021 Convertible debentures (continued) |
December 31, 2021 |
||||
Proceeds from issue of convertible debentures |
$ | |
||
Fair value adjustments (Note 23) |
||||
Total fair value of convertible debentures |
||||
Less: fair value of embedded derivative |
( |
) | ||
Less: transaction costs 1 |
( |
) | ||
Carrying value of liability at inception |
||||
Interest expense associated with liability |
||||
Debt extinguishment, including interest payable |
( |
) | ||
Foreign exchange adjustments |
( |
) | ||
Less: accrued interest included in accrued liabilities |
( |
) | ||
Carrying value of liability at end of period 2 |
$ |
1 |
Total transaction costs were $ |
2 |
Convertible debt in the principal amount of US$ |
December 31, 2021 |
||||
Fair value of embedded derivative at inception |
$ | |
||
Fair value decrease 1 |
( |
) | ||
Derecognition of embedded derivative on conversion |
( |
) | ||
Foreign exchange adjustments |
( |
) | ||
Balance, embedded derivative |
$ |
1 |
The fair value of the embedded derivative is remeasured at the end of each reporting period and on conversion and recognized in fair value (gain) loss on derivatives in the consolidated statements of loss and comprehensive loss (Note 23). |
December 31, 2021 |
December 31, 2020 |
|||||||
Derivative warrant liabilities - 2021 Debentures (a) |
$ | |
$ | – | ||||
Derivative warrant liabilities - USD equity financing (b) |
– | |||||||
Warrant liability related to business acquisition (c) |
||||||||
Other warrant liability (c) |
– | |||||||
Total, all current |
$ |
$ |
Derivative |
warrant liabilities |
December 31, 2021 |
August 13, 2021 |
|||||||
Share price at date of valuation |
$ | |
$ | |
||||
Exercise price |
$ | $ | ||||||
Risk free rate |
||||||||
Expected life (years) |
||||||||
Expected volatility 1 |
||||||||
Fair value per warrant 2 |
$ | $ |
1 |
Expected volatility at December 31, 2021 measured at implied volatility of traded warrants. |
2 |
Considers a liquidity discount of |
December 31, 2021 |
November 29, 2021 |
|||||||
Share price at date of valuation |
$ | |
$ | |
||||
Exercise price |
$ | $ | ||||||
Risk free rate |
||||||||
Expected life (years) |
||||||||
Expected volatility 1 |
||||||||
Fair value per warrant |
$ | $ |
1 |
Expected volatility at represents implied volatility of the Company’s traded warrants. |
|
c) |
Other warrant liabilities |
December 31, 2021 |
December 31, 2020 |
|||||||
US Government loans |
$ | – | $ | |||||
2021 Debentures subscriptions payable (Note 14(b)) |
– | |||||||
Total |
$ |
– |
$ |
|||||
Current portion 1 |
$ | – | ||||||
Non-current portion |
– | |||||||
$ |
– |
$ |
1 |
Includes US Government loans of $ |
a) |
Acquisition of Royalty interests |
i. | a receivable owing by Agnity to Flow of USD $ |
ii. | a monthly royalty payment stream until October 31, 2020 equal to the greater of: |
• | A monthly amount of USD $ |
• | |
iii. | commencing November 1, 2020, a monthly royalty payment stream equal to 4.25% of Agnity’s revenue for each calendar month in perpetuity. |
(i) | A secured loan agreement for USD $ |
• | Cash of USD $ |
• | Issue |
Share price |
$ | |
Risk free rate |
||
Expected life |
||
Expected volatility |
||
Expected dividends |
a) |
Acquisition of Royalty interests (continued) |
(i) | The Company also agreed to issue a quantity of its common shares based on the trading price of the Company. Specifically, for the period after January 22, 2019 and prior to January 22, 2025, if the five-day volume weighted average trading price of the Company’s common shares equals or exceeds: |
• | $ |
• | $ |
• | $ |
Barrier share price |
$ | |
Risk free rate |
||
Expected life |
||
Expected volatility |
||
Expected dividends |
b) |
Acquisition of Agnity |
b) |
Acquisition of Agnity (continued) |
Consideration transferred: |
Final |
|||
Change in fair-value of interest in Royalty Agreement (i) |
$ | |||
Assumption of Agnity’s liabilities |
||||
Total consideration transferred |
$ |
(i) |
The fair value of interest in the Royalty Agreement at April 22, 2019 was estimated using the discounted cash flow model. The major inputs employed in the model include forecasted royalty payments and the discount rate of |
Fair value of assets and liabilities recognized: |
Final |
|||
Cash and cash equivalents |
$ | |||
Trade and other receivables |
||||
Prepaid expenses and deposits |
||||
Long term receivable |
– | |||
Property and equipment |
||||
Intangible Asset – Technology |
||||
Intangible Asset – Customer Relationship |
||||
Accounts payable and accrued liabilities |
( |
) | ||
Deferred revenue |
( |
) | ||
Loans and borrowings |
( |
) | ||
Warrant liability (i) |
( |
) | ||
Due to related party |
( |
) | ||
Deferred income tax liability |
( |
) | ||
Net identifiable assets acquired (liabilities assumed) |
( |
) | ||
Allocation to non-controlling interest |
$ |
(i) | A warrant was issued by Agnity in 2015 which entitles the warrant holder to acquire |
b) |
Acquisition of Agnity (continued) |
c) |
Acquisition of mCloud Technologies Services Inc. |
Consideration transferred: |
Final |
|||
Cash consideration |
$ | |||
Fair value of demand promissory notes issued (1) |
||||
Fair value of common shares transferred (2) |
||||
Total consideration transferred |
$ |
c) |
Acquisition of mCloud Technologies Services Inc. (continued) |
Fair value of assets and liabilities recognized: |
Final |
|||
Cash and cash equivalents |
$ | |||
Trade and other receivables (includes Unbilled revenue of $ |
||||
Prepaid expenses and deposits |
||||
Right-of-use assets |
||||
Property and equipment |
||||
Intangible asset – Customer relationships |
||||
Intangible asset – Technology |
||||
Accounts payable and accrued liabilities |
( |
|||
Deferred revenue |
( |
) | ||
Lease liabilities |
( |
) | ||
Deferred income tax liability |
( |
) | ||
Fair value of net assets acquired |
||||
Goodwill |
$ |
|||
$ |
d) |
Acquisition of Construction Systems Associates, Inc. USA |
Final |
||||
Consideration transferred: |
||||
Cash consideration |
$ | |||
Fair value of common share consideration |
||||
Fair value of contingent consideration payable |
||||
Total consideration |
$ |
Fair value of assets and liabilities recognized: |
||||
Cash |
$ | |||
Trade and other receivables |
||||
Prepaid expenses and other deposits |
||||
Property and equipment |
||||
Right of use assets |
||||
Intangible - technology |
||||
Intangible - customer relationships |
||||
Accounts payable and accrued liabilities |
( |
) | ||
Short-term loan |
( |
) | ||
Lease liabilities |
( |
) | ||
Deferred tax liabilities |
||||
Fair value of net assets acquired |
$ |
|||
Goodwill |
$ |
e) |
Acquisition of kanepi |
Final |
||||
Consideration transferred: |
||||
Cash consideration |
$ | |||
Fair value of common share consideration |
||||
Fair value of contingent consideration payable |
||||
Total consideration |
$ |
Fair value of assets and liabilities recognized: |
||||
Cash |
$ | |||
Trade and other receivables |
||||
Other current assets |
||||
Property and equipment |
||||
Right of use assets |
||||
Intangible - technology |
||||
Intangible - customer relationships |
||||
Accounts payable and accrued liabilities |
( |
) | ||
Lease liabilities |
( |
) | ||
Deferred tax liabilities |
( |
) | ||
Fair value of net assets acquired |
$ |
|||
Goodwill |
$ |
December 31, 2021 |
December 31, 2020 |
|||||||
Opening balance |
$ | $ | ||||||
Contingent consideration changes related to CSA (Note 17) |
( |
) | ||||||
Contingent consideration changes related to kanepi (Note 17) |
( |
) | ||||||
Effect of foreign exchange differences |
( |
) | ( |
) | ||||
Current portion |
||||||||
Non-current portion |
||||||||
$ |
$ |
a) |
Common shares |
b) Warrants |
Number of Warrants |
Weighted Average Exercise Price $ | |||||
December 31, 2018 |
$ | |||||
Issued |
$ | |||||
Exercised |
( |
$ | ||||
Expired |
( |
|||||
December 31, 2019 |
$ | |||||
Issued |
||||||
Exercised |
( |
|||||
Expired |
( |
|||||
December 31, 2020 |
$ | |||||
Issued |
||||||
Expired |
( |
|||||
December 31, 2021 |
$ |
• |
• |
• |
• |
• |
• |
Expiry Date |
Exercise Price $ |
Outstanding Warrants | ||||
June 2022 |
||||||
July 2022 |
||||||
December 2022 |
||||||
January 2023 |
||||||
January 2023 |
||||||
February 2023 |
||||||
March 2023 |
||||||
May 2023 |
||||||
April 2024 |
||||||
June 2024 |
||||||
August 2024 |
||||||
January 2025 |
||||||
May 2025 |
||||||
July 2025 |
||||||
November 2026 |
||||||
$ |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Stock options (a) |
$ | $ | $ | |||||||||
Restricted share units (b) |
||||||||||||
Total |
$ |
$ |
$ |
a) |
Stock Options |
Number of Options |
Weighted Average Exercise Price |
Number of Options |
Weighted Average Exercise Price |
Number of Options |
Weighted Average Exercise Price |
|||||||||||||||||||
2021 |
2021 |
2020 |
2020 |
2019 |
2019 |
|||||||||||||||||||
Opening balance |
$ | $ | $ | |||||||||||||||||||||
Granted |
||||||||||||||||||||||||
Exercised |
– | – | ( |
) | ( |
) | ||||||||||||||||||
Forfeited |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Expired |
( |
) | ( |
) | – | – | ||||||||||||||||||
Cancelled |
– | – | ( |
) | – | – | ||||||||||||||||||
Outstanding at December 31 |
$ |
$ |
$ |
|||||||||||||||||||||
Exercisable at December 31 |
$ |
$ |
$ |
a) |
Stock Options (continued) |
Options Outstanding |
Options exercisable | |||||||||||||||||||||||
Range of prices |
Number |
Weighted average exercise price |
Weighted average life (years) |
Number |
Weighted average exercise price |
|||||||||||||||||||
$ |
$ | $ | ||||||||||||||||||||||
$ |
$ | |
$ | |||||||||||||||||||||
$ |
$ | $ | |
|||||||||||||||||||||
$ |
$ | $ | ||||||||||||||||||||||
$ |
$ |
2021 |
2020 |
2019 | ||||
Grant date share price |
$ |
$ |
$ | |||
Exercise price |
$ |
$ |
$ | |||
Risk-free rate |
||||||
Expected life, years |
||||||
Expected volatility |
||||||
Expected dividends |
– % | – % | – % | |||
Forfeiture rate |
– % |
b) |
Restricted Share Units (“RSUs”) |
b) |
Restricted Share Units (“RSUs”) (continued) |
Number of RSUs |
2021 |
2020 |
2019 |
|||||||||
Outstanding at January 1 |
||||||||||||
Granted |
||||||||||||
Exercised 1 |
( |
( |
( |
|||||||||
Forfeited |
( |
( |
( |
|||||||||
Withheld 1 |
( |
( |
– | |||||||||
Outstanding at December 31 |
||||||||||||
Exercisable at December 31 |
1 |
December 31, 2021 |
December 31, 2020 |
|||||||||||
NCI percentage |
||||||||||||
Current assets |
$ | $ | ||||||||||
Non-current assets |
||||||||||||
Current liabilities |
( |
( |
||||||||||
Non-current liabilities |
( |
( |
||||||||||
Net assets attributable to NCI |
$ | $ | ||||||||||
For the years ended |
December 31, 2021 |
December 31, 2020 |
December 31, 20 19 |
|||||||||
Revenue |
$ | $ | $ | |||||||||
Income (loss) allocated to NCI |
( |
|||||||||||
Other comprehensive income allocated to NCI |
( |
|||||||||||
Total comprehensive (loss) income attributable to NCI |
$ | ( |
$ | $ | ||||||||
Cash flows (used in) provided by operating activities |
$ | ( |
( |
|||||||||
Cash flows used in investing activities |
( |
– | ( |
|||||||||
Cash flows (used in) provided by financing activities |
( |
|||||||||||
Foreign exchange impact on cash held in USD |
( |
|||||||||||
Net (decrease) increase in cash and cash equivalents |
$ | ( |
$ | $ |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Interest on loans and borrowings (Note 12) |
$ | |
$ | $ | ||||||||
Interest on convertible debentures (Note 14) |
||||||||||||
Interest on lease liabilities (Note 8) |
||||||||||||
Transaction costs expensed 1 |
– | – | ||||||||||
Other finance costs |
– | – | ||||||||||
Total finance costs |
$ |
$ |
$ |
1 |
Transaction costs include costs incurred associated with financing or equity transactions that are not otherwise netted against the debt or equity instrument. The majority of costs are associated with the USD brokered public offering (Note 19(a)), the 2021 Debentures (Note 14(b)), the Fiera term loan amendment (Note 12) and the ATB facility amendment (Note 13). |
Year Ended December 31, |
2021 |
||||
Gain on embedded derivatives 1 |
$ | ( |
) | |
Deferred charge loss 1 |
||||
Loss on substantial modification and conversion 1 |
||||
Gain on warrant liability remeasurement (Note 15) 2 |
( |
) | ||
Total |
$ |
1 |
Associated with the 2021 Debentures (Note 14(b)) of which the majority is realized at December 31, 2021. |
2 |
Change in fair value unrealized (Note 26). |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Government assistance 1 |
$ | ( |
$ | ( |
$ | – | ||||||
US Government loan forgiveness 2 (Note 16) |
( |
( |
– | |||||||||
Derecognition of contingent consideration (Note 18) |
( |
– | – | |||||||||
Other |
( |
( |
( |
|||||||||
Total other income |
$ |
( |
$ |
( |
$ |
( |
1 |
Majority represents amounts received from the Canadian Government for wage and rental subsidies associated with COVID-19. The amount of government assistance available is dependent on the programs in place and the Company’s eligibility for these programs. |
2 |
Includes other income recognized as below market interest rate benefit. |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Current tax expense |
||||||||||||
Current year |
( |
) | ||||||||||
Changes in estimates related to prior years |
– | – | – | |||||||||
( |
||||||||||||
Deferred tax expense (recovery) |
||||||||||||
Origination and reversal of temporary differences |
( |
) | ( |
) | ( |
) | ||||||
Change in unrecognized deferred income tax assets |
||||||||||||
( |
( |
( |
||||||||||
Tax expense (recovery) |
$ |
( |
$ |
( |
$ |
( |
Year Ended December 31, |
||||||||||||
2021 |
2020 |
2019 |
||||||||||
Loss before taxes |
$ | ( |
$ | ( |
$ | ( |
||||||
Statutory income tax rate 1 |
% | % | % | |||||||||
Income tax recovery at statutory rate |
( |
( |
( |
|||||||||
Increase (decrease) in taxes resulting from: |
||||||||||||
Change in deferred tax assets not recognized |
||||||||||||
Foreign tax rate and other foreign tax differences |
( |
( |
( |
|||||||||
Change in enacted rates |
( |
– | ||||||||||
Share issuance costs and other |
( |
|||||||||||
Non-deductible transaction costs |
||||||||||||
Other non-deductible items |
||||||||||||
Tax expense (recovery) |
$ |
( |
$ |
( |
$ |
( |
1 |
Comprised of the Canadian Federal effective corporate tax rate of |
At December 31, 2020 |
Recovery/ (expense) through earnings |
Recovery/ (expense) through equity |
Recovery/ (expense) through OCI |
At December 31, 2021 |
||||||||||||||||||
Property and equipment |
$ | $ | ( |
$ | – | $ | $ | |||||||||||||||
Intangible assets |
( |
– | ( |
|||||||||||||||||||
Loans and accrued liabilities |
( |
– | ( |
( |
||||||||||||||||||
Share issuance costs |
– | – | ||||||||||||||||||||
Foreign exchange |
– | ( |
– | ( |
||||||||||||||||||
Non-capital losses/net operating losses |
( |
– | ( |
|||||||||||||||||||
Total |
$ |
( |
$ |
$ |
– |
$ |
$ |
( |
At December 31, 2019 |
Acquired in business combinations |
Recovery/ (expense) through earnings |
Recovery/ (expense) through equity |
Recovery/ (expense) through OCI |
At December 31, 2020 |
|||||||||||||||||||
Property and equipment |
$ | – | $ | ( |
$ | $ | – | $ | ( |
$ | ||||||||||||||
Intangible assets |
( |
( |
– | ( |
||||||||||||||||||||
Loans and accrued liabilities |
( |
– | ( |
( |
( |
|||||||||||||||||||
Share issuance costs |
– | – | – | – | ||||||||||||||||||||
Foreign exchange |
( |
– | – | – | ||||||||||||||||||||
Non-capital losses/net operating losses |
– | ( |
– | ( |
||||||||||||||||||||
Total |
$ |
( |
$ |
( |
$ |
$ |
$ |
$ |
( |
d) |
Deferred tax assets not recognized and tax losses carried forward |
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Net operating losses - United States |
$ | $ | ||||||
Non-capital losses - Canada |
||||||||
Foreign tax losses |
||||||||
Investment tax credits and research and development expenditures |
||||||||
Property and equipment |
||||||||
Share issuance costs |
||||||||
Other |
||||||||
$ |
$ |
a) |
Classification and measurement of financial assets and liabilities by category |
Financial assets |
Measurement basis |
December 31, 2021 |
December 31, 2020 |
|||||||
Cash and cash equivalents |
Amortized cost | $ | $ | |||||||
Trade and other receivables 1 |
Amortized cost | |||||||||
Long-term receivables |
Amortized cost | |||||||||
Derivative asset |
FVTPL | |||||||||
$ |
$ |
|||||||||
Financial liabilities |
||||||||||
Bank indebtedness |
Amortized cost | $ | $ | |||||||
Trade payables and accrued liabilities 1 |
Amortized cost | |||||||||
Loans and borrowings |
Amortized cost | |||||||||
Lease liabilities 2 |
Amortized cost | |||||||||
2019 Debentures - host liability 3 |
Amortized cost | |||||||||
2021 Debentures - host liability 3 |
Amortized cost | |||||||||
2021 Debentures embedded derivative |
FVTPL | |||||||||
Warrant liability - business acquisition |
FVTPL | |||||||||
Warrant liabilities - derivatives (Note 15) |
FVTPL | |||||||||
Business acquisition payable |
Amortized cost | |||||||||
Other liabilities |
Amortized cost | |||||||||
$ |
$ |
1 |
Excludes amounts for indirect taxes, income taxes and contract asset, where applicable. Note 27 describes credit risk associated with trade receivables including reconciliation of expected credit loss allowance. |
2 |
Lease liabilities are not subject to classification in the fair value hierarchy. |
3 |
2019 Debentures (Note 14(a)) and 2021 Debentures host liability (Note 14(b)). |
b) |
Measurement of fair value |
b) |
Measurement of fair value (continued) |
b) |
Measurement of fair value (continued) |
a) |
Liquidity risk (continued) |
At December 31, 2021 |
Undiscounted Contractual Cash Flows |
|||||||||||||||||||
Carrying Amount |
< 1 year |
1 – 2 years |
> 2 years |
Total |
||||||||||||||||
Bank indebtedness 1 |
$ | $ | $ | – | $ | – | $ | |||||||||||||
Trade payables and accrued liabilities |
– | – | ||||||||||||||||||
Loans and borrowings 2 |
– | |||||||||||||||||||
Lease liabilities 3 |
||||||||||||||||||||
2019 Debentures |
– | – | ||||||||||||||||||
2021 Debentures |
– | |||||||||||||||||||
Warrant liabilities 4 |
– | – | ||||||||||||||||||
Business acquisition payable |
– | – | ||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
1 |
No contractual maturity. Excludes interest charged on facility as detailed in Note 13. |
2 |
Includes term loan with a carrying value of $ |
3 |
Variable costs due under leases not included in this amount. Minimum payment related to leases which have not yet commenced are not included in this amount. See Note 29. |
4 |
Majority of liability will be settled by issuing common shares of the Company when warrants are exercised during the year. The remaining amount may be settled in cash or common shares of Agnity (Note 15). |
As at December 31, 2020 |
Undiscounted Contractual Cash Flows |
|||||||||||||||||||
Carrying Amount |
< 1 year |
1 – 2 years |
> 2 years |
Total |
||||||||||||||||
Bank indebtedness |
$ | $ | $ | – | $ | – | $ | |||||||||||||
Trade payables and accrued liabilities |
– | – | ||||||||||||||||||
Loans and borrowings |
||||||||||||||||||||
Lease liabilities |
||||||||||||||||||||
2019 Debentures |
– | |||||||||||||||||||
Warrant liabilities |
– | – | ||||||||||||||||||
Business acquisition payable |
– | |||||||||||||||||||
Other liabilities |
– | |||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
b) |
Credit risk |
b) |
Credit risk (continued) |
December 31, 2021 |
December 31, 2020 |
|||||||
Beginning balance |
$ | $ | ||||||
Increase in loss allowance |
||||||||
Amounts written off during the year as uncollectible |
( |
) | ( |
) | ||||
Effects of movement in exchange rates |
– | |||||||
Total |
$ |
$ |
c) |
Market risk |
For the years ended December 31, |
2021 |
2020 |
2019 |
|||||||||
Salaries, management and directors’ fees |
$ | $ | $ | |||||||||
Share-based payments |
||||||||||||
Total |
$ |
$ |
$ |
December 31, 2021 |
December 31, 2020 |
|||||||
Due to principal owner of Agnity 2 |
$ | $ | ||||||
Due to officer of Company for working capital loan 2 |
||||||||
Due to key management personnel 2 |
||||||||
Due to Agnity Communications Private Ltd. 3 |
||||||||
Loan due to former shareholder of CSA 4 |
||||||||
Amount due to related parties |
$ |
$ |
1 |
Unless otherwise noted, all amounts due are unsecured, non-interest bearing and due on demand. |
2 |
Included in trade accounts payable and accrued liabilities on the consolidated statements of financial position. |
3 |
Associated with consulting services paid to a company partially owned by the principal owner of Agnity. Consulting services were $ ; December 31, 2019 - $ Balance due included in trade accounts payable and accrued liabilities on the consolidated statements of financial position. |
4 |
Included in loans and borrowings (Note 12) on the consolidated statements of financial position. |
Undiscounted Contractual Cash Flows |
||||||||||||||||||||
< 1 year |
2 - 3 years |
4 - 5 years |
More than 5 years |
Total |
||||||||||||||||
Variable lease payments 1 |
$ | $ | $ | $ | $ | |||||||||||||||
Lease payments related to leases which have not yet commenced 2 |
||||||||||||||||||||
$ | |
$ | |
$ | |
$ | |
$ | |
1 |
Variable lease payments associated lease liabilities (Note 8). |
2 |
In October 2021, the Company executed a |
2021 |
2020 |
2019 |
||||||||||
Trade and other receivables ( increase) |
$ ( |
$ ( |
$ ( |
|||||||||
Long-term receivables decrease (increase) |
( |
( |
||||||||||
Prepaid expenses and other assets decrease ( increase) |
( |
( |
||||||||||
Trade payables and accrued liabilities (decrease) increase |
( |
|||||||||||
Deferred revenue increase |
||||||||||||
Decrease in working capital |
$ ( |
$ ( |
$ ( |
2021 |
2020 |
2019 |
||||||||||
Balance of loans, borrowings and PPP loans, beginning of year |
$ |
$ |
$ |
|||||||||
New advances |
||||||||||||
Repayments of principal |
( |
( |
( |
|||||||||
Repayments of interest |
( |
( |
( |
|||||||||
Liability assumed |
– | – | ||||||||||
Liability related items |
||||||||||||
Assumption of loans in business combination |
– | |||||||||||
Forgiveness of PPP Loans |
( |
( |
– | |||||||||
Finance fees paid |
( |
– | ||||||||||
Non-cash related items |
||||||||||||
Accretion of interest and debt issuance costs |
||||||||||||
Loss on debt modification |
– | – | ||||||||||
Foreign exchange and other |
( |
( |
||||||||||
Balance of loans, borrowings and PPP loans, end of year |
$ |
$ |
$ |
For the years ended December 31, |
2021 |
2020 |
2019 |
|||||||||||||
Value of shares issued in business combination |
$ | – | $ | |
$ | |
||||||||||
Value of shares issued on conversion of 2021 Debentures |
14(b) | $ | |
$ | – | $ | – | |||||||||
Value of share issued on conversion of 2019 Debentures |
$ | – | $ | $ | – | |||||||||||
Value of shares issued on AirFusion asset acquisition |
$ | – | $ | $ | – | |||||||||||
Settlement of liabilities through issuance of common shares or RSUs |
$ | – | $ | $ | ||||||||||||
Non-cash accretion of interest included in finance cost |
$ | $ | $ | |||||||||||||
Non-cash broker warrants compensation |
19 (b) |
$ | $ | – | $ | – | ||||||||||
Non-cash underwriter warrants compensation |
1 9 (b) |
$ | $ | – | $ | – | ||||||||||
Non-cash warrants consideration associated with credit facility |
$ | $ | – | $ | – | |||||||||||
Shares issued to extinguish the loan from Flow Capital |
$ | – | $ | – | $ | |||||||||||
Addition to right-of-use assets |
$ | – | $ | $ | ||||||||||||
Addition to lease liabilities |
$ | – | $ | $ |
Principle activity |
Place of business and operations |
Functional currency |
||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
A. |
Basis of Consolidation (continued) |
B. |
Foreign currency |
C. |
Revenue recognition |
D. |
Financial Instruments |
i. |
Recognition and initial measurement |
ii. |
Classification and subsequent measurement |
• | it is held within a business model whose objective is to hold assets to collect contractual cash flows; and |
• | its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. |
• | it is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and |
• | its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. |
iii. |
Derecognition of financial assets and liabilities |
iv. |
Impairment of non-derivative financial assets |
iv. |
Impairment of non-derivative financial assets (continued) |
E. |
Property and equipment |
Life | ||
Computer equipment |
||
Office furniture and equipment |
||
Leasehold improvements |
F. |
Intangible assets and goodwill |
Life | ||
Patents and trademarks |
||
Customer relationships |
||
Technology |
F. |
Intangible assets and goodwill (continued) |
• | Technical feasibility of completing the intangible asset results in the intangible asset being available for use or sale; |
• | There is an intention to complete the intangible asset and use or sell it; |
• | There is an ability to use or sell the intangible asset; |
• | Evidence to suggest how the intangible asset will generate probable future economic benefits; |
• | There is availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and, |
• | An ability to reliably measure the expenditure(s) attributable to the intangible asset during its development exists. |
G. |
Impairment of non-financial assets |
G. |
Impairment of non-financial assets (continued) |
H. |
Leases |
i. |
Recognition and initial measurement as a lessee |
• | fixed payments (including in-substance fixed payments), less any lease incentives receivable; |
• | variable lease payments that depend on an index or a rate (such as CPI), initially measured using the index or rate as at the commencement date; |
• | amounts expected to be payable by the Company under residual value guarantees; |
• | exercise price of a purchase option if the Company is reasonably certain to exercise that option; and |
• | payments of penalties for terminating the lease, if the lease term reflects the Company exercising an option to terminate the lease. |
ii. |
Classification and subsequent measurement as a lessee |
H. |
Leases (continued) |
I. |
Government grants |
J. |
Provisions |
K. |
Share related items |
K. |
Share related items (continued) |
L. |
Fair value measurement |
• | Level 1 inputs are quoted prices in active markets for identical assets or liabilities that the Company can access at the measurement date; |
• | Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and |
• | Level 3 inputs are unobservable inputs for the asset or liability. |
M. |
Convertible debentures |
M. |
Convertible debentures (continued) |
N. |
Warrant liabilities |
O. |
Income taxes and deferred taxation |
P. |
Accounting standards development |
Notes |
March 31, 2022 |
December 31, 2021 |
||||||||||
ASSETS |
||||||||||||
Current assets |
||||||||||||
Cash and cash equivalents |
$ |
$ |
||||||||||
Trade and other receivables |
5 |
|||||||||||
Current portion of prepaid expenses and other assets |
||||||||||||
Current portion of long-term receivables |
5 |
|||||||||||
Total current assets |
$ |
$ |
||||||||||
Non-current assets |
||||||||||||
Prepaid expenses and other assets |
$ |
$ |
||||||||||
Long-term receivables |
5 |
|||||||||||
Right-of-use assets |
6 |
|||||||||||
Property and equipment |
||||||||||||
Intangible assets |
||||||||||||
Goodwill |
||||||||||||
Total non-current assets |
$ |
$ |
||||||||||
Total assets |
$ |
$ |
||||||||||
LIABILITIES |
||||||||||||
Current liabilities |
||||||||||||
Bank indebtedness |
9 |
$ |
$ |
|||||||||
Trade payables and accrued liabilities |
7 |
|||||||||||
Deferred revenue |
4 |
|||||||||||
Current portion of loans and borrowings |
8 |
|||||||||||
Current portion of convertible debentures |
10 |
(a) |
||||||||||
Warrant liabilities |
11 |
|||||||||||
Current portion of lease liabilities |
6 |
|||||||||||
Business acquisition payable |
||||||||||||
Total current liabilities |
$ |
$ |
||||||||||
Non-current liabilities |
||||||||||||
Convertible debentures |
10 |
(b) |
$ |
$ |
||||||||
Lease liabilities |
6 |
|||||||||||
Loans and borrowings |
8 |
|||||||||||
Deferred income tax liabilities |
||||||||||||
Total liabilities |
$ |
$ |
||||||||||
EQUITY (DEFICIT) |
||||||||||||
Share capital |
||||||||||||
Contributed surplus |
||||||||||||
Accumulative other comprehensive income |
||||||||||||
Deficit |
( |
) |
( |
) | ||||||||
Total shareholders’ equity (deficit) |
$ |
( |
) |
$ |
||||||||
Non-controlling interest |
||||||||||||
Total equity (deficit) |
$ |
( |
) |
$ |
||||||||
Total liabilities and equity |
$ |
$ |
“Russ McMeekin” |
“Michael Allman” |
||
Director |
Director |
1 | Condensed Consolidated Interim Financial Statements |
Three months ended March 31, |
||||||||||||
Notes |
2022 |
2021 |
||||||||||
Recast (Note 2) |
||||||||||||
Revenue | 4 | $ |
||||||||||
Cost of sales | ( |
) |
( |
) | ||||||||
Gross profit |
$ |
$ |
||||||||||
Expenses |
||||||||||||
Salaries, wages and benefits | ||||||||||||
Sales and marketing | ||||||||||||
Research and development | ||||||||||||
General and administration | ||||||||||||
Professional and consulting fees | ||||||||||||
Share-based compensation | 13 | |||||||||||
Depreciation and amortization | ||||||||||||
Total expenses |
$ |
$ |
||||||||||
Operating loss |
$ |
$ |
||||||||||
Other expenses (income) |
||||||||||||
Finance costs | 15(a) | $ |
$ |
|||||||||
Foreign exchange loss | ||||||||||||
Business acquisition costs and other expenses | — |
|||||||||||
Fair value (gain) loss on derivatives | 15(b) | ( |
) |
|||||||||
Other income | 15(c) | ( |
) |
( |
) | |||||||
Loss before tax |
$ |
$ |
||||||||||
Current tax expense | ||||||||||||
Deferred tax recovery | ( |
) |
( |
) | ||||||||
Net loss for the period |
$ |
$ |
||||||||||
Other comprehensive (income) loss Foreign subsidiary translation differences |
( |
) |
( |
) | ||||||||
Comprehensive loss for the period |
$ |
$ |
Net loss (income) for the period attributable to: |
||||||||
mCloud Technologies Corp. shareholders | $ | $ | ||||||
Non-controlling interest | ( |
) | ||||||
$ |
$ |
Comprehensive loss (income) for the period attributable to: |
||||||||
mCloud Technologies Corp. shareholders | $ | $ | ||||||
Non-controlling interest | ( |
) | ||||||
$ |
$ |
Loss per share attributable to mCloud shareholders - basic and diluted |
$ | $ | ||||||
Weighted average number of common shares outstanding - basic and diluted |
2 | Condensed Consolidated Interim Financial Statements |
Notes |
Number of Shares |
Share Capital |
Contributed Surplus |
Accumulated Other Comprehensive Income (loss) |
Deficit |
Total Shareholders’ Equity (Deficit) |
Non- controlling Interest |
Total Equity (Deficit) | ||||||||||||||||||||||||||||
Balance, December 31, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
|||||||||||||||||||||||||||
Share-based payments |
13 |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||
RSUs exercised |
12(a) |
( |
) |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||
Warrants issued in financing |
12(b) |
— |
— |
— |
— |
— |
||||||||||||||||||||||||||||||
Net loss for the period |
— |
— |
— |
— |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||
Other comprehensive income for the perio d |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||
Balance, March 31, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) | |||||||||||||||||||||||
Balance, December 31, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
|||||||||||||||||||||||||||
Share-based payments |
— |
— |
— |
— |
— |
|||||||||||||||||||||||||||||||
RSUs exercised |
( |
) |
— |
— |
— |
— |
— |
|||||||||||||||||||||||||||||
Broker warrants issued |
— |
— |
— |
— |
— |
|||||||||||||||||||||||||||||||
Net (loss) income for the period |
— |
— |
— |
— |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||
Other comprehensive income for the period |
— |
— |
— |
— |
||||||||||||||||||||||||||||||||
Balance, March 31, 2021 - Recast (Note 2) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
3 | Condensed Consolidated Interim Financial Statements |
Three months ended March 31, |
||||||||||||
Notes |
2022 |
2021 |
||||||||||
Operating activities |
Recast (Note 2) |
|||||||||||
Net loss for the period | $ | ( |
) | $ | ( |
) | ||||||
Items not affecting cash: | ||||||||||||
Depreciation and amortization | ||||||||||||
Share-based compensation | 13 | |||||||||||
Finance costs | 15(a) | |||||||||||
Fair value (gain) loss on derivatives | 15(b) | ( |
) | |||||||||
Other income | 15(c) | ( |
) | ( |
) | |||||||
Recovery of expected credit loss | ( |
) | — | |||||||||
Unrealized foreign currency exchange (gain) loss | ( |
) | ||||||||||
Current tax expense | ||||||||||||
Deferred income tax recovery | ( |
) | ( |
) | ||||||||
Increase (decrease) in working capital | 16(a) |
( |
) | |||||||||
Interest paid |
( |
) |
( |
) | ||||||||
Net cash used in operating activities |
$ |
( |
) |
$ |
( |
) | ||||||
Investing activities |
||||||||||||
Acquisition of property and equipment |
$ |
( |
) |
$ |
( |
) | ||||||
Expenditure on intangible assets |
— |
( |
) | |||||||||
Net cash used in investing activities |
$ |
( |
) |
$ |
( |
) | ||||||
Financing activities |
||||||||||||
Payment of lease liabilities |
$ |
( |
) |
$ |
( |
) | ||||||
Repayment of loans |
( |
) |
( |
) | ||||||||
Proceeds from loans and bank indebtedness, net of transaction costs |
||||||||||||
Net change in bank overdraft |
||||||||||||
Proceeds from issuance of convertible debentures, net of costs |
— |
|||||||||||
Net cash provided by financing activities |
$ |
$ |
||||||||||
Net decrease in cash and cash equivalents |
$ |
( |
) |
$ |
( |
) | ||||||
Effect of exchange rate fluctuations on cash held |
( |
) |
( |
) | ||||||||
Cash and cash equivalents, beginning of period |
||||||||||||
Cash and cash equivalents, end of period |
$ |
$ |
4 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
|
5 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
|
• |
the plan for the repayment of the 2019 Convertible Debentures; |
• |
• |
the likelihood that undrawn funds under the revolving operating facility will be available and will not be required to be repaid (Note 9); |
• |
the required cash principal and interest payments on indebtedness; |
• |
the likelihood of payments required under contingent consideration arrangements; |
• |
the available funding of US$ 8); |
• |
cash inflows from current operations, expected government assistance in the form of wage and rent subsidies, and expected increases in revenues and cash flows resulting from new revenue contracts expected over the next 12 months due to the anticipated reduction of COVID-19 related restrictions; and |
• |
future debt and equity raises. |
6 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
Three months ended March 31, |
||||||||
2022 |
2021 |
|||||||
AssetCare initialization 1 |
$ | $ | ||||||
AssetCare over time 2 |
||||||||
Engineering services 3 |
||||||||
$ |
$ |
2 |
Revenues include sales of subscriptions to AssetCare, other subscriptions, post contract support and maintenance, perpetual software licenses, and installation and engineering services. |
3 |
Revenues includes consulting, implementation and integration services entered into on a time and materials basis or fixed fee basis without the use of AssetCare. |
Three months ended March 31, |
||||||||
Revenue recognized | 2022 |
2021 |
||||||
Over time | $ | $ | ||||||
At a point in time upon completion | ||||||||
$ |
$ |
Three months ended March 31, |
||||||||
2022 |
2021 |
|||||||
Canada | $ | $ | ||||||
Americas | ||||||||
Asia Pacific | ||||||||
Other | ||||||||
Total revenue | $ |
$ |
7 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
Unbilled revenue |
Deferred revenue |
|||||||
Balance at December 31, 2021 | $ |
$ |
||||||
Additions | ||||||||
Less: transferred to trade and other receivables | ( |
) | — | |||||
Less: recognized in revenue | — | ( |
) | |||||
Effect of movements in exchange rates | — | |||||||
Balance at March 31, 2022 |
$ |
$ |
March 31, 2022 |
December 31, 2021 |
|||||||
Trade receivables from contracts with customers | $ | $ | ||||||
Unbilled revenue (Note 4) | ||||||||
Indirect taxes receivable | ||||||||
Income taxes receivable | ||||||||
Other receivables | ||||||||
Contract asset | ||||||||
Loss allowance | ( |
) | ( |
) | ||||
Total trade and other receivables - current |
$ |
$ |
March 31, 2022 |
December 31, 2021 |
|||||||
Current portion of long-term receivables 1 |
$ | $ | ||||||
Non-current portion of long-term receivables 2 |
||||||||
Total long-term receivables |
$ |
$ |
8 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
March 31, 2022 |
December 31, 2021 |
|||||||
Trade payables | $ | $ | ||||||
Accrued liabilities | ||||||||
Interest payable | ||||||||
Mastercard facility | ||||||||
Due to related parties | ||||||||
Income taxes payable | ||||||||
Indirect taxes payable | ||||||||
Other | ||||||||
Total trade payables and accrued liabilities |
$ |
$ |
March 31, 2022 |
December 31, 2021 |
|||||||
Term loan (a) | $ | $ | ||||||
Nations Interbanc facility 2 |
||||||||
Debenture payable to Industry Canada | ||||||||
Loan payable to related party | ||||||||
Oracle financing | ||||||||
Other loans and financing | ||||||||
Total |
$ |
$ |
||||||
Current |
$ |
$ |
||||||
Non-current | $ | $ | ||||||
Total 1 |
$ |
$ |
1 |
Note 16(b) includes the reconciliation of liabilities to cash flows arising from financing activities. |
2 |
Nations advanced $ |
a) |
Term Loan |
9 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
b) |
Financing of Electric Vehicle Development Projects |
March 31, 2022 |
December 31, 2021 |
|||||||
ATB Financial revolving operating facility | $ | $ | ||||||
Bank overdraft | — | |||||||
Total |
$ |
$ |
March 31, 2022 |
December 31, 2021 |
|||||||
Opening balance | $ | $ | ||||||
Interest paid | ( |
) | ( |
) | ||||
Accreted interest at effective interest rate | ||||||||
Carrying amount of liability component | $ | $ | ||||||
Less: interest payable | ( |
) | ( |
) | ||||
Total - current |
$ |
$ |
10 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
a) |
2019 Convertible debentures (continued) |
b) |
2021 Convertible debentures |
March 31, 2022 |
December 31, 2021 |
|||||||
2021 Convertible debenture liability | $ | $ | ||||||
2021 Convertible debenture embedded derivative | ||||||||
Total - non-current |
$ |
$ |
March 31, 2022 |
December 31, 2021 |
|||||||
Derivative warrant liabilities - 2021 Debentures (a) | $ | $ | ||||||
Derivative warrant liabilities - USD equity financing (b) | ||||||||
Warrant liability related to business acquisition (c) | ||||||||
Other warrant liability (c) | — | |||||||
Total, all current |
$ |
$ |
a) |
Warrants associated with 2021 Debentures |
11 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
b) |
Warrants associated with USD equity financing |
c) |
Other warrant liabilities |
a) |
Common shares |
b) |
Warrants |
Number of Warrants |
Weighted Average Exercise Price | |||||||||
Balance, December 31, 2021 |
$ | |||||||||
Issued |
||||||||||
Balance, March 31, 2022 |
$ |
12 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
Three months ended March 31, |
||||||||
2022 |
2021 |
|||||||
Stock options (a) | $ | $ | ||||||
Restricted share units (b) | ||||||||
Total |
$ |
$ |
a) |
Stock Options |
Number of Options |
Weighted Average Exercise Price |
Weighted Average Remaining Contractual Life (years) | ||||||||||||
Outstanding, December 31, 2021 |
$ |
|||||||||||||
Granted |
$ | |||||||||||||
Forfeited |
( |
) | $ | |||||||||||
Expired |
( |
) | $ | |||||||||||
Outstanding, March 31, 2022 |
$ |
b) |
Restricted Share Units (“RSUs”) |
Number of RSUs |
||||||
Outstanding, December 31, 2021 |
||||||
Granted |
||||||
Exercised |
( |
) | ||||
Forfeited |
( |
) | ||||
Outstanding, March 31, 2022 |
||||||
Exercisable at March 31, 2022 |
13 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
a) |
Classification and measurement of financial assets and liabilities by category |
Financial assets |
Measurement basis |
March 31, 2022 |
December 31, 2021 |
|||||||
Cash and cash equivalents | Amortized cost | $ | $ | |||||||
Trade and other receivables 1 |
Amortized cost | |||||||||
Long-term receivables | Amortized cost | |||||||||
$ |
$ |
|||||||||
Financial liabilities |
||||||||||
Bank indebtedness | Amortized cost | $ | $ | |||||||
Trade payables and accrued liabilities 1 |
Amortized cost | |||||||||
Loans and borrowings | Amortized cost | |||||||||
Lease liabilities | Amortized cost | |||||||||
2019 Debentures - host liability | Amortized cost | |||||||||
2021 Debentures - host liability | Amortized cost | |||||||||
2021 Debentures embedded derivative | FVTPL | |||||||||
Warrant liability - business acquisition | FVTPL | |||||||||
Warrant liabilities - derivatives (Note 11) | FVTPL | |||||||||
Business acquisition payable | FVTPL | |||||||||
$ |
$ |
b) |
Measurement of fair value |
14 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
c) |
Financial instruments risk |
a) |
Finance Costs |
Three months ended March 31, | ||||||||
2022 |
2021 |
|||||||
Interest on loans and borrowings (Note 8) | $ | $ | ||||||
Interest on convertible debentures | ||||||||
Interest on lease liabilities | ||||||||
Transaction costs expensed | ||||||||
Other finance costs | ||||||||
Total finance costs |
$ |
$ |
b) |
Fair value gain (loss) on derivatives |
Three months ended March 31, | ||||||||
2022 |
2021 |
|||||||
Gain on warrant liability remeasurement (Note 11) 1 |
$ | ( |
) | $ | ||||
Gain on embedded derivatives 2 |
( |
) | ||||||
Deferred charge loss 2 |
||||||||
Total fair value (gain) loss on derivatives |
$ |
( |
) |
$ |
15 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
c) |
Other income |
Three months ended March 31, |
||||||||
2022 |
2021 |
|||||||
Government assistance 1 |
$ | ( |
) | $ | ( |
) | ||
Government loan forgiveness | ( |
) | ||||||
Derecognition of contingent consideration | ( |
) | ||||||
Other | ( |
) | ( |
) | ||||
Total other income |
$ |
( |
) |
$ |
( |
) |
a) |
Changes in non-cash working capital |
For the three months ended March 31, |
2022 |
2021 |
||||||
Trade and other receivables decrease (increase) | $ | $ | ( |
) | ||||
Long-term receivables (increase) | ( |
) | ( |
) | ||||
Prepaid expenses and other assets decrease (increase) | ( |
) | ||||||
Trade payables and accrued liabilities increase | ||||||||
Deferred revenue increase | ||||||||
Increase (decrease) in working capital |
$ |
$ |
( |
) |
b) |
Changes in liabilities arising from financing activities |
For the three months ended March 31, |
2022 |
2021 |
||||||
Balance of loans, borrowings and PPP loans, beginning of period | $ | $ | ||||||
New advances | ||||||||
Repayments of principal | ( |
) | ( |
) | ||||
Repayments of interest | ( |
) | ( |
) | ||||
Liability related items |
||||||||
Finance fees paid | ||||||||
Non-cash related items |
||||||||
Accretion of interest and debt issuance costs | ||||||||
Benefit from below market interest rate | ( |
) | ||||||
Foreign exchange and other | ( |
) | ( |
) | ||||
Balance of loans, borrowings and PPP loans, end of period |
$ |
$ |
c) |
Non-cash investing and financing activities |
For the three months ended March 31, |
2022 |
2021 |
||||||
Non-cash accretion of interest included in finance costs 1 |
$ | $ | ||||||
Addition of right-of-use assets (Note 6) | $ | $ | ||||||
Addition to lease liabilities (Note 6) | $ | $ | ||||||
Non-cash broker warrants compensation | $ | $ |
1 |
Associated with convertible debentures. |
16 | Condensed Consolidated Interim Financial Statements |
mCloud Technologies Corp. Notes to the Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2022 and 2021 |
a) |
Loans and Borrowings - Change to Term Loan |
b) |
Loans and Borrowings - Additional funding under promissory note with Carbon |
17 | Condensed Consolidated Interim Financial Statements |
(i) | To include any prospectus required by section 10(a)(3) of the Securities Act of 1933; |
(ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) (§230.424(b) of this chapter) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement. |
(iii) | To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; |
(i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424 (§230.424 of this chapter); |
(ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
(iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |
(iv) | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
mCloud Technologies Corp. | ||
By: | /s/ Russell H. McMeekin | |
Name: | Russell H. McMeekin | |
Title: | Chief Executive Officer (Principal Executive Officer) | |
Dated: | August 9, 2022 |
Signature |
Title |
Date | ||
/s/ Russell H. McMeekin |
Chief Executive Officer |
August 9, 2022 | ||
Russell H. McMeekin |
(Principal Executive Officer) |
|||
/s/ Chantal Schutz |
Chief Financial Officer |
August 9, 2022 | ||
Chantal Schutz |
(Principal Accounting and Financial Officer) |
|||
/s/ * |
Director |
August 9, 2022 | ||
Michael Allman |
||||
/s/ * |
Director |
August 9, 2022 | ||
Constantino Lanza |
||||
/s/ * |
Director |
August 9, 2022 | ||
Elizabeth MacLean |
||||
/s/ * |
Director |
August 9, 2022 | ||
Ian C. W. Russell |
*By: |
/s/ Russell H. McMeekin |
Attorney-in-fact |
August 9, 2022 | |||
Russell H. McMeekin |
Authorized U.S. Representative | ||
By: |
/s/ Russell H. McMeekin | |
Name: Russell H. McMeekin | ||
Title: Chief Executive Officer |
Exhibit 1.1
[1,000,000] UNITS
EACH CONSISTING OF
ONE 9.0% SERIES A CUMULATIVE PERPETUAL PREFERRED SHARE
AND NINE WARRANTS TO PURCHASE ONE COMMON SHARE
MCLOUD TECHNOLOGIES CORP.
UNDERWRITING AGREEMENT
[], 2022
Maxim Group LLC
Investment Banking
300 Park Avenue, 16th Floor
New York, New York 10022
As Representative of the Several Underwriters, if any, named in Schedule I hereto
Ladies and Gentlemen:
The undersigned, MCLOUD TECHNOLOGIES CORP., a company incorporated under the Business Corporations Act (British Columbia) (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of MCLOUD TECHNOLOGIES CORP., the Company), hereby confirms its agreement (this Agreement) with the several underwriters (such underwriters, including the Representative (as defined below), the Underwriters and each an Underwriter) named in Schedule I hereto for which MAXIM GROUP LLC (Maxim) is acting as representative to the several Underwriters (in such capacity, the Representative and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
It is understood that the several Underwriters are to make a public offering of the Securities as soon as the Representative deems it advisable to do so. The Securities are to be initially offered to the public at the public offering price set forth in the Prospectus. The Representative may from time to time thereafter change the public offering price and other selling terms. The Company understands that the Underwriters propose to make a public offering of the Units in the United States, directly and through other investment dealers and brokers in the United States upon the terms and conditions set forth in the Prospectuses (as defined below). It is acknowledged that neither the Company nor the Underwriters will market the Securities or provide marketing materials to any prospective purchasers in Canada.
It is further understood that Maxim will act as the Representative for the Underwriters in the offering and sale of the Closing Securities and, if any, the Option Securities in accordance with this Agreement.
ARTICLE 1
DEFINITIONS
1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:
$ or dollar shall mean U.S. dollars.
Action shall have the meaning ascribed to such term in Section 3.1(m).
Advance shall have the meaning ascribed to such term in Section 4.6(d).
Affiliate means with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with such Person as such terms are used in and construed under Rule 405 under the Securities Act.
Benefit Arrangements shall have the meaning ascribed to such term in Section 3.1(ss).
BHCA shall have the meaning ascribed to such term in Section 3.1(mm).
Board of Directors means the board of directors of the Company.
Business Day means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; provided that banks shall not be deemed to be authorized or obligated to be closed due to a shelter in place, non-essential employee or similar closure of physical branch locations at the direction of any governmental authority if such banks electronic funds transfer systems (including for wire transfers) are open for use by customers on such day.
Canadian Securities Authorities means the securities regulatory authorities in the province of British Columbia.
Canadian Securities Laws means the applicable rules and regulations under such laws, together with applicable published national, multilateral and local policy statements, instruments, notices and blanket orders of the Canadian Securities Authorities.
Closing means the closing of the purchase and sale of the Closing Securities pursuant to Section 2.1.
Closing Date means the hour and the date on the Trading Day on which all conditions precedent to (i) the Underwriters obligations to pay the Closing Purchase Price and (ii) the Companys obligations to deliver the Closing Securities, in each case, have been satisfied or waived, but in no event later than 10:00 a.m. (New York City time) on the second (2nd) Trading Day following the date hereof or at such earlier time as shall be agreed upon by the Representative and the Company.
Closing Purchase Price shall have the meaning ascribed to such term in Section 2.1(b), which aggregate purchase price shall be net of underwriting discounts and commissions.
Closing Securities shall have the meaning ascribed to such term in Section 2.1(a).
Closing Shares shall have the meaning ascribed to such term in Section 2.1(a).
Closing Units shall have the meaning ascribed to such term in Section 2.1(a).
Closing Warrants shall have the meaning ascribed to such term in Section 2.1(a).
2
Code shall have the meaning ascribed to such term in Section 3.1(ll).
Commission means the United States Securities and Exchange Commission.
Common Shares means the common shares of the Company, without par value, and any other class of securities into which such securities may hereafter be reclassified or changed.
Common Share Equivalents means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Shares.
Company Auditor means KPMG LLP, with offices located at Suite 3100 205 - 5 Avenue SW, Calgary, Alberta T2P 4B9.
Company Counsel means Sichenzia Ross Ference LLP, 1185 Avenue of Americas, 31st Floor, New York, NY 10036.
Company Canadian Counsel means Morton Law LLP, 1200-750 W. Pender Street, Vancouver, British Columbia, Canada, V6C 2T8.
Company IT Systems shall have the meaning ascribed to such term in Section 3.1(tt).
Disclosure Schedules means the Disclosure Schedules of the Company delivered concurrently herewith.
EDGAR shall have the meaning ascribed to such term in Section 3.1(a).
Effective Date means the date and time as of which the Registration Statement became effective in accordance with the rules and regulations under the Securities Act.
Environmental Laws shall have the meaning ascribed to such term in Section 3.1(p).
Exchange Act means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
Execution Date shall mean the date on which the parties execute and enter into this Agreement.
Exempt Issuance means the issuance of (a) Common Shares, restricted stock, restricted stock units or options to employees, officers, consultants, other service providers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible into Common Shares issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities or to extend the term of such securities and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as restricted securities (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section 4.21(a) herein, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.
3
FCPA means the Foreign Corrupt Practices Act of 1977, as amended.
FINRA means the Financial Industry Regulatory Authority.
General Disclosure Package shall have the meaning ascribed to such term in Section 3.1(c).
Federal Reserve shall have the meaning ascribed to such term in Section 3.1(mm).
Fox Rothschild means Fox Rothschild LLP, counsel to the Underwriters, with offices located at 222 South Ninth Street, Suite 2000, Minneapolis, MN 55402.
Hazardous Materials shall have the meaning ascribed to such term in Section 3.1(p).
IFRS shall have the meaning ascribed to such term in Section 3.1(k).
Indebtedness means (a) any liabilities for borrowed money or amounts owed in excess of $25,000 (other than trade accounts payable incurred in the ordinary course of business); (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Companys consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (c) the present value of any lease payments in excess of $25,000 due under leases required to be capitalized in accordance with IFRS.
Intellectual Property Rights shall have the meaning ascribed to such term in Section 3.1(s).
Liens means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.
Lock-Up Agreements means the lock-up agreements that are delivered on the date hereof by each of the Companys officers and directors and each other holder of Common Shares and Common Share Equivalents holding, on a fully diluted basis, three percent (3%) or more of the Companys issued and outstanding Common Shares, in substantially the form of Exhibit A attached hereto.
Marketing Materials shall have the meaning ascribed to such term in Section 6.1.
Material Adverse Effect shall have the meaning assigned to such term in Section 3.1(e).
Material Permit shall have the meaning ascribed to such term in Section 3.1(ii).
Money Laundering Laws shall have the meaning ascribed to such term in Section 3.1(nn).
Offering shall have the meaning ascribed to such term in Section 2.1(c).
4
Option Closing Date shall have the meaning ascribed to such term in Section 2.2(c).
Option Closing Purchase Price shall have the meaning ascribed to such term in Section 2.2(b), which aggregate purchase price shall be net of the underwriting discounts and commissions.
Option Securities shall have the meaning ascribed to such term in Section 2.2(a).
Option Shares shall have the meaning ascribed to such term in Section 2.2(a).
Option Warrants shall have the meaning ascribed to such term in Section 2.2(a).
Over-Allotment Option shall have the meaning ascribed to such term in Section 2.2(a).
Permitted Free Writing Prospectus shall have the meaning ascribed to such term in Section 4.2(c).
Person means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.
Preliminary Prospectus shall have the meaning ascribed to such term in Section 3.1(a).
Privacy and Data Security Laws shall have the meaning ascribed to such term in Section 3.1(a).
Proceeding means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.
Prospectus shall have the meaning ascribed to such term in Section 3.1(a).
Registration Statement shall have the meaning ascribed to such term in Section 3.1(a).
Required Approvals shall have the meaning ascribed to such term in Section 3.1(h).
Right of First Refusal shall have the meaning ascribed to such term in Section 4.20.
Rule 144 means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such rule.
Rule 424 means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such rule. Securities means the Closing Securities, the Option Securities and the Warrant Shares.
Securities Act means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
5
Series A Preferred Shares shall mean the 9.0% Series A Cumulative Perpetual Preferred Shares of the Company, without par value.
Share Purchase Price shall have the meaning ascribed to such term in Section 2.1(b).
Shares shall mean, collectively, the Series A Preferred Shares delivered to the Underwriters in accordance with Section 2.1(a)(ii) and Section 2.2(a).
Subject Transaction shall have the meaning ascribed to such term in Section 4.18.
Subsidiary means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.
Trading Day means a day on which the principal Trading Market is open for trading.
Trading Market means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading on the date in question: the OTCQB Venture Market, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange or the TSX Venture Exchange (or any successors to any of the foregoing).
Transaction Documents means this Agreement and all exhibits and schedules hereto, the Lock-Up Agreements, the Warrants, the Warrant Agent Agreement and any other documents or agreements executed in connection with the transactions contemplated hereunder.
Transfer Agent means American Stock Transfer & Trust Company, LLC, with a mailing address of 6201 15th Avenue, Brooklyn, New York 11219, and any successor transfer agent of the Company.
Underwriters Information shall have the meaning ascribed to such term in Section 6.1.
Units shall have the meaning ascribed to such term in Section 2.1(a)(i).
Warrant Agent means the Transfer Agent.
Warrant Agent Agreement means the warrant agent agreement by and between the Company and the Transfer Agent, as warrant agent, for the purpose of administering the Warrants, in the form of Exhibit G attached hereto.
Warrant Purchase Price shall have the meaning ascribed to such term in Section 2.1(b).
Warrant Shares means the Common Shares issuable upon exercise of the Warrants.
Warrants means, collectively, the Common Share purchase warrants delivered to the Underwriters in accordance with Section 2.1(a)(ii) and Section 2.2, which Warrants shall be exercisable immediately and have a term of exercise equal to five (5) years, in the form of Exhibit E attached hereto.
6
ARTICLE 2
PURCHASE AND SALE
2.1 Closing.
(a) Upon the terms and subject to the conditions set forth herein, the Company agrees to sell in the aggregate [1,000,000] Units (the Units), with each Unit consisting of one Series A Preferred Share and one-half of one Warrant to purchase one Common Share, subject to the terms and conditions stated herein, and each Underwriter agrees to purchase, severally and not jointly, at the Closing, the following securities of the Company:
(i) number of Units (the Closing Units) set forth opposite the name of such Underwriter on Schedule I hereto;
(ii) the number of Series A Preferred Shares (the Closing Shares) set forth opposite the name of such Underwriter on Schedule I hereto included in the Closing Units; and
(iii) the number of Warrants (Closing Warrants) to purchase Common Shares set forth opposite the name of such Underwriter on Schedule I hereto included in the Closing Units, which shall have an exercise price of $4.75 per share (subject to adjustment as provided therein) (collectively with the Closing Units and the Closing Shares, the Closing Securities).
The Units have no stand-alone rights and will not be certificated or issued as stand-alone securities. The Common Shares and the Warrants comprising the Units are immediately separable and will be issued separately in the Offering.
(b) The Underwriters, severally and not jointly, agree to purchase from the Company the number of Closing Units set forth opposite their respective names on Schedule I attached hereto and made a part hereof at a purchase price of $23.00 per Closing Unit (92% of the public offering price per Closing Unit)(the Closing Purchase Price), and the purchase price of each Closing Unit shall be allocated as follows: (i) $22.9172 per Closing Share (the Share Purchase Price) and (ii) $0.0092 per Closing Warrant (equal to $0.0828 per nine Warrants) (the Warrant Purchase Price). The Closing Units are to be offered initially to the public at the price of $25.00 per Unit ($24.91 per Series A Preferred Share and $0.01 per Warrant (equal to $0.09 per nine Warrants)), which offering price is also set forth on the cover page of the Prospectus.
(c) On the Closing Date, each Underwriter shall deliver or cause to be delivered to the Company, via wire transfer, immediately available funds equal to such Underwriters Closing Purchase Price and the Company shall deliver to, or as directed by, such Underwriter its respective Closing Securities and the Company shall deliver the other items required pursuant to Section 2.3 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.3 and 2.4, the Closing shall occur at the offices of Fox Rothschild or such other location as the Company and Representative shall mutually agree (including remotely by means of electronic transmission). The Securities are to be offered initially to the public at the offering price set forth on the cover page of the Prospectus (the Offering).
7
2.2 Over-Allotment Option.
(a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the Over-Allotment Option) to purchase up to [150,000] Series A Preferred Shares, representing fifteen percent (15%) of the Closing Shares sold as part of the Closing Units sold in the Offering (the Option Shares), and/or Warrants to purchase up to [1,350,000] Common Shares, representing fifteen percent (15%) of the Closing Warrants sold as part of the Closing Units sold in the Offering (the Option Warrants and, collectively with the Option Shares, the Option Securities), which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.
(b) In connection with an exercise of the Over-Allotment Option, (a) the purchase price to be paid for any Option Shares is equal to the product of the Share Purchase Price multiplied by the number of Option Shares to be purchased and (b) the purchase price to be paid for any Option Warrants is equal to the product of the Warrant Purchase Price multiplied by the number of Option Warrants to be purchased (the aggregate purchase price to be paid on an Option Closing Date, the Option Closing Purchase Price).
(c) The Over-Allotment Option granted pursuant to this Section 2.2 may be exercised by the Representative as to all (at any time) or any part (from time to time) of the Option Shares and/or Option Warrants in any combination thereof within 45 days after the Execution Date. An Underwriter will not be under any obligation to purchase any Option Securities prior to the exercise of the Over-Allotment Option by the Representative. The Over-Allotment Option granted hereby may be exercised by the giving of oral notice to the Company from the Representative, which must be confirmed in writing by overnight mail or facsimile or other electronic transmission setting forth the number of Option Shares and/or Option Warrants to be purchased and the date and time for delivery of and payment for the Option Securities (each, an Option Closing Date), which will not be later than the earlier of (i) 45 days after the Execution Date and (ii) two (2) full Business Days after the date of the notice or such other time as shall be agreed upon by the Company and the Representative, at the offices of Fox Rothschild or at such other place (including remotely by facsimile or other electronic transmission) as shall be agreed upon by the Company and the Representative. If such delivery and payment for the Option Securities does not occur on the Closing Date, each Option Closing Date will be as set forth in the notice. Upon exercise of the Over-Allotment Option, the Company will become obligated to convey to the Underwriters, and, subject to the terms and conditions set forth herein, the Underwriters will become obligated to purchase, the number of Option Shares and/or Option Warrants specified in such notice. The Representative may cancel the Over-Allotment Option at any time prior to the expiration of the Over-Allotment Option by written notice to the Company.
2.3 Deliveries. The Company shall deliver or cause to be delivered to each Underwriter (if applicable) the following:
(a) At the Closing Date, the Closing Shares included in the Closing Units and, as to each Option Closing Date, if any, the applicable Option Shares, which shares shall be delivered via The Depository Trust Company Deposit or Withdrawal at Custodian system for the accounts of the several Underwriters;
(b) At the Closing Date, the Closing Warrants included in the Closing Units and, as to each Option Closing Date, if any, the applicable Option Warrants, which Warrants shall be delivered via The Depository Trust Company Deposit or Withdrawal at Custodian system for the accounts of the several Underwriters;
8
(c) Contemporaneously herewith, evidence that the Company has filed an amendment to the Companys articles creating the Series A Preferred Shares and setting forth the rights and restrictions thereof;
(d) At the Closing Date and at each Option Closing Date, if any, the duly executed and delivered legal opinion and negative assurance letter of Company Counsel addressed to the Underwriters, dated as of the Closing Date and as to each Option Closing Date, if any, bring-down opinions and negative assurance letters from Company Counsel addressed to the Underwriters in form and substance satisfactory to counsel to the Underwriters;
(e) At the Closing Date and at each Option Closing Date, if any, the duly executed and delivered legal opinion and negative assurance letter of Company Canadian Counsel for the Company with respect to certain matters related to Canadian law, addressed to the Underwriters, dated as of the Closing Date and each Option Closing Date, if any, in form and substance satisfactory to counsel to the Underwriters;
(f) Contemporaneously herewith, a cold comfort letter, addressed to the Underwriters and in form and substance satisfactory in all respects to the Representative from the Company Auditor dated, respectively, as of the date of this Agreement and a bring-down letter dated as of the Closing Date and each Option Closing Date, if any;
(g) On the Closing Date and on each Option Closing Date, if any, the duly executed and delivered Officers Certificate, substantially in the form required by Exhibit B attached hereto;
(h) On the Closing Date and on each Option Closing Date, if any, the duly executed and delivered Secretarys Certificate, substantially in the form required by Exhibit C attached hereto;
(i) On the Closing Date and on each Option Closing Date, if any, a duly executed and delivered Chief Financial Officers Certificate, substantially in the form required by Exhibit D attached hereto, addressed to the Underwriters; and
(j) Such other customary certificates or documents as the Underwriters and Underwriters Counsel may have reasonably requested.
2.4 Closing Conditions. The respective obligations of each Underwriter hereunder in connection with the Closing and each Option Closing Date are subject to the following conditions being met:
(a) the accuracy in all material respects when made and on the date in question (other than representations and warranties of the Company already qualified by materiality, which shall be true and correct in all respects) of the representations and warranties of the Company contained herein (unless as of a specific date therein);
(b) all obligations, covenants and agreements of the Company required to be performed at or prior to the date in question shall have been performed;
(c) the delivery by the Company of the items set forth in Section 2.3 of this Agreement;
9
(d) the Registration Statement shall be effective on the date of this Agreement and at each of the Closing Date and each Option Closing Date, if any, no stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall have been instituted or shall be pending or contemplated by the Commission and any request on the part of the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representative;
(e) if required by FINRA, the Underwriters shall have received a notice of no objections from FINRA as to the amount of compensation allowable or payable to and the terms and arrangements for acting as the Underwriters as described in the Registration Statement;
(f) the (i) Series A Preferred Shares, including the Closing Shares and the Option Shares and (ii) Warrants, including the Warrant, have been approved for listing on the Nasdaq Capital Market;
(g) the Company has filed with the Commission a Form 8-A on the date hereof providing for the registration pursuant to Section 12(b) under the Exchange Act of the Series A Preferred Shares; and such Form 8-A has become effective under the Exchange Act. The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Shares or the Warrants under the Exchange Act, nor has the Company received any notification that the Commission is contemplating terminating such registration; and
(h) prior to and on each of the Closing Date and each Option Closing Date, if any: (i) there shall have been no material adverse change or development involving a prospective material adverse change in the condition or prospects or the business activities, financial or otherwise, of the Company and its Subsidiaries taken as a whole, from the latest dates as of which such condition is set forth in the Registration Statement, the General Disclosure Package and Prospectus; (ii) no Action, at law or in equity, shall have been pending or threatened against the Company or any Affiliate of the Company before or by any court or federal or state commission, board or other administrative agency wherein an unfavorable decision, ruling or finding may materially adversely affect the business, operations, prospects or financial condition or income of the Company, except as set forth in the Registration Statement, the General Disclosure Package and Prospectus; (iii) no stop order applicable to the Company shall have been issued under the Securities Act and no proceedings therefor shall have been initiated or threatened by the Commission; (iv) the Company has not incurred any material liabilities or obligations, direct or contingent, nor has it entered into any material transactions not in the ordinary course of business, other than pursuant to this Agreement and the transactions referred to herein; (v) the Company has not paid or declared any dividends or other distributions of any kind on any class of its capital stock; (vi) the Company has not altered its method of accounting; and (vii) the Registration Statement, the General Disclosure Package and the Prospectus and any amendments or supplements thereto shall contain all material statements which are required to be stated therein in accordance with the Securities Act and the rules and regulations thereunder and shall conform in all material respects to the requirements of the Securities Act and the rules and regulations thereunder, and neither the Registration Statement, the General Disclosure Package nor the Prospectus nor any amendment or supplement thereto shall contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.
10
If any of the conditions specified in this Section 2.4 shall not have been fulfilled when and as required by this Agreement, or if any of the certificates, opinions, written statements or letters furnished to the Representative or to Representatives counsel pursuant to this Section 2.4 shall not be reasonably satisfactory in form and substance to the Representative and to Representatives counsel, all obligations of the Underwriters hereunder may be cancelled by the Representative at, or at any time prior to, the consummation of the applicable Closing. Notice of such cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.
ARTICLE 3
REPRESENTATIONS AND WARRANTIES
3.1 Representations and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding Section of the Disclosure Schedules, the Company represents and warrants to the Underwriters as of the Execution Date, as of the Closing Date and as of each Option Closing Date, if any, as follows:
(a) Registration Statement; Prospectuses. The Company has filed with the Commission the Registration Statement, including any related Preliminary Prospectus or Prospectuses, for the registration of the Series A Preferred Shares under the Securities Act, which Registration Statement has been prepared by the Company in conformity with the requirements of the Securities Act and the rules and regulations of the Commission under the Securities Act. The registration of the Common Stock under the Exchange Act has been declared effective by the Commission on the date hereof. Copies of such Registration Statement and of each amendment thereto, if any, including the related Preliminary Prospectuses, heretofore filed by the Company with the Commission have been delivered to the Underwriters. The term Registration Statement means such registration statement on Form F-1 (File No. 333-264859), as amended, as of the relevant Effective Date, including financial statements, all exhibits and any information deemed to be included or incorporated by reference therein, including any information deemed to be included pursuant to Rule 430A or Rule 430B of the Securities Act and the rules and regulations thereunder, as applicable. If the Company files a registration statement to register a portion of the Public Shares and relies on Rule 462(b) of the Securities Act and the rules and regulations thereunder for such registration statement to become effective upon filing with the Commission (the Rule 462 Registration Statement), then any reference to the Registration Statement shall be deemed to include the Rule 462 Registration Statement, as amended from time to time. The term Preliminary Prospectus as used herein means a preliminary prospectus as contemplated by Rule 430 or Rule 430A of the Securities Act and the rules and regulations thereunder as included at any time as part of, or deemed to be part of or included in, the Registration Statement. The term Prospectus means the final prospectus in connection with this Offering as first filed with the Commission pursuant to Rule 424(b) of the Securities Act and the rules and regulations thereunder or, if no such filing is required, the form of final prospectus included in the Registration Statement at the Effective Date, except that if any revised prospectus or prospectus supplement shall be provided to the Representative by the Company for use in connection with the Public Shares which differs from the Prospectus (whether or not such revised prospectus or prospectus supplement is required to be filed by the Company pursuant to Rule 424(b)), the term Prospectus shall also refer to such revised prospectus or prospectus supplement, as the case may be, from and after the time it is first provided to the Representative for such use. Any reference herein to the terms amend, amendment or supplement with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include: (i) the filing of any document under the Exchange Act after the Effective Date, the date of such Preliminary Prospectus or the date of the Prospectus, as the case may be, which is incorporated therein by reference, and (ii) any such document so filed. All references in this Agreement to the Registration Statement, a Preliminary Prospectus and the Prospectus, or any amendments or supplements to any of the foregoing shall be deemed to include any copy thereof filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval System (EDGAR). The term General Disclosure Package means, collectively, the Permitted Free Writing Prospectus(es) (as defined below) issued at or prior to the date hereof, the most recent preliminary prospectus related to this Offering, and the information included on Schedule I and Schedule II hereto.
11
(b) Effectiveness of Registration. At the time of filing the Registration Statement, the Company met, and as of the date hereof the Company meets, the general eligibility requirements for use of Form F-1 under the Securities Act. Any amendment or supplement to the Registration Statement or the Prospectuses required by this Agreement will be so prepared and filed by the Company and, as applicable, the Company will use commercially reasonable efforts to cause it to become effective as soon as reasonably practicable. No stop order suspending the effectiveness of the Registration Statement is in effect and no proceedings for such for that purpose have been instituted or are pending or, to the best knowledge of the Company, are contemplated or threatened by the Commission. No order preventing or suspending the use of the Base Prospectuses, the Prospectus Supplements, the Prospectuses or any Permitted Free Writing Prospectus (as defined herein) has been issued by the Commission or any Canadian Securities Authority. The Company has delivered to the Underwriter one complete copy of the Registration Statement and a copy of each consent of experts filed as a part thereof, and conformed copies of the Registration Statement (without exhibits) and the Prospectuses, as amended or supplemented, in such quantities and at such places as the Underwriter has reasonably requested. At the time of filing the Registration Statement and at the earliest time after the filing of the Registration Statement that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Securities, the Company was not and, as of the date of this Agreement, is not, an Ineligible Issuer (as defined in Rule 405 under the Securities Act), without taking account of any determination by the Commission pursuant to Rule 405 under the Securities Act that it is not necessary that the Company be considered an Ineligible Issuer. Time of Sale means [8:00 a.m.] New York City time on the date of this Agreement.
(c) Accuracy. Each part of the Registration Statement, when such part became or becomes effective, at any deemed effective date pursuant to Form F-1 and the Rules and Regulations on the date of filing thereof with the Commission and at the Time of Sale and Closing Date, and the Prospectus, on the date of filing thereof with the Commission and at the Time of Sale and Closing Date, conformed in all material respects or will conform in all material respects with the requirements of the Rules and Regulations; each part of the Registration Statement, when such part became or becomes effective, did not and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus, on the date of filing thereof with the Commission, and the Prospectus and the applicable Permitted Free Writing Prospectus(es), if any, issued at or prior to such Time of Sale, taken together (collectively, and with respect to the Securities, together with the public offering price of such Securities, the General Disclosure Package) and at the Time of Sale and Closing Date, did not and will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; except that the foregoing shall not apply to statements or omissions in any such document made in reliance upon and in conformity with information relating to the Underwriter furnished in writing to the Company by the Underwriter specifically for inclusion in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, or any amendment or supplement thereto, it being understood and agreed that the only such information furnished by the Underwriter consists of the information described as such herein.
12
(d) Subsidiaries. All of the Subsidiaries of the Company are set forth on Schedule 3.1(d). The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.
(e) Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Companys ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a Material Adverse Effect).
(f) Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents to which it is a party and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Companys stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.
(g) No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Companys or any Subsidiarys certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.
13
(h) Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filing with the Commission of the Prospectus, (ii) such filings as are required to be made under applicable state securities laws and (iii) application(s) to each applicable Trading Market for the listing of the Shares and Warrants for trading thereon in the time and manner required thereby (collectively, the Required Approvals).
(i) Issuance of Securities. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Warrant Shares are duly authorized and, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number of Common Shares issuable pursuant to this Agreement and issuable upon exercise of the Warrants. The Securities are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company. All corporate action required to be taken for the authorization, issuance and sale of the Securities has been duly and validly taken. The Securities conform in all material respects to all statements with respect thereto contained in the Registration Statement, the General Disclosure Package and the Prospectus.
(j) Capitalization. The capitalization of the Company as of the date hereof is as set forth under the heading Capitalization in the Prospectus. No Person other than the Representative has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents, except such rights which have been waived prior to the date hereof. Except as a result of the purchase and sale of the Securities or as set forth on Schedule 3.1(j), there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any Common Shares or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional Common Shares or Common Share Equivalents or the capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue Common Shares or other securities to any Person (other than the Underwriters). There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or phantom stock plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities and other laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. All of the securities of the Company have been duly authorized and validly issued in accordance with all requisite laws. The authorized shares of the Company conform in all material respects to all statements relating thereto contained in the Registration Statement, the General Disclosure Package and the Prospectus. The offers and sales of the Companys securities were at all relevant times either registered under the Canadian Securities Laws, the Securities Act and the applicable state securities or Blue Sky laws or, based in part on the representations and warranties of the purchasers, exempt from such registration requirements. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Companys capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Companys stockholders.
14
(k) Canadian Reporting Issuer; Financial Statements. The Company (i) is a reporting issuer (within the meaning of Canadian Securities Laws) or the equivalent in the province of British Columbia, and (ii) is not in default of any of the requirements of the Canadian Securities Laws. The financial statements of the Company included in the Registration Statement, the Preliminary Prospectus, the General Disclosure Package, and the Prospectus comply in all material respects with applicable accounting and legal requirements with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with International Financial Reporting Standards applied on a consistent basis during the periods involved (IFRS), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by IFRS, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The agreements and documents described in the Registration Statement, the Preliminary Prospectus, the General Disclosure Package and the Prospectus conform in all material aspects to the descriptions thereof contained therein and there are no agreements or other documents required by the Canadian Securities Laws, the Securities Act and the rules and regulations thereunder to be described in the Registration Statement, the Preliminary Prospectus, the General Disclosure Package or the Prospectus or to be filed as exhibits to the Registration Statement, that have not been so described or filed. Each agreement or other instrument (however characterized or described) to which the Company is a party or by which it is or may be bound or affected and (i) that is referred to in the Registration Statement, the General Disclosure Package or the Prospectus, or (ii) is material to the Companys business, has been duly authorized and validly executed by the Company, is in full force and effect in all material respects and is enforceable against the Company and, to the Companys knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors rights generally, (y) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefore may be brought. None of such agreements or instruments has been assigned by the Company, and neither the Company nor, to the Companys knowledge, any other party is in default thereunder and, to the Companys knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder. To the Companys knowledge, performance by the Company of the material provisions of such agreements or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation, those relating to environmental laws and regulations. There are no pro forma or as adjusted financial statements which are required to be included in the Registration Statement, the General Disclosure Package and the Prospectus which have not been included as so required. The pro forma and pro forma as adjusted financial information, if any, included in the Registration Statement, the General Disclosure Package and the Prospectus has been properly compiled and prepared in accordance with the applicable legal and accounting requirements and include all adjustments necessary to present fairly in accordance with IFRS the pro forma and as adjusted financial position of the respective entity or entities presented therein at the respective dates indicated and their cash flows and the results of operations for the respective periods specified. The assumptions used in preparing the pro forma and pro forma as adjusted financial information, if any, included in the Registration Statement, the General Disclosure Package and the Prospectus provide a reasonable basis for presenting the significant effects directly attributable to the transactions or events described therein. The related pro forma and pro forma as adjusted adjustments give appropriate effect to those assumptions; and the pro forma and pro forma as adjusted financial information reflect the proper application of those adjustments to the corresponding historical financial statement amounts.
15
(l) Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements included within the Registration Statement, except as specifically disclosed in the Registration Statement, the Preliminary Prospectus, the General Disclosure Package and the Prospectus, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Companys financial statements pursuant to IFRS or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans and the issuance of Common Share Equivalents as disclosed in the Registration Statement. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is made. Unless otherwise disclosed in the Registration Statement, the Company has not: (i) issued any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any other distribution on or in respect to its capital stock.
(m) Litigation. There has not been, and to the knowledge of the Company there is not pending or contemplated, any action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an Action) which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor, to the Companys knowledge, any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. To the knowledge of the Company, there has not been, and there is not pending or contemplated, any investigation by the Canadian Securities Authorities or the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Canadian Securities Laws, the Exchange Act or the Securities Act.
16
(n) Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Companys or the Subsidiaries employees is a member of a union that relates to such employees relationship with the Company or such Subsidiary, and neither the Company nor any of the Subsidiaries is a party to a collective bargaining agreement, and the Company and the Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of the Subsidiaries to any liability with respect to any of the foregoing matters that would reasonably be expected to have a Material Adverse Effect. The Company and the Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(o) Compliance. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.
(p) Environmental Laws. The Company and the Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, Hazardous Materials) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (Environmental Laws); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval, except where, in the case of (i), (ii) and (iii), the failure to do so could not be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.
17
(q) Privacy and Data Security Laws and Regulations. The Company and the Subsidiaries have (i) operated and currently operate their respective businesses in a manner compliant with all applicable foreign, federal, state and local laws and regulations, all contractual obligations and all Company policies (internal and posted) related to privacy and data security applicable to the Companys and the Subsidiaries collection, use, handling, transfer, transmission, storage, disclosure and/or disposal of the data of their respective customers, employees and other third parties (the Privacy and Data Security Laws), and (ii) implemented, monitored and have been and are in compliance with, applicable administrative, technical and physical safeguards and policies and procedures designed to ensure compliance with Privacy and Data Security Laws, except as would not be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. Except as described in the Registration Statement, the General Disclosure Package or the Prospectus, or as disclosed to the Representative, there has been no loss or unauthorized access, use, modification or breach of security of customer, employee or third party data maintained by or on behalf of the Company and the Subsidiaries, and neither the Company nor any of the Subsidiaries has notified, nor has the current intention to notify, any customer, governmental entity or the media of any such event with regard to any material data breach.
(r) Title to Assets. Except as described in the Registration Statement, the General Disclosure Package or the Prospectus, the Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with IFRS and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.
(s) Intellectual Property. The Company and the Subsidiaries have, or have rights to use or own or possess, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights it believes are necessary or required for use in connection with their respective businesses as described in the Registration Statement, the General Disclosure Package or the Prospectus and which the failure to so have could have a Material Adverse Effect (collectively, the Intellectual Property Rights). To the knowledge of the Company, the Company is not now infringing, and upon further development or commercialization of any product or service described in the Registration Statement, the General Disclosure Package or the Prospectus, will not infringe on, any valid claim of any issued patents, copyrights or trademarks of others. The Company has not conducted a freedom to operate study. None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement, except where such action would not reasonably be expected to have a Material Adverse Effect. Other than as specifically described in the Registration Statement, the General Disclosure Package or the Prospectus, neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the Registration Statement, the General Disclosure Package or the Prospectus, a written notice of a claim or otherwise has any knowledge that the Companys products or planned products as described in the Registration Statement, the General Disclosure Package or the Prospectus violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights either currently are or ultimately shall be enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and the Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
18
(t) Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.
(u) Transactions With Affiliates and Employees. Except as set forth in the Registration Statement, General Disclosure Package or Prospectus, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from, any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.
(v) Sarbanes-Oxley; Internal Accounting Controls. Except as described in the Registration Statement, the General Disclosure Package or the Prospectus, the Companys disclosure controls and procedures and internal controls are effective. The Company and the Subsidiaries are in material compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with managements general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with IFRS and to maintain asset accountability, (iii) access to assets is permitted only in accordance with managements general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act and Canadian Securities Laws) that comply with the requirements of the Exchange Act and Canadian Securities Laws; such disclosure controls and procedures have been designed to ensure that material information relating to the Company is made known to the Companys principal executive officer and principal financial officer by others within those entities; such disclosure controls and procedures are effective.
19
(w) Certain Fees. Except as set forth in the Registration Statement, the General Disclosure Package and Prospectus, no brokerage or finders fees or commissions are or will be payable by the Company, any Subsidiary or Affiliate of the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. There are no other arrangements, agreements or understandings of the Company or, to the Companys knowledge, any of its stockholders that may affect the Underwriters compensation, as determined by FINRA. Other than payments to the Underwriters for this Offering or as disclosed in the Registration Statement, the Company has not made and has no agreements, arrangements or understanding to make any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finders fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any direct or indirect affiliation or association with any FINRA member, within the 180-day period preceding the initial filing of the Registration Statement through the 90-day period after the Effective Date. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its affiliates, except as specifically authorized herein.
(x) Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities will not be or be an Affiliate of, an investment company within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an investment company subject to registration under the Investment Company Act of 1940, as amended.
(y) Registration Rights. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Canadian Securities Law or the Securities Act of any securities of the Company or any Subsidiary, other than those rights that have been disclosed in the Registration Statement, General Disclosure Package, or Prospectus or that have been waived or satisfied.
(z) Compliance with Exchange Act. The Common Shares and Series A Preferred Shares are registered pursuant to Section 12(b) of the Exchange Act and the Company has filed with the Commission a Form 8-A on the date hereof providing for the registration of the Series A Preferred Shares pursuant to Section 12(b) under the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Shares or Series A Preferred Shares under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. The Company has taken all actions necessary to register the Warrants pursuant to Section 12(b) of the Exchange Act by filing with the Commission a Form 8-A. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Shares, Series A Preferred Shares or Warrants are or have been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Shares, Series A Preferred Shares and Warrants are currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees of the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer. The (i) Series A Preferred Shares, including the Closing Shares and the Option Shares, and (ii) Warrants and the Warrant Shares have been approved for listing on the Nasdaq Capital Market, subject to official notice of issuance.
20
(aa) Compliance with Listing Requirements. The Company has taken all necessary actions to ensure that, upon such time as the Nasdaq Capital Market shall have approved the Series A Preferred Shares and Warrants for listing, it is in compliance with all applicable corporate governance requirements set forth in the rules of the Nasdaq Capital Market that are in effect. Without limiting the generality of the foregoing: (i) all members of the Companys board of directors who are required to be independent (as that term is defined under applicable laws, rules and regulations), including, without limitation, all members of the audit committee of the Companys board of directors, meet the qualifications of independence as set forth under applicable laws, rules and regulations and (ii) the audit committee of the Companys Board of Directors has at least one member who is an audit committee financial expert (as that term is defined under applicable laws, rules and regulations).
(bb) Application of Takeover Protections. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Companys articles of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable as a result of the Underwriters and the Company fulfilling their obligations or exercising their rights under the Transaction Documents.
(cc) Statistical, Industry-Related and Market-Related Data. The statistical, industry-related and market-related data included in the Registration Statement, the General Disclosure Package and the Prospectus are based on or derived from sources which the Company reasonably and in good faith believes are reliable and accurate, and such data agree with the sources from which they are derived.
(dd) No Integrated Offering. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this Offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable stockholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.
(ee) Solvency. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Companys assets exceeds the amount that will be required to be paid on or in respect of the Companys existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Companys assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.
21
(ff) Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and the Subsidiaries each (i) has made or filed all federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim. The provisions for taxes payable, if any, shown on the financial statements filed with or as part of the Registration Statement are sufficient for all accrued and unpaid taxes, whether or not disputed, and for all periods to and including the dates of such consolidated financial statements. The term taxes mean all federal, state, local, foreign, and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind whatsoever, together with any interest and any penalties, additions to tax, or additional amounts with respect thereto. The term returns means all returns, declarations, reports, statements, and other documents required to be filed in respect to taxes.
(gg) Foreign Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA. The Company has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the FCPA.
(hh) Accountants. To the knowledge and belief of the Company, the Company Auditor (i) is an independent registered public accounting firm and (ii) shall express its opinion with respect to the financial statements to be included in the Companys annual information form for the fiscal year ending December 31, 2022.
(ii) Regulatory; Compliance with Laws. (A) The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the Registration Statement, the General Disclosure Package or the Prospectus, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (each, a Material Permit), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit. The disclosures in the Registration Statement concerning the effects of federal, state, local and all foreign regulation on the Companys business as currently contemplated are correct in all material respects. The Company has not failed to file with the applicable regulatory authorities any filing, declaration, listing, registration, report or submission that is required to be so filed for the Companys business operation as currently conducted. All such filings were in material compliance with applicable laws when filed and no deficiencies have been asserted in writing by any applicable regulatory authority with respect to any such filings, declarations, listings, registrations, reports or submissions.
22
(jj) Stock Option Plans. Each stock option granted by the Company under the Companys stock option plan was granted (i) in accordance with the terms of the Companys stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Shares on the date such stock option would be considered granted under IFRS and applicable law. No stock option granted under the Companys stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or the Subsidiaries or their financial results or prospects.
(kk) Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Companys knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department.
(ll) U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended (the Code), and the Company shall so certify upon the Representatives request.
(mm) Bank Holding Company Act. Neither the Company nor any of the Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the BHCA) and to regulation by the Board of Governors of the Federal Reserve System (the Federal Reserve). Neither the Company nor any of the Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of the Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.
(nn) Money Laundering. The operations of the Company and the Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the Money Laundering Laws), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.
(oo) D&O Questionnaires. To the Companys knowledge, all information contained in the questionnaires completed by each of the Companys directors and officers immediately prior to the Offering is true and correct in all respects and the Company has not become aware of any information which would cause the information disclosed in such questionnaires to become inaccurate and incorrect.
23
(pp) FINRA Affiliation. No officer, director or any beneficial owner of five percent (5%) or more of the Companys Common Shares or Common Share Equivalents has any direct or indirect affiliation or association with any FINRA member (as determined in accordance with the rules and regulations of FINRA) that is participating in the Offering. Except for securities purchased on the open market, no Company Affiliate is an owner of stock or other securities of any member of FINRA. No Company Affiliate has made a subordinated loan to any member of FINRA. No proceeds from the sale of the Securities (excluding underwriting compensation as disclosed in the Registration Statement and the Prospectus) will be paid to any FINRA member, any persons associated with a FINRA member or an affiliate of a FINRA member. Except as disclosed in the Prospectus, the Company has not issued any warrants or other securities or granted any options, directly or indirectly, to the Representative or any of the Underwriters named on Schedule I hereto within the 180-day period prior to the initial filing date of the Prospectus. Except as disclosed in the Registration Statement and except for securities issued to the Representative as disclosed in the Prospectus and securities sold by the Representative on behalf of the Company, no person to whom securities of the Company have been privately issued within the 180-day period prior to the initial filing date of the Prospectus is a FINRA member, is a person associated with a FINRA member or is an affiliate of a FINRA member. No FINRA member participating in the Offering has a conflict of interest with the Company. For this purpose, a conflict of interest exists when a FINRA member, the parent or affiliate of a FINRA member or any person associated with a FINRA member in the aggregate beneficially own five percent (5%) or more of the Companys outstanding subordinated debt or common equity, or five percent (5%) or more of the Companys preferred equity. FINRA member participating in the Offering includes any associated person of a FINRA member that is participating in the Offering, any member of such associated persons immediate family and any affiliate of a FINRA member that is participating in the Offering. Any person associated with a FINRA member means (1) a natural person who is registered or has applied for registration under the rules of FINRA and (2) a sole proprietor, partner, officer, director, or branch manager of a FINRA member, or other natural person occupying a similar status or performing similar functions, or a natural person engaged in the investment banking or securities business who is directly or indirectly controlling or controlled by a FINRA member. When used in this Section 3.1(pp) the term affiliate of a FINRA member or affiliated with a FINRA member means an entity that controls, is controlled by or is under common control with a FINRA member. The Company will advise the Representative and Fox Rothschild if it learns that any officer, director or owner of five percent (5%) or more of the Companys outstanding Common Shares or Common Share Equivalents is or becomes an affiliate or associated person of a FINRA member firm.
(qq) Officers Certificate. Any certificate signed by any duly authorized officer of the Company and delivered to Fox Rothschild on behalf of the Representative shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.
(rr) Board of Directors. The qualifications of the persons serving as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder applicable to the Company and the rules of the Trading Market. At least one member of the Board of Directors qualifies as a financial expert as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and the rules of the Trading Market. In addition, at least a majority of the persons serving on the Board of Directors qualify as independent as defined under the rules of the Trading Market.
24
(ss) Employee Plans. The Registration Statement, Preliminary Prospectus and the Prospectus identify each employment, severance or other similar agreement, arrangement or policy and each material plan or arrangement required to be disclosed pursuant to the rules and regulations providing for insurance coverage (including any self-insured arrangements), workers compensation, disability benefits, severance benefits, supplemental unemployment benefits, vacation benefits or retirement benefits, or deferred compensation, profit-sharing, bonuses, stock options, stock appreciation rights or other forms of incentive compensation, or post-retirement insurance, compensation or benefits, which: (i) is not an Employee Plan; (ii) is entered into, maintained or contributed to, as the case may be, by the Company or any of its Subsidiaries; and (iii) covers any officer or director or former officer or director of the Company or any of its Subsidiaries. These agreements, arrangements, policies or plans are referred to collectively as Benefit Arrangements. Each Benefit Arrangement has been maintained in material compliance with its terms and with the requirements of applicable law. Except as disclosed in the Registration Statement, Preliminary Prospectus and the Prospectus, there is no liability in respect of post-retirement health and medical benefits for retired employees of the Company or any of its Subsidiaries, other than medical benefits required to be continued under applicable law.
(tt) IT Systems. Except as would not, individually or in the aggregate, have a Material Adverse Effect, the Company reasonably believes that (i) the Company and the Subsidiaries own or have a valid right to access and use all computer systems, networks, hardware, software, databases, websites, and equipment used to process, store, maintain and operate data, information, and functions used in connection with the business of the Company and the Subsidiaries (the Company IT Systems), (ii) the Company IT Systems are adequate for, and operate and perform as required in connection with, the operation of the business of the Company and the Subsidiaries as currently conducted and (iii) the Company and the Subsidiaries have implemented reasonable backup, security and disaster recovery technology consistent with applicable regulatory standards.
(uu) No Relationships with Customers and Suppliers. No relationship, direct or indirect, exists between or among the Company, on the one hand, and the directors, officers, stockholders, customers or suppliers of the Company or any of the Companys affiliates, on the other hand, which is required to be described in the Registration Statement, the General Disclosure Package and the Prospectus or a document incorporated by reference therein and which is not so described.
(vv) No Transfer Taxes. There are no transfer taxes or other similar fees or charges under Canadian or U.S. federal law or the laws of any state, province or any political subdivision thereof, required to be paid in connection with the execution and delivery of this Agreement or the issuance by the Company or sale by the Company of the Securities. No stamp duty, registration or documentary taxes, duties or similar charges are payable under the federal laws of Canada or the laws of any province in connection with: (i) the execution and delivery of this Agreement; or (ii) the enforcement or admissibility in evidence of this Agreement; or (iii) the issuance, sale and delivery to the Underwriter of the Units; or (iv) the sale of the Units through the Underwriter to U.S. residents.
ARTICLE 4
OTHER AGREEMENTS OF THE PARTIES
4.1 Amendments to Registration Statement. The Company has delivered, or will as promptly as practicable deliver, to the Underwriters complete conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof, and conformed copies of the Registration Statement (without exhibits), the Prospectus, as amended or supplemented, and the General Disclosure Package in such quantities and at such places as an Underwriter reasonably requests. Neither the Company nor any of its directors and officers has distributed and none of them will distribute, prior to the Closing Date, any offering material in connection with the offering and sale of the Securities other than the Prospectus, the General Disclosure Package and the Registration Statement. The Company shall not file any such amendment or supplement to which the Representative shall reasonably object in writing.
25
4.2 Federal Securities Laws.
(a) Compliance. During the time when a Prospectus is required to be delivered under the Securities Act, the Company will use its best efforts to comply with all requirements imposed upon it by the Securities Act and the rules and regulations thereunder and the Exchange Act and the rules and regulations thereunder, as from time to time in force, so far as necessary to permit the continuance of sales of or dealings in the Securities in accordance with the provisions hereof and the Prospectus. If at any time when a Prospectus relating to the Securities is required to be delivered under the Canadian Securities Laws or the Securities Act, any event shall have occurred as a result of which, in the opinion of counsel for the Company or counsel for the Representative, the Prospectus, as then amended or supplemented, includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, or if it is necessary at any time to amend the Prospectus to comply with the Securities Act, the Company will notify the Underwriters promptly and prepare and file with the Commission, subject to Section 4.1 hereof, an appropriate amendment or supplement in accordance with the Securities Act.
(b) Exchange Act Registration. For a period of three years from the Execution Date, the Company will use its best efforts to maintain the registration of the Common Shares, Series A Preferred Shares and the Warrants under the Exchange Act; provided, that such provision shall not prevent a sale, merger or similar transaction involving the Company. The Company will not deregister the Common Shares, Series A Preferred Shares or the Warrants under the Exchange Act without the prior written consent of the Representative, which consent shall not be unreasonably withheld and provided that such provision shall not prevent a sale, merger or similar transaction involving the Company.
(c) Free Writing Prospectuses. The Company represents and agrees that it has not made and will not make any offer relating to the Securities that would constitute an issuer free writing prospectus, as defined in Rule 433 of the rules and regulations under the Securities Act, without the prior written consent of the Representative. Any such free writing prospectus consented to by the Representative is herein referred to as a Permitted Free Writing Prospectus. The Company represents that it will treat each Permitted Free Writing Prospectus as an issuer free writing prospectus as defined in the rules and regulations under the Securities Act, and has complied and will comply with the applicable requirements of Rule 433 of the Securities Act, including timely Commission filing where required, legending and record keeping.
4.3 Delivery to the Underwriters of Prospectuses. The Company will deliver to the Underwriters, without charge, from time to time during the period when the Prospectus is required to be delivered under the the Securities Act or the Exchange Act such number of copies of each Prospectus as the Underwriters may reasonably request.
26
4.4 Effectiveness and Events Requiring Notice to the Underwriters. The Company will use its best efforts to cause the Registration Statement to remain effective with a current prospectus until the later of nine (9) months from the Execution Date and the date on which the Warrants are no longer outstanding and will notify the Underwriters and the holders of the Warrants promptly and confirm the notice in writing: (i) of the effectiveness of the Registration Statement and any amendment thereto; (ii) of the issuance by the Commission of any stop order or of the initiation, or the threatening, of any proceeding for that purpose; (iii) of the issuance by any state securities commission of any proceedings for the suspension of the qualification of the Securities for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose; (iv) the electronic filing with the Commission of any amendment or supplement to the Registration Statement or Prospectus; (v) of the receipt of any comments or request for any additional information from the Commission; and (vi) of the happening of any event during the period described in this Section 4.4 that, in the judgment of the Company, makes any statement of a material fact made in the Registration Statement, the General Disclosure Package or the Prospectus untrue or that requires the making of any changes in the Registration Statement, the General Disclosure Package or the Prospectus in order to make the statements therein, in light of the circumstances under which they were made, not misleading. If the Canadian Securities Authorities, the Commission or any state securities commission shall enter a stop order or suspend such qualification at any time, the Company will make every reasonable effort to obtain promptly the lifting of such order.
4.5 Review of Financial Statements. For a period of three (3) years from the Execution Date, the Company shall file with the SEC all reports required to be filed pursuant to the Exchange Act and, at its expense, shall cause its regularly engaged independent registered public accounting firm to review (but not audit) the Companys financial statements included in such reports, provided that such provision shall not prevent a sale, merger or similar transaction involving the Company.
4.6 Reports to the Underwriters; Expenses of the Offering.
(a) Periodic Reports, etc. For a period of three (3) years from the Execution Date, the Company will furnish or make available to the Underwriters copies of such financial statements and other periodic and special reports as the Company from time to time furnishes generally to holders of any class of its securities and also promptly furnish or make available to the Underwriters: (i) a copy of each periodic report the Company shall be required to file with the Canadian Securities Authorities or the Commission; (ii) a copy of every press release and every news item and article with respect to the Company or its affairs which was released by the Company; (iii) a copy of each registration statement filed by the Company under the Canadian Securities Laws or the Securities Act; (iv) such additional documents and information with respect to the Company and the affairs of any future Subsidiaries of the Company as the Representative may from time to time reasonably request; provided that the Underwriters shall each sign, if requested by the Company, a Regulation FD compliant confidentiality agreement which is reasonably acceptable to the Representative in connection with such Underwriters receipt of such information. Documents filed with the SEDAR or EDGAR system shall be deemed to have been delivered to the Underwriters pursuant to this Section.
(b) Transfer Sheets. For a period of one (1) year from the Execution Date, the Company shall retain the Transfer Agent or a transfer and registrar agent acceptable to the Representative and will furnish to the Underwriters at the Companys sole cost and expense such transfer sheets of the Companys securities as an Underwriter may reasonably request, including the daily and monthly consolidated transfer sheets of the Transfer Agent and the Depository Trust Company, provided, however, that such requests cannot be made more than once monthly; and provided that such provision shall not prevent a sale, merger or similar transaction involving the Company.
(c) Reserved.
27
(d) General Expenses Related to the Offering. The Company hereby agrees to pay on each of the Closing Date and each Option Closing Date, if any, to the extent not paid at the Closing Date, all expenses incident to the performance of the obligations of the Company under this Agreement, including, but not limited to: (a) all filing fees and communication expenses relating to the registration of the Securities to be sold in the Offering (including the Option Securities) with the Commission; (b) all FINRA Public Offering Filing System fees associated with the review of the Offering by FINRA; all fees and expenses relating to the listing of such Securities on the Trading Market and such other stock exchanges as the Company and the Representative together determine; (c) the costs of all mailing and printing of the underwriting documents (including, without limitation, the Underwriting Agreement, and any blue sky surveys and, if appropriate, any agreement among underwriters, any agreements with selected dealers, underwriters questionnaire and power of attorney), Registration Statements, Prospectuses and all amendments, supplements and exhibits thereto and as many preliminary and final Prospectuses as the Representative may reasonably deem necessary; (d) the costs of preparing, printing and delivering the Securities; (e) fees and expenses of the Transfer Agent for the Securities (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company); (f) stock transfer and/or stamp taxes, if any, payable upon the transfer of securities from the Company to the Underwriters; (g) the fees and expenses of the Companys accountants; (h) the fees and expenses of the Companys legal counsel and other agents and representatives; (i) the Underwriters costs of mailing prospectuses to prospective investors; (j) all fees, expenses and disbursements relating to background checks of the Companys officers and directors; (k) the fees and expenses associated with the Underwriters use of i-Deals book-building, prospectus tracking and compliance software (or other similar software) for the Offering; (l) the fees and expenses of the Underwriters legal counsel and (m) the Companys actual road show expenses for the Offering. The Underwriters may also deduct from the net proceeds of the Offering payable to the Company on the Closing Date, or each Option Closing Date, if any, all out-of-pocket fees, expenses and disbursements (including legal fees and expenses) of the Underwriters incurred as a result of providing services related to the Offering to be paid by the Company to the Underwriters; provided, however, that all such costs and expenses pursuant to clauses (j), (k) and (l) of this Section 4.6(d), which are incurred by the Underwriters and for which the Company shall be responsible shall not exceed $125,000 in the aggregate in the event of a Closing of the Offering ($25,000 of which has been paid as an advance (the Advance) prior to the Execution Date) and a maximum of $25,000 (inclusive of the Advance) in the event there is not a Closing. In the event the offering is terminated, the Advance received against reasonable out-of-pocket expenses incurred in connection with the offering will be returned to the Company to the extent not actually incurred in accordance with FINRA Rule 5110(g)(4)(A).
4.7 Application of Net Proceeds. The Company will apply the net proceeds from the Offering received by it in a manner consistent with the application described under the caption Use of Proceeds in the Prospectus.
4.8 Delivery of Earnings Statements to Security Holders. The Company will timely file such reports pursuant to the Exchange Act as are necessary in order to make generally available to its security holders as soon as practicable, but not later than the first day of the fifteenth (15th) full calendar month following the Execution Date, an earnings statement (which need not be certified by independent public or independent certified public accountants unless required by the Securities Act or the rules and regulations under the Securities Act, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Securities Act) covering a period of at least twelve consecutive months beginning after the Execution Date.
4.9 Stabilization. Neither the Company, nor, to its knowledge, any of its employees, directors or stockholders (without the consent of the Representative) has taken or will take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to cause or result in, under the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities.
28
4.10 Internal Controls. The Company will maintain a system of internal accounting controls sufficient to provide reasonable assurances that: (i) transactions are executed in accordance with managements general or specific authorization; (ii) transactions are recorded as necessary in order to permit preparation of financial statements in accordance with IFRS and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with managements general or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
4.11 Accountants. For a period of three (3) years from the Effective Date, the Company shall continue to retain a nationally recognized, independent PCAOB registered public accounting firm. The Underwriters acknowledge that the Company Auditor is acceptable to the Underwriters.
4.12 FINRA. The Company shall advise the Underwriters (who shall make an appropriate filing with FINRA) if it is aware that any officer, director, five percent (5%) or greater stockholder of the Company or Person that received the Companys unregistered equity securities in the past 180 days is or becomes an affiliate or associated person of a FINRA member firm prior to the earlier of the termination of this Agreement or the conclusion of the distribution of the Offering.
4.13 No Fiduciary Duties. The Company acknowledges and agrees that the Underwriters responsibility to the Company is solely contractual and commercial in nature, based on arms-length negotiations and that neither the Underwriters nor their affiliates or any selected dealer shall be deemed to be acting in a fiduciary capacity, or otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with the Offering and the other transactions contemplated by this Agreement. Notwithstanding anything in this Agreement to the contrary, the Company acknowledges that the Underwriters may have financial interests in the success of the Offering that are not limited to the difference between the price to the public and the purchase price paid to the Company by the Underwriters for the Securities and the Underwriters have no obligation to disclose, or account to the Company for, any of such additional financial interests. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any breach or alleged breach of fiduciary duty by the Underwriters.
4.14 Warrant Shares. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the issuance of the Warrant Shares, or if the Warrant is exercised via cashless exercise at a time when such Warrant Shares would be eligible for resale under Rule 144 by a non-affiliate of the Company, the Warrant Shares issued pursuant to any such exercise shall be issued free of all restrictive legends. If at any time following the date hereof the Registration Statement (or any subsequent registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise available for the sale of the Warrant Shares, the Company shall immediately notify the holders that have provided it an address of the Warrants in writing that such registration statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and available for the sale of the Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any holder thereof to sell, any of the Warrant Shares in compliance with applicable federal and state securities laws).
4.15 Board Composition and Board Designations. The qualifications of the persons serving as board members of the Company and the overall composition of the Board of Directors shall comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and with the listing requirements of the Nasdaq Capital Market and, if applicable, at least one member of the Board of Directors must qualify as a financial expert as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder.
29
4.16 Securities Laws Disclosure; Publicity. At the request of the Representative, by 9:00 a.m. (New York City time) on the date hereof or, if this Agreement is executed after 9:00 a.m. (New York City time) by the time reasonably requested by the Representative, the Company shall issue a press release disclosing the material terms of the Offering. The Company and the Representative shall consult with each other in issuing any press releases with respect to the Offering, and neither the Company nor any Underwriter shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. The Company will not issue press releases or engage in any other publicity, without the Representatives prior written consent, which consent will not be unreasonably withheld, for a period ending at 5:00 p.m. (New York City time) on the first business day following the 45th day following the Closing Date, other than normal and customary releases issued in the ordinary course of the Companys business.
4.17 Stockholder Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Underwriter of the Securities is an Acquiring Person under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Underwriter of Shares could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Shares.
4.18 Reservation of Common Shares. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times while any of the Series A Preferred Shares or Warrants are outstanding, free of preemptive rights, a sufficient number of Common Shares for the purpose of enabling the Company to issue Option Shares pursuant to the Over-Allotment Option, Common Shares upon conversion of the Series A Preferred Shares and Warrant Shares pursuant to any exercise of the Warrants.
4.19 Listing of Series A Preferred Shares and Warrants. The Series A Preferred Shares and Warrants have been approved for trading on the Nasdaq Capital Market. The Company agrees to use its best efforts to effect and maintain the trading of the Common Shares, Series A Preferred Shares and Warrants on the Nasdaq Capital Market for at least three (3) years after the Closing Date; provided that such provision shall not prevent a sale, merger or similar transaction involving the Company.
4.20 Right of First Refusal. Upon the Closing of the Offering, for a period of nine (9) months from such Closing, the Company grants Maxim the right of first refusal (the Right of First Refusal) to act as lead managing underwriter and book-runner for any and all future public or private equity, equity-linked or debt (excluding commercial bank debt) offerings undertaken during such period by the Company, any Subsidiary, or any successor to the Company (each, a Subject Transaction), at Maxims sole and exclusive discretion, on terms and conditions customary to Maxim for such Subject Transactions. For the avoidance of any doubt, the Company shall not retain, engage or solicit any additional investment banker, book-runner, financial advisor, underwriter and/or placement agent in a Subject Transaction without the express written consent of Maxim.
30
The Company shall notify Maxim of its intention to pursue a Subject Transaction, including the material terms thereof, by providing written notice thereof by email, registered mail or overnight courier service addressed to Maxim. If Maxim fails to exercise its Right of First Refusal with respect to any Subject Transaction within ten (10) Business Days after the delivery of such written notice, then Maxim shall have no further claim or right with respect to the Subject Transaction. Maxim may elect, in its sole and absolute discretion, not to exercise its Right of First Refusal with respect to any Subject Transaction; provided that any such election by Maxim shall not adversely affect its Right of First Refusal with respect to any other Subject Transaction during the nine (9) month period agreed to above.
4.21 Subsequent Equity Sales.
(a) From the date hereof until ninety (90) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Common Shares, Series A Preferred Shares or Common Share Equivalents.
Notwithstanding the foregoing, this Section 4.21 shall not apply in respect of an Exempt Issuance.
4.22 Capital Changes. Until ninety (90) days after the Closing Date, the Company shall not undertake a reverse or forward stock split or reclassification of the Common Shares without the prior written consent of Maxim.
4.23 Research Independence. The Company acknowledges that each Underwriters research analysts and research departments, if any, are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters research analysts may hold and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the Offering that differ from the views of its investment bankers. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriters investment banking divisions. The Company acknowledges that each Representative is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or equity securities of the Company.
ARTICLE 5
DEFAULT BY UNDERWRITERS
If on the Closing Date or any Option Closing Date, if any, any Underwriter shall fail to purchase and pay for the portion of the Closing Securities or Option Securities, as the case may be, which such Underwriter has agreed to purchase and pay for on such date (otherwise than by reason of any default on the part of the Company), the Representative, or if the Representative is the defaulting Underwriter, the non-defaulting Underwriters, shall use their reasonable efforts to procure within thirty-six (36) hours thereafter one or more of the other Underwriters, or any others, to purchase from the Company such amounts as may be agreed upon and upon the terms set forth herein, the Closing Securities or Option Securities, as the case may be, which the defaulting Underwriter or Underwriters failed to purchase. If during such thirty-six (36) hours the Representative shall not have procured such other Underwriters, or any others, to purchase the Closing Securities or Option Securities, as the case may be, agreed to be purchased by the defaulting Underwriter or Underwriters, then (a) if the aggregate number of Closing Securities or Option Securities, as the case may be, with respect to which such default shall occur does not exceed ten percent (10%) of the Closing Securities or Option Securities, as the case may be, covered hereby, the other Underwriters shall be obligated, severally, in proportion to the respective numbers of Closing Securities or Option Securities, as the case may be, which they are obligated to purchase hereunder, to purchase the Closing Securities or Option Securities, as the case may be, which such defaulting Underwriter or Underwriters failed to purchase, or (b) if the aggregate number of Closing Securities or Option Securities, as the case may be, with respect to which such default shall occur exceeds ten percent (10%) of the Closing Securities or Option Securities, as the case may be, covered hereby, the Company or the Representative will have the right to terminate this Agreement without liability on the part of the non-defaulting Underwriters or of the Company except to the extent provided in Article 6 hereof. In the event of a default by any Underwriter or Underwriters, as set forth in this Article 5, the applicable Closing Date may be postponed for such period, not exceeding seven days, as the Representative, or if the Representative is the defaulting Underwriter, the non-defaulting Underwriters, may determine in order that the required changes in the Prospectus or in any other documents or arrangements may be effected. The term Underwriter includes any person substituted for a defaulting Underwriter. Any action taken under this Article 5 shall not relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this Agreement.
31
ARTICLE 6
INDEMNIFICATION
6.1 Indemnification of the Underwriters. The Company shall indemnify and hold harmless each Underwriter, its affiliates, the directors, officers, employees and agents of such Underwriter and each person, if any, who controls such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act from and against any and all losses, claims, liabilities, expenses and damages (including any and all investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding between any of the indemnified parties and any indemnifying parties or between any indemnified party and any third party, or otherwise, or any claim asserted), to which they, or any of them, may become subject under the Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise out of or are based on (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), including the information deemed to be a part of the Registration Statement at the time of effectiveness and at any subsequent time pursuant to Rules 430A and 430B of the Securities Act and the rules and regulations thereunder, as applicable, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in any preliminary prospectus, any preliminary prospectus supplement, any Permitted Free Writing Prospectus or the Prospectus (or any amendment or supplement to any of the foregoing) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (iii) any untrue statement or alleged untrue statement of a material fact contained in any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the Offering of the Securities, including any roadshow or investor presentations made to investors by the Company (whether in person or electronically) (collectively, Marketing Materials) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (iv) in whole or in part any inaccuracy in any material respect in the representations and warranties of the Company contained herein; provided, however, that the Company shall not be liable to the extent that such loss, claim, liability, expense or damage is based on any untrue statement or omission or alleged untrue statement or omission made in reliance on and in conformity with Underwriters Information. This indemnity agreement will be in addition to any liability that the Company might otherwise have. For all purposes of this Agreement, the information set forth in the Prospectus in the Discretionary Accounts, Price Stabilization, Short Positions and Penalty Bids and Electronic Distribution sections under the caption Underwriting constitutes the only information (the Underwriters Information) relating to the Underwriters furnished in writing to the Company by the Underwriters through the Representative specifically for inclusion in the preliminary prospectus, the Registration Statement or the Prospectus.
32
6.2 Indemnification of the Company. Each Underwriter, severally and not jointly, agrees to indemnify and hold harmless the Company, its affiliates, the directors, officers, employees and agents of the Company and each other person or entity, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against any losses, liabilities, claims, damages and expenses whatsoever, as incurred (including but not limited to reasonable attorneys fees and any and all reasonable expenses whatsoever, incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, and any and all amounts paid in settlement of any claim or litigation), joint or several, to which they or any of them may become subject under the Securities Act, the Exchange Act or otherwise, insofar as such losses, liabilities, claims, damages or expenses (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement at the time of effectiveness and at any subsequent time pursuant to Rules 430A and 430B of the Securities Act and the rules and regulations thereunder, any Preliminary Prospectus, the Prospectus, or any amendment or supplement to any of them, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that any such loss, liability, claim, damage or expense (or action in respect thereof) arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon the Underwriters Information; provided, however, that in no case shall any Underwriter be liable or responsible for any amount in excess of the underwriting discount and commissions applicable to the Securities purchased by such Underwriter hereunder.
6.3 Indemnification Procedures. Any party that proposes to assert the right to be indemnified under this Article 6 shall, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this Article 6, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party shall not relieve the indemnifying party from any liability that it may have to any indemnified party under the foregoing provisions of this Article 6 unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable out-of-pocket costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (i) the employment of counsel by the indemnified party has been authorized in writing by one of the indemnifying parties in connection with the defense of such action, (ii) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (iii) the indemnified party has reasonably concluded that a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party shall not have the right to direct the defense of such action on behalf of the indemnified party), (iv) the indemnifying party does not diligently defend the action after assumption of the defense, or (v) the indemnifying party has not in fact employed counsel satisfactory to the indemnified party to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel shall be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees, disbursements and other charges shall be reimbursed by the indemnifying party promptly as they are incurred. An indemnifying party shall not be liable for any settlement of any action or claim effected without its written consent (which consent will not be unreasonably withheld or delayed). No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this Article 6 (whether or not any indemnified party is a party thereto), unless (x) such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising or that may arise out of such claim, action or proceeding and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party, and (y) the indemnifying party confirms in writing its indemnification obligations hereunder with respect to such settlement, compromise or judgment. Notwithstanding the foregoing, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by this Article 6 effected without its written consent if (A) such settlement is entered into more than forty-five (45) days after receipt by such indemnifying party of the aforesaid request, (B) such indemnifying party shall have received notice of the terms of such settlement at least thirty (30) days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.
33
6.4 Contribution. In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this Article 6 is applicable in accordance with its terms but for any reason is held to be unavailable, the Company and the Underwriters shall contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than the Underwriters, such as persons who control the Company within the meaning of the Securities Act, officers of the Company who signed the Registration Statement and directors of the Company, who may also be liable for contribution), to which the Company and the Underwriter may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other from the Offering of the Securities pursuant to this Agreement. The relative benefits received by the Company and the Underwriters shall be deemed to be in the same proportion as (x) the total proceeds from the Offering (net of underwriting discount and commissions but before deducting expenses) received by the Company bears to (y) the underwriting discount and commissions received by the Underwriters, in each case as set forth in the table on the cover page of the Prospectus. If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and the Underwriters, on the other, with respect to the statements or omissions which resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant to this Section 6.4 were to be determined by pro rata allocation or by any other method of allocation (even if the Underwriters were treated as one entity for such purpose) which does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense or damage, or action in respect thereof, referred to above in this Section 6.4 shall be deemed to include, for purpose of this Section 6.4, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 6.4, no Underwriter shall be required to contribute any amount in excess of the underwriting discounts and commissions received by it. No person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 6.4, any person who controls a party to this Agreement within the meaning of the Securities Act will have the same rights to contribution as that party, and each officer of the Company who signed the Registration Statement will have the same rights to contribution as the Company, and each director, officer, employee, counsel or agent of an Underwriter will have the same rights to contribution as such Underwriter, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this Section 6.4, will notify any such party or parties from whom contribution may be sought, but the omission so to notify will not relieve the party or parties from whom contribution may be sought from any other obligation it or they may have under this Section 6.4. The obligations of the Underwriters to contribute pursuant to this Section 6.4 are several in proportion to the respective number of Securities to be purchased by each of the Underwriters hereunder and not joint. No party will be liable for contribution with respect to any action or claim settled without its written consent (which consent will not be unreasonably withheld).
6.5 Survival. The indemnity and contribution agreements contained in this Article 6 and the representations and warranties of the Company contained in this Agreement shall remain operative and in full force and effect regardless of (i) any investigation made by or on behalf of any Underwriter or any controlling Person thereof, (ii) acceptance of any of the Securities and payment therefor or (iii) any termination of this Agreement.
34
ARTICLE 7
MISCELLANEOUS
7.1 Termination.
(a) Termination Right. The Representative shall have the right to terminate this Agreement by notifying the Company at any time prior to any Closing Date, (i) if any domestic or international event or act or occurrence has materially disrupted, or in their opinion will in the immediate future materially disrupt, general securities markets in the United States; or (ii) if trading on any Trading Market shall have been suspended or materially limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been required by FINRA or by order of the Commission or any other government authority having jurisdiction, or (iii) if the United States shall have become involved in a new war or an increase in major hostilities, or (iv) if a banking moratorium has been declared by a New York State or federal authority, or (v) if a moratorium on foreign exchange trading has been declared which materially adversely impacts the United States securities markets, or (vi) if the Company shall have sustained a material loss by fire, flood, accident, hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have been insured, will, in the Representatives opinion, make it inadvisable to proceed with the delivery of the Securities, or (vii) if the Company is in material breach of any of its representations, warranties or covenants hereunder, or (viii) if the Representative shall have become aware after the date hereof of such a material adverse change in the conditions or prospects of the Company, or such adverse material change in general market conditions as in the Representatives judgment would make it impracticable to proceed with the Offering, sale and/or delivery of the Securities or to enforce contracts made by the Underwriters for the sale of the Securities.
(b) Expenses. In the event this Agreement shall be terminated pursuant to Section 7.1(a), within the time specified herein or any extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to Maxim its actual and accountable out of pocket expenses related to the transactions contemplated herein then due and payable up to $25,000 (all of which has been paid as an Advance prior to the Execution Date) (provided, however, that such expense cap in no way limits or impairs the indemnification and contribution provisions of this Agreement). Notwithstanding the foregoing, any Advance received by the Representative will be reimbursed to the Company to the extent not actually incurred in compliance with FINRA Rule 5110(g)(4)(A).
(c) Indemnification. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Article 6 shall not be in any way effected by such election or termination or failure to carry out the terms of this Agreement or any part hereof.
7.2 Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, any Preliminary Prospectus and the Prospectus, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules. Notwithstanding anything herein to the contrary, the Engagement Agreement, dated April 27, 2022 (Engagement Agreement), by and between the Company and Maxim, shall continue to be effective and the terms therein, including, without limitation, Section 14 with respect to any future offerings, shall continue to survive and be enforceable by Maxim in accordance with its terms, provided that, in the event of a conflict between the terms of the Engagement Agreement and this Agreement, the terms of this Agreement shall prevail.
35
7.3 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number (if any) or e-mail attachment at the email address set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number or e-mail attachment at the e-mail address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.
7.4 Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Maxim. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
7.5 Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.
7.6 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
7.7 Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, stockholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any action, suit or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action or proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Article 6, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.
7.8 Survival. The representations and warranties contained herein shall survive the Closing and the Option Closing, if any, and the delivery of the Securities.
36
7.9 Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a .pdf format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or .pdf signature page were an original thereof.
7.10 Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.
7.11 Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Underwriters and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at law would be adequate.
7.12 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.
7.13 Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and Common Shares in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Shares that occur after the date of this Agreement.
7.14 WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVE FOREVER ANY RIGHT TO TRIAL BY JURY.
7.15 No Third Party Beneficiaries. The provisions of this Agreement shall be binding upon and shall inure solely to the benefit of the parties hereto, are not intended to confer upon any Person other than the parties hereto and the Underwriters where so indicated any rights, benefits, remedies, obligations or liabilities hereunder.
(Signature Pages Follow)
37
If the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement among the Company and the several Underwriters in accordance with its terms.
Very truly yours, | ||
MCLOUD TECHNOLOGIES CORP. | ||
By: |
| |
Name: |
Russel H. McMeekin | |
Title: |
Chief Executive Officer | |
Address for Notice: 550-510 Burrard Street Vancouver, BC V6C 3A8 Attention: Russel H. McMeekin, Chief Executive Officer | ||
Copy to: Sichenzia Ross Ference LLP 1185 Avenue of the Americas, 31st Floor New York, NY 10036 E-mail: mross@srf.law Attention: Marc J. Ross
Accepted by the Representative, acting for themselves and as Representative of the Underwriters named on Schedule I hereto, as of the date first above written: | ||
MAXIM GROUP LLC | ||
By: |
| |
Name: |
Clifford A. Teller | |
Title: |
Executive Managing Director, Investment Banking | |
Address for Notice: 300 Park Avenue, 16th Floor New York, New York 10022 Facsimile: (212) 895-3783 E-mail: cteller@maximgrp.com Attention: Clifford A. Teller | ||
Copy to: Fox Rothschild LLP 222 South Ninth Street, Suite 2000 Minneapolis, MN 55402 E-mail: bhanson@foxrothschild.com Attention: Brett Hanson, Esq. |
SCHEDULE I
SCHEDULE OF UNDERWRITERS
Underwriters | Closing Units |
Closing Shares |
Closing Warrants |
Closing Purchase Price | ||||||
Maxim Group LLC |
[] | [] | [] | $ | [] | |||||
American Trust Investment Services Inc. |
[] | [] | [] | $ | [] | |||||
Total |
[1,000,000] | [1,000,000] | [9,000,000] | $ | [23,000,000] |
Schedule I-1
SCHEDULE II
Pricing Information
Number of Closing Units: [1,000,000]
Number of Closing Shares: [1,000,000]
Number of Closing Warrants: [9,000,000]
Number of Option Shares: [150,000]
Number of Option Warrants: [1,350,000]
Public Offering Price per Closing Unit: $25.00
Public Offering Price per Option Share: $24.91
Public Offering Price per Option Warrant: $0.01 (equal to $0.09 per nine Warrants)
Underwriting Discount per Closing Unit: $2.00
Underwriting Discount per Option Share: $1.9928
Underwriting Discount per Option Warrant: $0.0008 (equal to $0.0072 per nine Warrants)
Proceeds to Company per Closing Unit (before expenses): $23.00
Proceeds to Company per Option Share (before expenses): $22.9172
Proceeds to Company per Option Warrant: $0.0092 (equal to $0.0828 per nine Warrants)
Schedule II-1
EXHIBIT A
FORM OF LOCK-UP AGREEMENT
[_____________], 2022
Maxim Group LLC
300 Park Avenue, 16th Floor
New York, New York 10022
Re: | mCloud Technologies Corp.Public Offering |
Ladies and Gentlemen:
The undersigned, a holder of common shares, without par value (the Common Shares), or rights to acquire Common Shares, of mCloud Technologies Corp. (the Company), understands that you are the representative (the Representative) of the several underwriters (collectively, the Underwriters) named or to be named in the final form of Schedule I to the underwriting agreement (the Underwriting Agreement) to be entered into among the Underwriters and the Company, providing for the public offering (the Public Offering) of 9.0% Series A Cumulative Perpetual Preferred Shares (the Shares) and warrants to purchase Common Shares (collectively, the Securities) pursuant to a registration statement filed or to be filed with the U.S. Securities and Exchange Commission (the SEC). Capitalized terms used herein and not otherwise defined shall have the meanings set forth for them in the Underwriting Agreement.
In consideration of the Underwriters agreement to enter into the Underwriting Agreement and to proceed with the Public Offering of the Securities, and for other good and valuable consideration, receipt of which is hereby acknowledged, the undersigned hereby agrees, for the benefit of the Company, the Representative and the other Underwriters that, without the prior written consent of the Representative, the undersigned will not, during the period specified in the following paragraph (the Lock-Up Period), directly or indirectly, unless otherwise provided herein, (a) offer, sell, agree to offer or sell, solicit offers to purchase, grant any call option or purchase any put option with respect to, pledge, encumber, assign, borrow or otherwise dispose of (each a Transfer) any Relevant Security (as defined below) or otherwise publicly disclose the intention to do so, or (b) establish or increase any put equivalent position or liquidate or decrease any call equivalent position with respect to any Relevant Security (in each case within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the Exchange Act), and the rules and regulations thereunder) with respect to any Relevant Security or otherwise enter into any swap, derivative or other transaction or arrangement that Transfers to another, in whole or in part, any economic consequence of ownership of a Relevant Security, whether or not such transaction is to be settled by the delivery of Relevant Securities, other securities, cash or other consideration, or otherwise publicly disclose the intention to do so. As used herein, the term Relevant Security means any Common Shares, any warrant to purchase Common Shares or any other security of the Company or any other entity that is convertible into, or exercisable or exchangeable for, Common Shares or any other equity security of the Company, in each case owned beneficially or otherwise by the undersigned on the date of closing of the Public Offering or acquired by the undersigned during the Lock-Up Period.
The restrictions in the foregoing paragraph shall not apply to any exercise (including a cashless exercise or broker-assisted exercise and payment of tax obligations) of options or warrants to purchase Common Shares; provided that any Common Shares received upon such exercise, conversion or exchange will be subject to this Lock-Up Period. The Lock-Up Period will commence on the date of this Lock-up Agreement and continue and include the date that is one-hundred and eighty (180) days after the closing of the Public Offering.
Exhibit A-1
In addition, the undersigned further agrees that, except for the registration statement filed or to be filed in connection with the Public Offering, during the Lock-Up Period the undersigned will not, without the prior written consent of the Representative: (a) file or participate in the filing with the SEC of any registration statement or circulate or participate in the circulation of any preliminary or final prospectus or other disclosure document, in each case with respect to any proposed offering or sale of a Relevant Security, or (b) exercise any rights the undersigned may have to require registration with the SEC of any proposed offering or sale of a Relevant Security.
In furtherance of the undersigneds obligations hereunder, the undersigned hereby authorizes the Company during the Lock-Up Period to cause any transfer agent for the Relevant Securities to decline to transfer, and to note stop transfer restrictions on the stock register and other records relating to, Relevant Securities for which the undersigned is the record owner and the transfer of which would be a violation of this Lock-Up Agreement and, in the case of Relevant Securities for which the undersigned is the beneficial but not the record owner, agrees that during the Lock-Up Period it will cause the record owner to cause the relevant transfer agent to decline to transfer, and to note stop transfer restrictions on the stock register and other records relating to, such Relevant Securities to the extent such transfer would be a violation of this Lock-Up Agreement.
Notwithstanding the foregoing, the undersigned may transfer the undersigneds Relevant Securities:
(i) as a bona fide gift or gifts,
(ii) to any trust, partnership, limited liability company or other legal entity commonly used for estate planning purposes which is established for the direct or indirect benefit of the undersigned or a member of members of the immediate family of the undersigned,
(iii) if the undersigned is a corporation, partnership, limited liability company, trust or other business entity (1) to another corporation, partnership, limited liability company, trust or other business entity that is a direct or indirect affiliate (as defined in Rule 405 under the Securities Act of 1933, as amended) of the undersigned, (2) to limited partners, limited liability company members or stockholders of the undersigned, or (3) in connection with a sale, merger or transfer of all or substantially all of the assets of the undersigned or any other change of control of the undersigned, not undertaken for the purpose of avoiding the restrictions imposed by this Lock-Up Agreement,
(iv) if the undersigned is a trust, to the beneficiary of such trust,
(v) by testate or intestate succession, or
(vi) by operation of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement,
provided, that (A) such transfer shall not involve a disposition for value, (B) the transferee agrees in writing with the Underwriters and the Company to be bound by the terms of this Lock-Up Agreement, and (C) such transfer would not require any filing under Section 16(a) of the Exchange Act and no such filing is voluntarily made.
Exhibit A-2
For purposes of this Lock-Up Agreement, immediate family shall mean any relationship by blood, marriage or adoption, not more remote than first cousin.
The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement and that this Lock-Up Agreement has been duly authorized (if the undersigned is not a natural person) and constitutes the legal, valid and binding obligation of the undersigned, enforceable in accordance with its terms. Upon request, the undersigned will execute any additional documents necessary in connection with the enforcement hereof. Any obligations of the undersigned shall be binding upon the successors and assigns of the undersigned from the date of this Lock-Up Agreement.
The undersigned understands that, if the Underwriting Agreement does not become effective, or if the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Securities to be sold thereunder, the undersigned shall be released from all obligations under this Lock-Up Agreement.
The undersigned, whether or not participating in the Public Offering, understands that the Underwriters are entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this Lock-Up Agreement.
This Lock-Up Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of laws principles thereof. Delivery of a signed copy of this Lock-Up Agreement by facsimile or e-mail/.pdf transmission shall be effective as the delivery of the original hereof.
Very truly yours, | ||||
Signature: |
| |||
Name (printed): |
| |||
Title (if applicable): |
| |||
Entity (if applicable): |
|
Exhibit A-3
EXHIBIT B
OFFICERS CERTIFICATE
MCLOUD TECHNOLOGIES CORP.
The undersigned, Russel H. McMeekin and Chantal Schutz, the duly elected and duly qualified Chief Executive Officer and Chief Financial Officer, respectively, of mCloud Technologies Corp., a company incorporated under the Business Corporations Act (British Columbia) (the Company), hereby certify the following on behalf of the Company, in connection with the transactions contemplated by the Underwriting Agreement (the Underwriting Agreement), dated [], 2022, by and between the Company and Maxim Group LLC, as representative of the several Underwriters named on Schedule I thereto:
1. The undersigned officers have carefully examined the Registration Statement, the General Disclosure Package, any Issuer Free Writing Prospectus and the Prospectus and, in their opinion, the Registration Statement and each amendment thereto, as of time it became effective and as of the Closing Date did not include any untrue statement of a material fact and did not omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, and the General Disclosure Package, as of its date and as of the Closing Date, any Issuer Free Writing Prospectus as of its date and as of the Closing Date and the Prospectus and each amendment or supplement thereto, as of the respective date thereof and as of the Closing Date, did not include any untrue statement of a material fact and did not omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances in which they were made, not misleading.
2. Since the effective date of the Registration Statement, no event has occurred which should have been set forth in a supplement or amendment to the Registration Statement, the General Disclosure Package or the Prospectus.
3. To the best of their knowledge after reasonable investigation, as of the Closing Date, the representations and warranties of the Company in the Underwriting Agreement are true and correct and the Company has complied in all material respects with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date.
4. There has not been, subsequent to December 31, 2021, any material adverse change in the financial position or results of operations of the Company, or any change or development that, singularly or in the aggregate, would involve a Material Adverse Effect.
5. All correspondence between the Company or its counsel and the Commission are accurate and complete in all material respects.
Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Underwriting Agreement.
This certificate is to assist the Underwriters in conducting and documenting their investigation of the affairs of the Company in connection with the Offering of the Public Shares pursuant to the terms of the Underwriting Agreement and the other transactions described in the Transaction Documents, and each of the Underwriters, Fox Rothschild LLP, Sichenzia Ross & Ference LLP and Morton Law LLP is entitled to rely on this Certificate for such purpose and (if applicable) in connection with the delivery by such counsel of their respective legal opinions and negative assurance statement.
Exhibit B-1
IN WITNESS WHEREOF, the undersigned have executed this Officers Certificate on behalf of the Company as of this [__] day of [____], 2022.
| ||
Name: |
Russel H. McMeekin | |
Title: |
Chief Executive Officer | |
| ||
Name: |
Chantal Schutz | |
Title: |
Chief Financial Officer |
[SIGNATURE PAGE TO OFFICERS CERTIFICATE]
Exhibit B-2
EXHIBIT C
SECRETARYS CERTIFICATE
MCLOUD TECHNOLOGIES CORP.
[___], 2022
The undersigned, acting solely in his/her capacity as the duly elected, qualified and acting Secretary of mCloud Technologies Corp., a company incorporated under the Business Corporations Act (British Columbia) (the Company), and not in his/her individual capacity, hereby gives this certificate pursuant to Section 2.3 of that certain underwriting agreement, dated [], 2022, by and between the Company and Maxim Group LLC, as representative of the several Underwriters named on Schedule I thereto (the Underwriting Agreement). Unless otherwise defined herein, the capitalized terms used herein shall have the meanings ascribed to them in the Underwriting Agreement.
The undersigned, [_________], Secretary of the Company, hereby certifies as of the date hereof as follows:
1. Attached hereto as Exhibit A is a true, correct and complete copy of the Companys memorandum of articles, as amended, in effect on the date hereof (the Articles). The Articles are in full force and effect on the date hereof, and no further amendments or modifications to the Articles have been authorized or filed.
2. Attached hereto as Exhibit B is a true, correct and complete copies of resolutions duly adopted by the Companys board of directors or a committee thereof at meetings held on [_____], 2022 and [____], 2022, in which the transactions contemplated by the Registration Statement, the Prospectus and the Transaction Documents were authorized and approved. Such resolutions are in full force and effect, have not been amended, modified or rescinded and are the only resolutions related to the subject matter thereof.
3. Each person who, as a director or officer of the Company, signed, and delivered by facsimile, portable document file (.pdf) or otherwise (a) the Underwriting Agreement, (b) the Transaction Documents and (c) any and all other documents or instruments executed and delivered to the Representative in connection with the transactions contemplated by the Underwriting Agreement, was duly elected or appointed, qualified and acting as such director or officer, and was duly authorized to execute and deliver such documents or other instruments at the respective times of such execution and delivery.
4. All persons who, as officers or directors of the Company or attorneys-in-fact of such officers or directors, signed, and delivered by facsimile, portable document file (.pdf) or otherwise: (a) the Registration Statement on Form F-1, as amended (File No. 333-264859), that the Company filed with the Commission on May 11, 2022, which was subsequently declared effective by the Commission on [], 2022, and (b) any and all other documents or instruments executed and delivered to the Commission in connection with such Registration Statement were, at the respective times of such signing, delivery or filing, duly elected or appointed, qualified and acting as such director, officer or duly appointed and acting as such attorney-in-fact, and the signatures of such persons appearing on such documents are their genuine signatures or true facsimiles or portable document thereof.
5. Attached hereto as Exhibit C are true, correct and complete copies of a good standing (or equivalent) certificate as of a recent date for the Company and each Subsidiary by the relevant authority of its jurisdiction of incorporation or organization, and such certificates attached thereto have not been amended (except as attached thereto) since the date reflected thereon.
Exhibit C-1
6. Russel H. McMeekin, the Companys Chief Executive Officer, has executed and delivered on behalf of the Company the Underwriting Agreement and the other Transaction Documents in accordance with their respective terms thereof.
This certificate is to assist the Underwriters in conducting and documenting their investigation of the affairs of the Company in connection with the Offering of the Public Shares pursuant to the terms of the Underwriting Agreement and the other transactions described in the Transaction Documents, and each of the Underwriters, Fox Rothschild LLP, Sichenzia Ross & Ference LLP and Morton Law LLP is entitled to rely on this Certificate for such purpose and (if applicable) in connection with the delivery by such counsel of their respective legal opinions and negative assurance statement.
This certificate may be executed in multiple counterparts, each of which shall be deemed an original, and all of which taken together shall constitute one and the same instrument. Delivery of an executed signature page of this certificate by electronic or facsimile transmission shall be as effective as delivery of a manually executed counterpart hereof.
[Signature page follows]
Exhibit C-2
IN WITNESS WHEREOF, I have hereunder signed my name on this [__] day of [___], 2022.
| ||
Name: |
[___________] | |
Title: |
Secretary |
The undersigned as Chief Executive Officer of the Company hereby certifies that [_____] is the duly elected, appointed, qualified and acting Secretary of the Company, and that the signature appearing above is his genuine signature.
______________________________________
Russel H. McMeekin, Chief Executive Officer
[Signature page to mCloud Technologies Corp. Secretarys Certificate]
Exhibit C-3
Secretarys Certificate
Exhibit A
Memorandum of Articles
Exhibit C-4
Secretarys Certificate
Exhibit B
Board Resolutions
Exhibit C-5
Secretarys Certificate
Exhibit C
Good Standing Certificates
Exhibit C-6
EXHIBIT D
CHIEF FINANCIAL OFFICERS CERTIFICATE
MCLOUD TECHNOLOGIES CORP.
[____], 2022
I, Chantal Schutz, do hereby certify that I am the Chief Financial Officer, of mCloud Technologies Corp., a company incorporated under the Business Corporations Act (British Columbia) (the Company), and, in my capacity as such and not in any individual capacity, and based upon a diligent examination of the financial records of the Company, the scope and nature of such examination being designed to identify information relevant to the subjects addressed below, do hereby certify to the Representative (as defined below) that:
1. I am providing this certificate in connection with the offering (the Offering) by the Company of an aggregate of [_____] 9.0% Series A Cumulative Perpetual Preferred Shares of the Company, without par value (the Series A Shares), and warrants to purchase Common Shares, pursuant to Section 2.3 of that certain underwriting agreement, dated [], 2022 (the Underwriting Agreement), by and between the Company and Maxim Group LLC, as representative of the several Underwriters named on Schedule I thereto. The Offering is being made pursuant to the registration statement on Form F-1, as amended (File No. 333-264859) (the Registration Statement) that was initially filed with the Securities and Exchange Commission (the SEC) under the Securities Act of 1933, as amended, on May 11, 2022 and that was subsequently declared effective by the SEC on [], 2022. Unless otherwise defined herein, the capitalized terms used herein shall have the meanings ascribed to them in the Underwriting Agreement.
2. I am familiar with the accounting, operations and records systems of the Company and its subsidiaries and I have responsibility for the Companys financial and accounting matters. I have (i) read the Registration Statement and the Prospectus; and (ii) supervised the compilation of and reviewed the financial information set forth in the Registration Statement and the Prospectus (collectively, the Financial Information). Such Financial Information has been derived from the applicable accounting or financial records of the Company or its subsidiaries, which I believe, to the best of my knowledge, are accurate, complete and reliable.
3. There were no significant decreases in the Companys cash and cash equivalents, total current liabilities and operating expenses during the Companys fiscal quarter ended June 30, 2022 as compared with amounts shown on the Companys unaudited interim financial statements for the fiscal quarter ended December 31, 2021, except as disclosed in the Registration Statement or the Prospectus.
4. [I have prepared or reviewed the amounts and information identified in the pages of the Registration Statement and the Prospectus, attached as Annex A hereto (collectively, the Financial and Numerical Information). To the best of my knowledge, such Financial and Numerical Information, as of the date hereof, matches or is accurately derived from the applicable accounting or financial records of the Company or its subsidiaries.]
This certificate is to assist the Underwriters in conducting and documenting their investigation of the affairs of the Company in connection with the Offering of the Public Shares pursuant to the terms of the Underwriting Agreement and the other transactions described in the Transaction Documents, and each of the Underwriters, Fox Rothschild LLP, Sichenzia Ross & Ference LLP and Morton Law LLP is entitled to rely on this Certificate for such purpose and (if applicable) in connection with the delivery by such counsel of their respective legal opinions and negative assurance statement.
Exhibit D-1
IN WITNESS WHEREOF, the undersigned has executed and delivered this Chief Financial Officer Certificate on behalf of the Company as of the date first written above.
MCLOUD TECHNOLOGIES CORP. | ||
By: |
| |
Name: |
Chantal Schutz | |
Title: |
Chief Financial Officer |
[Signature page to Chief Financial Officer Certificate mCloud Technologies Corp.]
EXHIBIT E
FORM OF WARRANT
[Attached hereto]
Exhibit E-1
EXHIBIT F
FORM OF WARRANT AGENT AGREEMENT
[Attached hereto]
Exhibit F-1
Exhibit 4.1
27.3 | 9.0 % Series A Cumulative Perpetual Preferred Shares |
27.3.1 | Designation and Number of Shares. |
There shall hereby be created and established a series of preferred shares of the Company designated as Series A Cumulative Perpetual Preferred Shares (the Series A Preferred Shares). The authorized number of Series A Preferred Shares shall be 2,300,000. The Company shall have the authority to issue fractional shares of the Series A Preferred Shares. Each Series A Preferred Share shall be identical in all respects to every other Series A Preferred Share, except that Series A Preferred Shares issued after the date of the first issuance of Series A Preferred Shares (the Original Issue Date) shall accrue dividends from the later of the Original Issue Date and the Dividend Payment Date (as defined hereafter) immediately prior to the original issue date of such additional shares for which full cumulative dividends have been paid. As used in this Article 27.3, accrual (or similar terms) used with respect to a dividend or dividend period refers only to the determination of the amount of such dividend and does not imply that any right to a dividend in any dividend period that arises prior to the date on which such dividend is declared.
27.3.2 | Ranking. |
(1) | The Series A Preferred Shares will, as to dividend rights and rights as to the distribution of assets upon the Companys liquidation, dissolution or winding up, rank: |
(a) | senior to all classes or series of the Common Shares and to all other shares issued by the Company expressly designated as ranking junior to the Series A Preferred Shares, |
(b) | on parity with any future class or series of the Companys shares expressly designated as ranking on parity with the Series A Preferred Shares; |
(c) | junior to any future class or series of the Companys shares expressly designated as ranking senior to the Series A Preferred Shares; and |
(d) | junior to all the Companys existing and future indebtedness (including subordinated indebtedness and any indebtedness convertible into Common Shares or preferred shares) and other liabilities with respect to assets available to satisfy claims against the Company and structurally subordinated to the indebtedness and other liabilities of (as well as any preferred equity interests held by others in) existing or future subsidiaries of the Company. |
(2) | The Company may issue junior shares described in Article 27.3.2(1)(a) above and parity shares described in Article 27.3.2(b) above at any time and from time to time in one or more series without the consent of the holders of the Series A Preferred Shares. The Companys ability to issue any senior shares described in Article 27.3.2(c) above is limited as described in Article 27.3.10(4)(a). |
27.3.3 | Dividends. |
(1) | Subject to the preferential rights, if any, of the holders of any class or series of shares of the Company ranking senior to the Series A Preferred Shares as to dividends, the holders of Series A Preferred Shares will be entitled to receive, when, as and if declared by the board of directors (or a duly authorized committee of the board of directors), only out of funds legally available for the payment of dividends, cumulative cash dividends at the annual rate of 9.0% of the $25.00 liquidation preference per year (equivalent to $2.25 per year); provided, however, that (a) on the fifth annual anniversary of the Original Issue Date, the dividend rate will increase to 13.0% of the $25.00 liquidation preference per year (equivalent to $3.25 per year) and (b) the dividend rate will increase on the dates that are three, six and nine months after the fifth annual anniversary of the Original Issue Date, respectively, to 17.0% (equivalent to $4.25 per year), 21.0% (equivalent to $5.25 per year) and 25.0% (equivalent to $6.25 per year) of the $25.00 liquidation preference per year. A dividend period is the period from and including a dividend payment date (as defined herein) (except that the initial dividend period shall commence on and include the Original Issue Date) and continuing to, but excluding, the next succeeding dividend payment date. Dividends on the Series A Preferred Shares will accumulate and be cumulative from, and including, the Original Issue Date; except that Series A Preferred Shares issued after the Original Issue Date shall accrue dividends from the later of the Original Issue Date and the dividend payment date (as defined herein) immediately prior to the Original Issue Date of such additional shares for which full cumulative dividends have been paid. The Company will be entitled to defer the payment of any declared dividends on the Series A Preferred Stock until the occurrence of a liquidation or Change of Control Event (as defined herein) approved by the Board of Directors of the Company. |
(2) | Dividends, when, as and if declared by the board of directors (or a duly authorized committee of the board of directors), will be payable monthly in arrears on the same day of the month as the Original Issue Date, each of which is a dividend payment date; provided that if any dividend payment date is not a business day (as defined below), then such date will nevertheless be a dividend payment date but the dividend which would otherwise have been payable on that dividend payment date, when, as and if declared, will be paid on the next succeeding business day and no interest, additional dividends or other sums will accumulate on the amounts so payable for the period from and after that dividend payment date to that next succeeding business day. As used in this Article 27.3, business day means any day, other than a Saturday or Sunday, that is neither a legal holiday nor a day on which banking institutions in New York City are authorized or required by law, regulation or executive order to close. |
(3) | Any dividend, including any dividend payable on the Series A Preferred Shares for any dividend period (or portion thereof) will be computed on the basis of a 360-day year consisting of twelve 30-day months. Dividends are payable to holders of record of Series A Preferred Shares as they appear on the central securities register for the Series A Preferred Shares or, where a transfer agent is appointed to maintain the register for the Series A Preferred Shares, in the records of the Companys transfer agent (the Transfer Agent) at the close of business on the applicable record date, which will be the date designated by the board of directors (or a duly authorized committee of the board of directors) for the payment of a dividend that is not more than thirty (30) nor less than ten (10) days prior to the applicable dividend payment date. |
(4) | The board of directors (or a duly authorized committee of the board of directors) will not authorize, pay or set apart for payment by the Company any dividend on the Series A Preferred Shares at any time that: |
(a) | the terms and provisions of any of the Companys agreements, including any agreement relating to the Companys indebtedness, prohibits such authorization, payment or setting apart for payment; |
(b) | the terms and provisions of any of the Companys agreements, including any agreement relating to the Companys indebtedness, provides that such authorization, payment or setting apart for payment thereof would constitute a breach of, or a default under, such agreement; or |
(c) | the law, including the Business Corporations Act, restricts or prohibits the authorization or payment of dividends on the Series A Preferred Shares. |
Notwithstanding the foregoing, dividends on the Series A Preferred Shares will accumulate whether or not (i) the terms and provisions of any of the Companys agreements relating to its indebtedness prohibit such authorization payment or setting apart for payment, (ii) the Company has earnings, (iii) there are funds legally available for the payment of the dividends, (iv) or the dividends are authorized. Accordingly, if the board of directors (or a duly authorized committee of the board of directors) does not declare a dividend on the Series A Preferred Shares payable in respect of any dividend period before the related dividend payment date, such dividend shall accumulate and an amount equal to such accumulated dividend shall become payable out of funds legally available therefor upon the liquidation, dissolution or winding up of the Companys affairs (or earlier redemption of such Series A Preferred Shares), to the extent not paid prior to such liquidation, dissolution or winding up or earlier redemption, as the case may be. No interest, or sums in lieu of interest, will be payable in respect of any dividend payment or payments on the Series A Preferred Shares, which may be in arrears, and holders of Series A Preferred Shares will not be entitled to any dividends in excess of the full cumulative dividends described above. Any dividend payment made on the Series A Preferred Shares shall first be credited against the earliest accumulated but unpaid dividends due with respect to those shares.
27.3.4 | Restrictions on Dividends, Redemption and Repurchases. |
(1) | So long as any Series A Preferred Shares remain outstanding, unless the Company also has either paid or declared and set apart for payment full cumulative dividends on the Series A Preferred Shares for all past completed dividend periods, the Company will not during any dividend period: |
(a) | pay or declare and set apart for payment any dividends or declare or make any distribution of cash or other property on Common Shares or other shares that rank junior to or on parity with the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon the Companys voluntary or involuntary liquidation, dissolution or winding up (other than, in each case, (i) a dividend paid in Common Shares or other shares ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon the Companys voluntary or involuntary liquidation, dissolution or winding up or (ii) any declaration of a Common Share dividend in connection with any shareholders rights plan, or the issuance of rights, shares or other property under any shareholders rights plan, or the redemption or repurchase of rights pursuant to the plan); |
(b) | redeem, purchase or otherwise acquire Common Shares or other shares that rank junior to or on parity with the Series A Preferred Shares (other than the Series A Preferred Shares) with respect to dividend rights and rights to the distribution of assets upon the Companys voluntary or involuntary liquidation, dissolution or winding up (other than (i) by conversion into or exchange for Common Shares or other shares ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon the Companys voluntary or involuntary liquidation, dissolution or winding up, (ii) the redemption of shares pursuant to the provisions of these Articles relating to the restrictions upon ownership and transfer of shares, (iii) a purchase or exchange offer made on the same terms to holders of all outstanding Series A Preferred Shares and any other shares that rank on parity with the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon the Companys voluntary or involuntary liquidation, dissolution or winding up, (iv) purchases, redemptions or other acquisitions of shares of the Company ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon the Companys voluntary or involuntary liquidation, dissolution or winding up pursuant to any employment contract, dividend reinvestment and share purchase plan, benefit plan or other similar arrangement with or for the benefit of employees, officers, directors, consultants or advisors, (v) through the use of the proceeds of a substantially contemporaneous sale of shares ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon the Companys voluntary or involuntary liquidation, dissolution or winding up, or (vi) purchases or other acquisitions of shares of the Company pursuant to a contractually binding share repurchase plan existing prior to the preceding dividend payment date on which dividends were not paid in full); or |
(c) | redeem, purchase or otherwise acquire Series A Preferred Shares (other than (i) by conversion into or exchange for Common Shares or other shares ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon the Companys voluntary or involuntary liquidation, dissolution or winding up, (ii) a purchase or exchange offer made on the same terms to holders of all outstanding Series A Preferred Shares or (iii) with respect to redemptions, a redemption pursuant to which all Series A Preferred Shares are redeemed). |
(2) | Notwithstanding the foregoing, if the board of directors (or a duly authorized committee of the board of directors) elects to declare only partial instead of full dividends for a dividend payment date and related dividend period on the Series A Preferred Shares or any class or series of the Companys shares that rank on parity with the Series A Preferred Shares with respect to dividends, then, to the extent permitted by the terms of the Series A Preferred Shares and each outstanding class or series of the Companys shares that rank on parity with the Series A Preferred Shares with respect to dividends, such partial dividends shall be declared on Series A Preferred Shares and class or series of the Companys shares that rank on parity with the Series A Preferred Shares with respect to dividends, and dividends so declared shall be paid, as to any such dividend payment date and related dividend period, in amounts such that the ratio of the partial dividends declared and paid on each such series to full dividends on each such series is the same. As used in this paragraph, full dividends means, as to any class or series of the Companys shares that rank on parity with the Series A Preferred Shares with respect to dividends that bear dividends on a cumulative basis, the amount of dividends that would need to be declared and paid to bring such class or series of the Companys shares that rank on parity with the Series A Preferred Shares with respect to dividends current in dividends, including undeclared dividends for past dividend periods. To the extent a dividend period with respect to the Series A Preferred Shares or any class or series of the Companys shares that rank on parity with the Series A Preferred Shares with respect to dividends (in either case, the first series) coincides with more than one dividend period with respect to another series as applicable (in either case, a second series), then, for purposes of this paragraph, the board of directors (or a duly authorized committee of the board of directors) may, to the extent permitted by the terms of each affected series, treat such dividend period for the first series as two or more consecutive dividend periods, none of which coincides with more than one dividend period with respect to the second series, or may treat such dividend period(s) with respect to any class or series of the Companys shares that rank on parity with the Series A Preferred Shares with respect to dividends and dividend period(s) with respect to the Series A Preferred Shares for the purposes of this paragraph in any other manner that it deems to be fair and equitable in order to achieve ratable payments of dividends on such class or series of the Companys shares that rank on parity with the Series A Preferred Shares with respect to dividends and the Series A Preferred Shares. |
(3) | Subject to the foregoing, dividends (payable in cash, shares or otherwise) as may be determined by the board of directors (or a duly authorized committee of the board of directors) may be declared and paid on any Common Shares or other shares ranking junior to the Series A Preferred Shares with respect to dividend rights and rights to the distribution of assets upon the Companys voluntary or involuntary liquidation, dissolution or winding up from time to time out of any funds legally available therefor, and the Series A Preferred Shares shall not be entitled to participate in any such dividend. |
27.3.5 Liquidation Preference.
(1) | In the event of the voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the holders of Series A Preferred Shares will be entitled to be paid out of the assets of the Company legally available for distribution to its shareholders (i.e., after satisfaction of all the Companys liabilities to creditors, if any) and, subject to the rights of holders of any shares of each other class or series of shares ranking, as to rights to the distribution of assets upon the Companys voluntary or involuntary liquidation, dissolution or winding up, senior to the Series A Preferred Shares, a liquidation preference of $25.00 per share, plus an amount equal to any accumulated and unpaid dividends to the date of payment (whether or not declared), before any distribution or payment may be made to holders of shares of Common Shares or any other class or series of the Companys shares ranking, as to rights to the distribution of assets upon any voluntary or involuntary liquidation, dissolution or winding up, junior to the Series A Preferred Shares (the liquidation preference). |
(2) | If, upon such voluntary or involuntary liquidation, dissolution or winding up of the Companys affairs, the assets of the Company legally available for distribution to the Companys shareholders are insufficient to pay the full amount of the liquidation preference on all outstanding Series A Preferred Shares and the corresponding amounts payable on all shares of each other class or series of shares of the Company ranking, as to rights to the distribution of assets upon any voluntary or involuntary liquidation, dissolution or winding up, on parity with the Series A Preferred Shares, then the holders of Series A Preferred Shares and each such other class or series of shares of the Company ranking, as to rights to the distribution of assets upon the Companys voluntary or involuntary liquidation, dissolution or winding up, on parity with the Series A Preferred Shares will share ratably in any distribution of assets in proportion to the full liquidation preference to which they would otherwise be respectively entitled. In any such distribution, the liquidation preference of any holder of the Companys shares other than the Series A Preferred Shares means the amount otherwise payable to such holder in such distribution (assuming no limitation on the Companys assets available for such distribution), including an amount equal to any declared but unpaid dividends in the case of any holder or Shares on which dividends accrue on a non-cumulative basis and, in the case of any holder of shares on which dividends accrue on a cumulative basis, an amount equal to any unpaid, accrued, cumulative dividends, whether or not earned or declared, as applicable. |
(3) | Holders of Series A Preferred Shares will be entitled to written notice of any voluntary or involuntary liquidation, dissolution or winding up of the Company, no fewer than thirty (30) days and no more than sixty (60) days prior to the payment date. |
(4) | If the liquidation preference has been paid in full to all holders of Series A Preferred Shares and each such other class or series of shares ranking, as to rights to the distribution of assets any voluntary or involuntary liquidation, dissolution or winding up, on parity with the Series A Preferred Shares, holders of Series A Preferred Shares and each such other class or series of shares ranking, as to rights to the distribution of assets upon any voluntary or involuntary liquidation, dissolution or winding up, on parity with the Series A Preferred Shares will have no right or claim to any of the Companys remaining assets and the holders of shares of Common Shares or any class or series of shares ranking, as to rights to the distribution of assets any voluntary or involuntary liquidation, dissolution or winding up, junior to the Series A Preferred Shares, will be entitled to receive all of the Companys remaining assets according to their respective rights and preferences. |
(5) | The consolidation, merger or other business combination of the Company with or into any other entity or the sale, lease, transfer or conveyance of all or substantially all of the assets, property or business of the Company will not be deemed to constitute a liquidation, dissolution or winding up of the Company. |
27.3.6 | Optional Redemption. |
(1) | The Series A Preferred Shares are perpetual and have no maturity date. The Series A Preferred Shares are not redeemable prior to the one-year anniversary of the Original Issue Date, except under the circumstances described in Article 27.3.8 hereof. |
(2) | On or after the one-year anniversary of the Original Issue Date, the Series A Preferred Shares may be redeemed at the Companys option, in whole or in part, from time to time, at a redemption price of $25.00 per Series A Preferred Share, plus all dividends accumulated and unpaid (whether or not declared) on the Series A Preferred Shares up to, but not including, the date of such redemption (the Redemption Date), upon the giving of notice, as provided in Article 27.3.7 hereof. |
27.3.7 | Redemption Procedures. |
(1) | In the event the Company elects to redeem Series A Preferred Shares, notice of redemption will be mailed to each holder of record of Series A Preferred Shares called for redemption at such holders address as it appears on the Companys share transfer records, not less than thirty (30) nor more than sixty (60) days prior to the Redemption Date. Any notice mailed as provided in this paragraph shall be conclusively presumed to have been duly given, whether or not the holder receives such notice, but failure duly to give such notice by mail, or any defect in such notice or in the mailing thereof, to any holder of Series A Preferred Shares designated for redemption shall not affect the validity of the proceedings for the redemption of any other Series A Preferred Shares. Notwithstanding the foregoing, if the Series A Preferred Shares are issued in book-entry form through The Depository Trust Company (DTC) or any other similar facility, notice of redemption may be given to the holders of Series A Preferred Shares at such time and in any manner permitted by such facility. |
(2) | The notice will notify the holder of the election to redeem the shares and will state at least the following: |
(a) | the Redemption Date; |
(b) | the redemption price; |
(c) | the number of Series A Preferred Shares to be redeemed (and, if fewer than all the shares are to be redeemed, the number of shares to be redeemed from such holder or the method for determining such number); |
(d) | the place(s) where holders may surrender certificates, if any, evidencing the Series A Preferred Shares for payment; |
(e) | if applicable, that the Series A Preferred Shares are being redeemed pursuant to the Companys special optional redemption right in connection with the occurrence of a Delisting Event, Change of Control or $8 VWAP Event (each as defined hereafter), as applicable, and a brief description of the transaction or transactions or circumstances constituting such Delisting Event, Change of Control or $8 VWAP Event, as applicable; and |
(f) | that dividends on such Series A Preferred Shares will cease to accumulate on the date prior to the Redemption Date. |
(3) | If fewer than all of the outstanding Series A Preferred Shares are to be redeemed, the shares to be redeemed will be determined pro rata (as nearly as practicable without creating fractional shares) or by lot. So long as all Series A Preferred Shares are held of record by the nominee of DTC, the Company will give notice, or cause notice to be given, to DTC of the number of Series A Preferred Shares to be redeemed, and DTC will determine the number of Series A Preferred Shares to be redeemed from the account of each of its participants holding such shares in its participant account. Thereafter, each participant will select the number of shares to be redeemed from each beneficial owner for whom it acts (including the participant, to the extent it holds Series A Preferred Shares for its own account). A participant may determine to redeem Series A Preferred Shares from some beneficial owners (including the participant itself) without redeeming Series A Preferred Shares from the accounts of other beneficial owners. Subject to the provisions hereof, the board of directors (or a duly authorized committee of the board of directors) shall have full power and authority to prescribe the terms and conditions on which Series A Preferred Shares shall be redeemed from time to time. If the Company shall have issued certificates for the Series A Preferred Shares and fewer than all shares represented by any certificates are redeemed, new certificates shall be issued representing the unredeemed shares without charge to the holders thereof. |
(4) | On or after the Redemption Date, each holder of Series A Preferred Shares to be redeemed that holds a certificate other than through DTC book entry must present and surrender the certificates evidencing the Series A Preferred Shares at the place designated in the notice of redemption and shall be entitled to the redemption price and any accumulated and unpaid dividends payable upon the redemption following the surrender. |
(5) | From and after the Redemption Date or, if notice of redemption has been duly given, and if on or before the Redemption Date specified in the notice, all funds necessary for the redemption have been set aside by the Company, separate and apart from the Companys other funds, in trust for the pro rata benefit of the holders of the shares called for redemption, so as to be and continue to be available for that purpose, then, in each case unless the Company defaults in payment of the redemption price: (i) all dividends on the shares designated for redemption in the notice will cease to accumulate on or after the Redemption Date; (ii) all rights of the holders of the shares, except the right to receive the redemption price thereof (including all accumulated and unpaid dividends up to the date prior to the Redemption Date), will cease and terminate; and (iii) the shares designated for redemption in the notice will be deemed to not be outstanding for any purpose whatsoever. |
(6) | Any funds held in trust and unclaimed at the end of two years from the Redemption Date, to the extent permitted by law, shall be released from the trust so established and may be commingled with the Companys other funds, and after that time the holders of the shares so called for redemption shall look only to the Company for payment of the redemption price of such shares. |
(7) | Notwithstanding any other provision herein, any declared but unpaid dividends payable on a Redemption Date that occurs subsequent to the applicable record date for a dividend period shall not be paid to the holder entitled to receive the redemption price on the Redemption Date, but rather shall be paid to the holder of record of the redeemed shares on such record date relating to the applicable dividend payment date. |
27.3.8 | Special Optional Redemption. |
(1) | During any period of time (whether before or after the one-year anniversary of the Original Issue Date) that both (i) the Series A Preferred Shares are no longer (a) listed on The Nasdaq Stock Market LLC (Nasdaq), the New York Stock Exchange LLC (the NYSE), or the NYSE American LLC (the (NYSE AMER) or (b) listed or quoted on an exchange or quotation system that is a successor to Nasdaq, the NYSE or the NYSE AMER, and (ii) the Company is not subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the Exchange Act), but any Series A Preferred Shares are still outstanding (collectively, a Delisting Event), the Company may, at its option, redeem the Series A Preferred Shares, in whole or in part and within ninety (90) days after the date of the Delisting Event, by paying $25.00 per Series A Preferred Share, plus all dividends accumulated and unpaid (whether or not declared) on the Series A Preferred Shares up to, but not including, the Redemption Date. |
(2) | During any period of time (whether before or after one-year anniversary of the Original Issue Date), upon the occurrence of a Change of Control (as defined hereafter), the Company may, at its option, redeem the Series A Preferred Shares, in whole or in part and within ninety(90) days after the first date on which such Change of Control occurred, by paying $25.00 per Series A Preferred Share, plus all dividends accumulated and unpaid (whether or not declared) on the Series A Preferred Shares up to, but not including, the date of such redemption. |
(3) | During any period of time (whether before or after one-year anniversary of the Original Issue Date) upon the occurrence of an $8 VWAP Event (as defined hereafter), the Company may at its option redeem the Series A Preferred Shares, in whole or in part and within ninety (90) days after the date of the Delisting Event, by paying $25.00 per Series A Preferred Share, plus all dividends accumulated and unpaid (whether or not declared) on the Series A Preferred Shares up to, but not including, the Redemption Date. |
(4) | As used in this Certificate, a Change of Control is when, after the Original Issue Date, the following have occurred and are continuing: |
(a) | any person or persons acting together which would constitute a group for purposes of Section 13(d) of the Exchange Act (other than the Company or any subsidiary of the Company) shall beneficially own (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, at least 25% of the total voting power of all classes of capital stock of the Company entitled to vote generally in the election of the board of directors; |
(b) | Current Directors (as herein defined) shall cease for any reason to constitute at least a majority of the members of the board of directors (for this purpose, a Current Director shall mean any member of the Board as of the date hereof and any successor of a Current Director whose election, or nomination for election by the Companys shareholders, was approved by at least a majority of the Current Directors then on the board of directors); |
(c) | (i) the complete liquidation of the Company or (ii) the merger or consolidation of the Company, other than a merger or consolidation in which (x) the holders of the common shares of the Company immediately prior to the consolidation or merger have, directly or indirectly, at least a majority of the common shares of the continuing or surviving corporation immediately after such consolidation or merger or (y) the board of directors immediately prior to the merger or consolidation would, immediately after the merger or consolidation, constitute a majority of the board of directors of the continuing or surviving corporation, which liquidation, merger or consolidation has been approved by the shareholders of the Company; or |
(d) | the sale or other disposition (in one transaction or a series of transactions) of all or substantially all of the assets of the Company pursuant to an agreement (or agreements) which has (have) been approved by the shareholders of the Company. |
(5) | As used in this Certificate, an $8 VWAP Event is when, after the Original Issue Date, the volume weighted average price of the Common Shares on the Nasdaq Capital Market for five consecutive trading days (as reported by Bloomberg L.P. based on a trading day from 9:30 a.m. to 4:02 p.m. (New York City time)) is at least $8.00. |
(6) | The redemption procedures set forth in Article 27.3.7 will apply to any redemption under this Article 27.3.8. |
27.3.9 | Conversion. |
(1) | The Series A Preferred Shares are convertible into Common Shares at a conversion ratio of (a) the $25.00 per share liquidation preference divided by (b) $2.75. Any declared but unpaid dividends shall be paid upon such a conversion to the holder of Series A Preferred Stock in cash. Notwithstanding the foregoing, the Series A Preferred Shares are not convertible into or exchangeable for any other property or securities of the Company or any other entity, except as provided for in this Article 27.3.9. |
(2) | The Company will not issue fractional Common Shares upon the conversion of Series A Preferred Shares. In the event that the conversion would result in the issuance of fractional shares of Common Shares, the Company will pay the holder of Series A Preferred Shares the cash value of such fractional shares in lieu of such fractional shares based on a value per full Common Share of $2.75. |
(3) | To exercise the conversion right, each holder of Series A Preferred Shares will be required to notify the Company of the number of Series A Preferred Shares to be converted and otherwise to comply with any applicable procedures required by the Transfer Agent or DTC for effecting the conversion. |
(4) | Series A Preferred Shares as to which the conversion right has been properly exercised will be converted into the applicable number of Common Shares (the Conversion Shares). The Company will take commercially reasonable efforts to deliver the applicable Conversion Shares no later than the third business day following receipt of the conversion notice from the holder of Series A Preferred Shares. |
27.3.10 | Voting Rights. |
(1) | Holders of Series A Preferred Shares shall not have any voting rights, except as set forth in this Article 27.3.10 or as otherwise required by law. |
(2) | In any matter in which the Series A Preferred Shares may vote (as expressly provided herein or as may be required by law), each Series A Preferred Share shall be entitled to one vote per $25.00 of liquidation preference; provided that if the Series A Preferred Shares and any other Shares ranking on parity to the Series A Preferred Shares as to dividend rights and rights as to the distribution of assets upon the Companys liquidation, dissolution or winding up are entitled to vote together as a single class on any matter, the holders of each will vote in proportion to their respective liquidation preferences. |
(3) | As used in this Article 27.3, voting preferred shares means any other class or series of the Companys preferred shares ranking equally with the Series A Preferred Shares as to dividends (whether cumulative or non-cumulative) and the distribution of the Companys assets upon liquidation, dissolution or winding up and upon which like voting rights to the Series A Preferred Shares have been conferred and are exercisable. |
(4) | So long as any Series A Preferred Shares remain outstanding, the Company will not, without the consent or the affirmative vote of the holders of at least two-thirds of the outstanding Series A Preferred Shares and each other class or series of preferred shares entitled to vote thereon (voting together as a single class), given in person or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose: |
(a) | authorize, create or issue, or increase the number of authorized or issued number of shares of, any class or series of shares ranking senior to the Series A Preferred Shares with respect to payment of dividends or the distribution of assets upon the liquidation, dissolution or winding up of the Company or reclassify any authorized shares of the Company into any such shares, or create, authorize or issue any obligation or security convertible into or evidencing the right to purchase any such shares; or |
(b) | amend, alter or repeal the provisions of these Articles or the Companys Notice of Articles, insofar as the Notice of Articles relates to the Companys authorized capital, including the terms of the Series A Preferred Shares, whether by merger, consolidation, transfer or conveyance of all or substantially all of the Companys assets or otherwise, so as to materially and adversely affect the rights, preferences, privileges or voting powers of the Series A Preferred Shares, taken as a whole. |
(5) | If any event described in Article 27.3.10(4)(b) would materially and adversely affect the rights, preferences, privileges or voting powers of the Series A Preferred Shares, taken as a whole, disproportionately relative to any other class or series of voting preferred Shares, the affirmative vote of the holders of at least two-thirds of the outstanding Series A Preferred Shares, voting as a separate class, will also be required. Furthermore, if holders of Series A Preferred Shares receive the $25.00 per share of the Series A Preferred Shares liquidation preference plus all accrued and unpaid dividends thereon or greater amounts pursuant to the occurrence of any of the event described in 27.3.10(4)(b), then such holders shall not have any voting rights with respect to the event described in 27.3.10(4)(b). |
(6) | The following actions are not deemed to materially and adversely affect the rights, preferences, powers or privileges of the Series A Preferred Shares: |
(a) | any increase in the number of authorized Common Shares or preferred shares or the creation or issuance of shares or any class or series ranking, as to dividends (whether cumulative or not) or the distribution of assets upon the Companys liquidation, dissolution or winding up, on parity with, or junior to, the Series A Preferred Shares; or |
(b) | the amendment, alteration or repeal or change of any provision of the Articles or the Companys Notice of Articles, insofar as the Notice of Articles relates to the Companys authorized capital, as a result of a merger, consolidation, reorganization or other business combination, if (x) the Series A Preferred Shares remain outstanding or, in the case of any such merger or consolidation with respect to which the Company is not the surviving or resulting entity, the Series A Preferred Shares are converted into or exchanged for preference securities of the surviving or resulting entity or its ultimate parent, and (y) such shares remaining outstanding or such preference securities, as the case may be, have such rights, preferences, privileges and voting powers, and limitations and restrictions thereof, taken as a whole, as are not materially less favorable to the holders thereof than the rights, preferences, privileges and voting powers, and restrictions and limitations thereof, of the Series A Preferred Shares, taken as a whole, immediately prior to such consummation. |
(7) | Without the consent of the holders of Series A Preferred Shares, the Company may amend, alter, supplement or repeal any terms of the Series A Preferred Shares: |
(a) | to cure any ambiguity, or to cure, correct or supplement any provision contained in this Article 27.3 for the Series A Preferred Shares that may be defective or inconsistent, so long as such action does not materially and adversely affect the rights, preferences, privileges and voting powers of the Series A Preferred Shares, taken as a whole; |
(b) | to conform this Article 27.3 to the description of the Series A Preferred Shares set forth in the Companys final prospectus filed with the U.S. Securities and Exchange Commission related to the initial issuance of Series A Preferred Shares in connection with the Companys Registration Statement on Form F-1 (Registration No. 333-264859); or |
(c) | to make any provision with respect to matters or questions arising with respect to the Series A Preferred Shares that is not inconsistent with the provisions of this Article 27.3. |
(8) | The foregoing voting provisions will not apply if, at or prior to the time when the act with respect to which the vote would otherwise be required shall be effected, all outstanding Series A Preferred Shares have been redeemed or called for redemption on proper notice and sufficient funds have been set aside by the Company for the benefit of the holders of Series A Preferred Shares to effect the redemption within ninety (90) days unless all or a part of the outstanding Series A Preferred Shares are being redeemed with the proceeds from the sale of shares of, any class or series of shares ranking senior to the Series A Preferred Shares with respect to payment of dividends or the distribution of assets upon the Companys liquidation, dissolution or winding up. |
(9) | The rules and procedures for calling and conducting any meeting of the holders of Series A Preferred Shares (including, without limitation, the fixing of a record date in connection therewith), the solicitation and use of proxies at such a meeting, the obtaining of written consents and any other aspect or matter with regard to such a meeting or such consents shall be governed by any rules the board of directors (or a duly authorized committee of the board of directors), in its discretion, may adopt from time to time, which rules and procedures shall conform to the requirements of these Articles, applicable law (including the Business Corporations Act) and any national securities exchange or other trading facility on which the Series A Preferred Shares may be listed or traded at the time. |
(10) | Holders of Series A Preferred Shares will not have any voting rights with respect to, and the consent of the holders of Series A Preferred Shares is not required for, the taking of any corporate action, including any merger or consolidation involving the Company or a sale of all or substantially all of the Companys assets, regardless of the effect that such merger, consolidation or sale may have upon the powers, preferences, voting power or other rights or privileges of the Series A Preferred Shares, except as set forth above. |
27.3.11 | Redemption Upon Request of Holder in Connection with Change of Control. |
(1) | Upon the occurrence of a Change of Control that is approved by the Board of Directors, each holder of Series A Preferred Shares may require the Company to redeem all or a portion of such holders Series A Preferred Shares at a per share redemption price of $25.00, plus declared and unpaid dividends to, but excluding, the effective date of the Change of Control). |
(2) | Upon not less than 30 nor more than 60 days following the occurrence of a Change of Control, the Company will provide to holders of Series A Preferred Shares a written notice (in a manner prescribed by this Article 27.3) of occurrence of the Change of Control that describes the procedure for delivering a redemption request pursuant to this Article 27.3.11 (a Change of Control Redemption Request). Holders will be required to tender such Series A Preferred Shares in connection with the delivery of a Change of Control Redemption Request and will receive payment for the redemption of such Series A Preferred Shares no later than the third business day following the delivery of the Change of Control Redemption Request. |
(3) | In addition to the procedures set forth in this Article 27.3.11, the redemption procedures set forth in Article 27.3.7(4) and (7) will apply to any redemption under this Article 27.3.11. |
27.3.12 | No Preemptive Rights. |
Holders of Series A Preferred Shares do not have any preemptive rights.
27.3.13 | No Maturity, Sinking Fund or Mandatory Redemption. |
The Series A Preferred Shares have no maturity date and the Company is not required to redeem the Series A Preferred Shares at any time. Accordingly, the Series A Preferred Shares will remain outstanding indefinitely, unless the Company decides, at its option, to exercise its redemption right or, under circumstances where the holders of Series A Preferred Shares have a conversion right, such holders convert the Series A Preferred Shares into the Companys common Shares. The Series A Preferred Shares are not subject to any sinking fund.
27.3.14 | Exclusion of Other Rights. |
The Series A Preferred Shares do not have any voting powers, preferences or relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set forth in this Article 27.3.
27.3.15 | Headings of Subdivisions. |
The headings of the various subdivisions of this Article 27.3 are for convenience of reference only and shall not affect the interpretation of any of the provisions hereof.
27.3.16 | Severability of Provisions. |
If any preferences or other rights, voting powers, restrictions, limitations as to dividends or other distributions, qualifications or terms or conditions of redemption of the Series A Preferred Shares set forth in this Article 27.3 are invalid, unlawful or incapable of being enforced by reason of any rule of law or public policy, all other preferences or other rights, voting powers, restrictions, limitations as to dividends or other distributions, qualifications or terms or conditions of redemption of Series A Preferred Shares set forth in this Article 27.3 which can be given effect without the invalid, unlawful or unenforceable provision thereof shall, nevertheless, remain in full force and effect and no preferences or other rights, voting powers, restrictions, limitations as to dividends or other distributions, qualifications or terms or conditions of redemption of the Series A Preferred Shares herein set forth shall be deemed dependent upon any other provision thereof unless so expressed therein.
27.3.17 | Record Holders. |
To the fullest extent permitted by applicable law, the Company and the Transfer Agent may deem and treat the record holder of any share of the Series A Preferred Shares as the true and lawful owner thereof for all purposes, and neither the Company nor the Transfer Agent shall be affected by any notice to the contrary.
27.3.18 | Notices. |
All notices or communications in respect of the Series A Preferred Shares will be sufficiently given if given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in this Article 27.3 or in these Articles or by applicable law.
27.3.19 | Certificates. |
The Company may at its option issue Series A Preferred Shares without certificates. If DTC or its nominee is the registered owner of the Series A Preferred Shares, the following provisions of this Article 27.3.19 shall apply. If and as long as DTC or its nominee is the registered owner of the Series A Preferred Shares, DTC or its nominee, as the case may be, shall be considered the sole owner and holder of all such Series A Preferred Shares of which DTC or its nominee is the registered owner for all purposes under the instruments governing the rights and obligations of holders of Series A Preferred Shares. If DTC discontinues providing its services as securities depositary with respect to the Series A Preferred Shares, or if DTC ceases to be registered as a clearing agency under applicable securities laws, in the event that a successor securities depositary is not obtained within ninety (90) days, the Company shall either print and deliver certificates for the Series A Preferred Shares or provide for the direct registration of the Series A Preferred Shares with the Transfer Agent. If the Company decides to discontinue the use of the system of book-entry-only transfers through DTC (or a successor securities depositary), the Company shall print certificates representing the Series A Preferred Shares and deliver such certificates to DTC or shall provide for the direct registration of the Series A Preferred Shares with the Transfer Agent. Except in the limited circumstances referred to above, owners of beneficial interests in the Series A Preferred Shares of which DTC or its nominee is the registered owner:
(a) | shall not be entitled to have such Series A Preferred Shares registered in their names; |
(b) | shall not receive or be entitled to receive physical delivery of securities certificates in exchange for beneficial interests in the Series A Preferred Shares; and |
(c) | shall not be considered to be owners or holders of Series A Preferred Shares for any purpose under the instruments governing the rights and obligations of holders of Series A Preferred Shares. |
27.3.20 | Restatement of Articles. |
On any restatement of these Articles, Article 27.3.1 through Article 27.3.19 of this Article 27.3 shall be included in the Articles under the heading 9.0% Series A Cumulative Perpetual Preferred Shares and this Article 27.3.20 may be omitted. If the board of directors so determines, the numbering of Article 27.3.1 through Article 27.3.19 may be changed for convenience of reference or for any other proper purpose.
Exhibit 5.1
Our File No.: 4609.103
August 9, 2022
MCLOUD TECHNOLOGIES CORP.
550-510 Burrard Street
Vancouver, British Columbia Canada, V6C 3A8
Ladies and Gentlemen:
Re: MCLOUD TECHNOLOGIES CORP. - Registration Statement on Form F-1
We have acted as British Columbia counsel to mCloud Technologies Corp. (the Company), a British Columbia company, in connection with the registration (including in connection with an over-allotment option granted to the representative of the underwriters) by the Company of (i) $28,750,000 9.0% Series A Cumulative Perpetual Preferred Shares (the Preferred Shares) and accompanying (ii) warrants to purchase common shares (the Warrants), with each Preferred Share to be sold with nine accompanying Warrants, in connection with an underwritten public offering of the Company (the Offering).
In connection with this opinion, we have reviewed and relied upon originals, photocopies or copies, certified or otherwise identified to our satisfaction, of the Registration Statement on Form F-1 (Registration Statement No. 333-264859) (the Registration Statement) filed by the Company with the Securities and Exchange Commission and as to which this opinion is filed as an exhibit, the exhibits to the Registration Statement including the form of Underwriting Agreement between the Company and Maxim Group LLC., as representative of the underwriters listed therein, the Companys Notice of Articles, the Companys Articles, records of the Companys corporate proceedings in connection with the Offering, and such other documents, records, certificates, memoranda and other instruments as we deem necessary as a basis for this opinion. With respect to the foregoing documents, we have assumed, without independent investigation: (i) the authenticity of all records, documents, and instruments submitted to us as originals; (ii) the genuineness of all signatures on all agreements, instruments and other documents submitted to us; (iii) the legal capacity and authority of all persons or entities (other than the Company) executing all agreements, instruments or other documents submitted to us; (iv) the authenticity and the conformity to the originals of all records, documents, and instruments submitted to us as copies; (v) that the statements contained in the certificates and comparable documents of public officials, officers and representatives of the Company and other persons on which we have relied for purposes of this opinion are true and correct; (vi) that the Registration Statement has been declared effective pursuant to the Securities Act of 1933, as amended (the Securities Act); and (vii) that the resolutions of the Companys directors approving the Offering and the creation of the Preferred Shares, both dated July 15, 2022, are true and complete copies of the proceedings of the Board related to the approval of the Offering and the creation of the Preferred Shares and that the resolutions have not been altered, amended or rescinded as at the date of this opinion. We have also obtained from officers of the Company certificates as to certain factual matters and, insofar as this opinion is based on matters of fact, we have relied on such certificates without independent investigation. With respect to the Underwriting Agreement and the Warrants, all of which are governed by and construed in accordance with the laws of the State of New York, we have assumed that these agreements comply with and do not violate the laws of the State of New York.
Our opinion is limited to laws of the Province of British Columbia. We have not considered, and have not expressed any opinion with regard to, or as to the effect of, any other law, rule, or regulation, state or federal, applicable to the Company. In particular, we express no opinion as to United States federal securities laws.
Based upon and subject to the foregoing, we are of the opinion that (i) upon payment to the Company of the consideration in such amount and form as shall be determined by its Board of Directors (the Board) or by an authorized committee thereof, the Preferred Shares, when issued and sold in the Offering as described in the Registration Statement, will be duly and validly issued, fully paid and non-assessable; (ii) the common shares underlying the Preferred Shares, when issued and sold by the Company and delivered by the Company in accordance with and in the manner described in the Registration Statement and the Rights and Restrictions for 9.0% Cumulative Series A Preferred Shares , will be validly issued, fully paid and non-assessable, and (iii) the common shares underlying the Warrants, when issued and sold by the Company and delivered by the Company against receipt of the exercise price therefor as shall be determined by the Board or an authorized committee thereof, in accordance with and in the manner described in the Registration Statement and the Warrants, will be validly issued, fully paid and non-assessable.
We hereby consent to the filing of this opinion as an exhibit to the Companys Registration Statement and to the use of our name wherever it appears in the Registration Statement. In giving such consent, we do not believe that we are experts within the meaning of such term as used in the Securities Act, or the rules and regulations of the Securities and Exchange Commission issued thereunder with respect to any part of the Registration Statement, including this opinion as an exhibit or otherwise.
We further consent to the incorporation by reference of this letter and consent into any registration statement filed pursuant to Rule 462(b) under the Securities Act with respect to the Securities.
Very truly yours, |
||||
/s/ Morton Law LLP | ||||
Morton Law LLP |
Exhibit 5.2
August 9, 2022
mCloud Technologies Corp.
550-510 Burrard Street
Vancouver, British Columbia
Canada, V6C 3A8
Ladies and Gentlemen:
This opinion is furnished to you in connection with a Registration Statement on Form F-1 (Registration No. 333-264859) (as amended to date, the Registration Statement) filed by mCloud Technologies Corp., a British Columbia company (the Company), with the Securities and Exchange Commission (the Commission) under the Securities Act of 1933, as amended (the Securities Act), relating to the registration in connection with a proposed public offering (including in connection with an over-allotment option granted to the representative of the underwriters) of up to $28,750,000 9.0% Series A Cumulative Perpetual Preferred Shares, no par value per share, with a $25.00 liquidation preference per share (the Series A Preferred Shares) and accompanying nine warrants to purchase one common share, no par value per share (the Warrants and, together with the Series A Preferred Shares, and the common shares underlying the Warrants, the Securities). Each Series A Preferred Share will be issued together with nine Warrants. The Company has engaged Maxim Group LLC, to act as the representative of the underwriters in connection with the proposed public offering of the Company.
We are acting as U.S. securities counsel for the Company in connection with the Registration Statement. In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of such records of the Company and such agreements, certificates and statements of public officials, certificates of officers or representatives of the Company, and such other documents, certificates and records as we have deemed necessary or appropriate as a basis for the opinion set forth herein. In our examination, we have assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified or photostatic copies and the authenticity of all originals of such latter documents. As to any facts material to the opinions expressed herein which were not independently established or verified, we have relied upon oral or written statements and representations of officers and other representatives of the Company and others, including those set forth in the Form of Underwriting Agreement, copy of which has been filed as Exhibit 1.1 to the Registration Statement (the Underwriting Agreement).
We are admitted to the Bar in the State of New York. We express no opinion as to the laws of any jurisdiction other than the laws of the State of New York.
You are separately receiving an opinion from Morton Law LLP with respect to the corporate proceedings relating to the issuance of the Securities.
Based upon the foregoing and subject to the assumptions and qualifications set forth herein, we are of the opinion that the Warrants, when issued and sold by the Company and delivered by the Company in accordance with and in the manner described in the Registration Statement and Underwriting Agreement, when executed and delivered by the Company, will constitute the valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, moratorium and similar laws affecting creditors rights generally and equitable principles of general applicability and comply with and do not violate the laws of the State of New York.
We express no opinion as to the enforceability of any rights to indemnification or contribution provided for in the Underwriting Agreement that are violative of the public policy underlying any law, rule or regulation.
We consent to the filing of this opinion as an exhibit to the Registration Statement and we further consent to the use of our name under the caption Legal Matters in the Registration Statement and the prospectus that forms a part thereof. In giving these consents, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission. This opinion letter is given as of the date hereof and we do not undertake any liability or responsibility to inform you of any change in circumstances occurring, or additional information becoming available to us, after the date hereof which might alter the opinions contained herein.
Very truly yours, |
/s/ Sichenzia Ross Ference LLP |
Sichenzia Ross Ference LLP |
Exhibit 10.16
AMENDED AND RESTATED ROYALTY PURCHASE AGREEMENT
TIDS AGREEMENT is made October 27, 2016,
BETWEEN:
AGNITY GLOBAL, INC.
(the Corporation)
- and-
AGNITY COMMUNICATIONS, INC.
(Communications)
- and-
AGNITY HEALTHCARE, INC.
(Healthcare)
- and -
SPINACOM, INC. (former Agnity, Inc.)
(Spinacom)
- and-
GRENVILLE STRATEGIC ROYALTY CORP.
(the Purchaser)
WHEREAS the Parties entered into a royalty purchase agreement dated October 30, 2015 (the Initial Agreement);
WHEREAS subsequent to the date of the Initial Agreement, the Purchaser advanced the sum of $750,000 to the Corporation in consideration for the issuance to the Purchaser of an unsecured convertible promissory note in such principal amount (the Note);
WHEREAS effective as of the date of this Agreement the Purchaser elected to convert the principal amount of $750,000 owing under the Note (the Principal Amount), and all accrued but unpaid interest thereon, being $84,750 (the Interest), into an Additional Royalty Interest, such that upon such conversion the aggregate of the Principal Amount and the Interest, being $834,750 (the Aggregate Note Amount), shall be deemed to be a Subsequent Installment in such amount; and
WHEREAS the Parties wish to amend and restate the Initial Agreement in accordance with the terms and conditions contained herein.
THE PARTIES agree as follows:
ARTICLE 1
DEFINITIONS AND INTERPRETATION
1.1 | Definitions |
Capitalized terms not otherwise defined herein shall have the respective meanings ascribed to such terms in Schedule A attached hereto.
1.2 | Certain Rules of interpretation |
In this Agreement:
(a) | Currency - Unless otherwise specified, all references to money amounts are to the lawful currency of the United States of America. |
(b) | Governing Law - This Agreement is a contract made under, governed by and construed in accordance with the laws of the Province of Ontario and the federal laws of Canada applicable in the Province of Ontario. |
(c) | Headings - Headings of Articles and Sections are inserted for convenience of reference only and do not affect the construction or interpretation of this Agreement. |
(d) | Including - Where the word including or includes is used in this Agreement, it means including (or includes) without limitation. |
(e) | Number and Gender - Unless the context requires otherwise, words importing the singular include the plural and vice versa and words importing gender include all genders. |
(f) | Statutory References - A reference to a statute includes all regulations made pursuant to the statute and, unless otherwise specified, the provisions of any statute or regulation that amends, supplements or supersedes the statute or the regulation. |
(g) | Schedules - The schedules attached to this Agreement (as the same may be amended from time to time, whether by way of an amendment to this Agreement or otherwise) are incorporated into, and form an integral part of, this Agreement. |
1.3 | Knowledge |
Unless otherwise stated herein, any reference to the knowledge of the Corporation means the actual knowledge of the officers and directors of each member of the Agnity Group, after reasonable inquiry and investigation in the normal exercise of such individuals duties.
- 2 -
1.4 | Entire Agreement; Waiver |
This Agreement constitutes the entire agreement among the Parties and sets out all the covenants, promises, warranties, representations, conditions, understandings and agreements among the Parties concerning the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, whether oral or written, including those contained in any term sheet or letter of intent between the Corporation and the Purchaser. There are no covenants, promises, warranties, representations, conditions, understandings or other agreements, oral or written, express, implied or collateral between or among the Parties in connection with the subject matter of this Agreement except as specifically set forth in this Agreement. o waivers of or exceptions to any term, condition or provision of this Agreement, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision.
1.5 | Disclosure Letter |
Any disclosure made in a section of the Disclosure Letter shall be deemed to be disclosed for one or more sections of the Disclosure Letter to the extent that such disclosure sets forth facts in sufficient detail so that its application to such other section of the Disclosure Letter is reasonably clear.
ARTICLE 2
INSTALLMENTS AND ROYALTIES
2.1 | Payment of lnstallments |
(a) | The Corporation acknowledges and agrees that: |
(i) | $2,000,000, plus all applicable Taxes thereon (the Initial Installment), was previously advanced to or for the benefit of the Corporation pursuant to the terms of the Initial Agreement and shall be deemed for all purposes of this Agreement to have been paid by the Purchaser under this Agreement; and |
(ii) | the Aggregate Note Amount shall be deemed to be a Subsequent Installment for all purposes of, and shall be subject in all respects to the terms of, this Agreement, and the Note is deemed to be paid in full and terminated effective as of the date of this Agreement. |
(b) | Upon mutual written agreement of the Purchaser and the Corporation, and subject to the satisfactions of all conditions contained herein, the Purchaser may (but shall have no obligation to) purchase and the Corporation may (but shall have no obligation to) sell one or more additional royalties from the Corporation in such amount as may be agreed upon by the Corporation and the Purchaser (each additional payment by the Purchaser to the Corporation being a Subsequent Installment). |
- 3 -
2.2 | Gross Sales Royalty |
As consideration for, and conditional on, the payment by the Purchaser of all Installments, and subject to the terms hereof, the Corporation covenants and agrees to pay to the Purchaser, at such times and in such manner as required by Sections 2.4 and 2.5, subject to termination or reduction as set forth in this Agreement, a royalty (each, a Royalty Payment) determined in accordance with the following (the Gross Sales Royalty):
(a) | for and in respect of the period that commenced on October 30, 2015 and ending on (and including) December 31, 2015, the Parties acknowledge and agree that the Corporation was obligated to pay and did pay to the Purchaser the Minimum Monthly Amount on a monthly basis, pro-rated for any partial month; |
(b) | for and in respect of the period that commenced on January 1, 2016 and ended on (and including) October 31, 2016, the Parties acknowledge that the Corporation was obligated to pay and did pay to the Purchaser a monthly Royalty Payment (pro-rated for any partial month) equal to the greater of (x) the Minimum Monthly Amount, and (y) the amount equal to 3.00% of Revenue of the Agnity Group during each such calendar month; |
(c) | commencing on (and including) November 1, 2016 and ending on (and including) October 31, 2020, the Corporation shall pay to the Purchaser a monthly Royalty Payment (pro-rated for any partial month) equal to the greater of (x) the Minimum Monthly Amount, and (y) the amount equal to 4.25% of Revenue of the Agnity Group during each such calendar month (it being understood that: (i) the first payment to be made under this Section 2.2(c) shall be made by the Corporation on November 30, 2016, which amount shall represent the Royalty Payment attributable to the month of November, 2016; and (ii) the last payment to be made under this Section 2.2(c) shall be made by the Corporation on October 31, 2020, which amount shall represent the Royalty Payment attributable to the month of October, 2020); and |
(d) | effective as of November 1, 2020, the Corporation shall pay to the Purchaser a monthly Royalty Payment (pro-rated for any partial month) equal to 4.25% of Revenue of the Agnity Group during each such calendar month (it being understood that the first payment to be made under this Section 2.2(c) shall be made by the Corporation November 30, 2020, which amount shall represent the Royalty Payment attributable to the month of November, 2020). |
(e) | If the Purchaser advances a Subsequent Installment to the Corporation (subsequent and in addition to the Aggregate Note Amount), the applicable Gross Sales Royalty will be adjusted proportionately based on the actual amount of the Subsequent Installment that is advanced to the Corporation. For illustrative purposes only, assuming that only the Initial Installment and the Aggregate Note Amount has been advanced to the Corporation, if the Purchaser advances a Subsequent Installment of $100,000 to the Corporation, the Gross Sales Royalty will, effective as of the date on which the Subsequent Installment is advanced to the Corporation, automatically and without any further action or formality of any Party, increase from 4.25% to 4.40% (being 4.25 + (l00,000/2,834,750 x 4.25)). |
- 4 -
(f) | The applicable Gross Sales Royalty will be reduced proportionately contemporaneously with the exercise of the Note Principal Buyout Option. As such, if the Corporation makes a Note Principal Buyout Payment, the applicable Gross Sales Royalty will be reduced proportionately based on the actual amount of the Note Principal Buyout Payment that is made to the Purchaser. For illustrative purposes only, assuming that the Corporation makes a Note Principal Buyout Payment of $750,000 to the Corporation, the Gross Sales Royalty will, effective as of the date on which the Note Principal Buyout Payment is made to the Purchaser, automatically and without any further action or formality of any Party, decrease from 4.25% to 3.13% (being 4.25(750,00012,834,750 x 4.25)). |
2.3 | Minimum Monthly Amount |
(a) | Notwithstanding the Gross Sales Royalty rate in effect from time to time, but subject to Sections 2.3(b) and 2.3(c), if only the Initial Installment and the Aggregate Note Amount are paid to or otherwise received by the Corporation, no Royalty Payment in respect of a calendar month during the period commencing on the date of the Initial Agreement and ending on October 31, 2020 will be less than $41,667 (pro-rated for any partial month), it being understood that if the actual calculation of a Royalty Payment to be paid in such circumstance is less than such amount, the Gross Sales Royalty then in effect will be deemed to be amended (in respect of such Royalty Payment only) to be such percentage as would result in such Royalty Payment being $41,667 (pro-rated for any partial month) (the Minimum Monthly Amount). |
(b) | If the Purchaser advances a Subsequent Installment to the Corporation (not taking into account the Aggregate Note Amount), the then applicable Minimum Monthly Amount will be adjusted proportionately based on the actual amount of each Subsequent Installment that is advanced to the Corporation. For illustrative purposes only, if only the Initial Installment is paid to or otherwise received by the Corporation (not taking into account the Aggregate Note Amount) and the Purchaser advances a Subsequent Installment in the amount of $100,000 prior to October 31, 2020, the Minimum Monthly Amount will be deemed to be amended to be $43,750.35 (pro-rated for any partial month) (being 41,667 + (100,000/2,000,000 X 41,667)). |
(c) | The applicable Minimum Monthly Amount will be: (i) reduced by 75% contemporaneously with the completion of the Buy-down Option; and (ii) extinguished pursuant to the completion of the Change of Control Buyout Option. |
2.4 | Payment Mechanism, Adjustments and Delinquent Royalty Payments |
(a) | In accordance with the payment procedures specified in Section 2.5: |
(i) | on the last Business Day of each calendar month until October 31, 2020, the Corporation shall pay to the Purchaser the amount determined in accordance with Section 2.2(c) in respect of such calendar month (which amount shall, for the month of November, 2016, be determined based on Revenue of the Agnity Group for and in respect of the month of October, 2016), subject to reconciliation pursuant to Sections 2.4(b), 2.4(c) and 2.4(d); |
- 5 -
(ii) | on the last Business Day of each calendar month commencing with and following November 30, 2020, the Corporation shall pay to the Purchaser the amount determined in accordance with Section 2.2(d) in respect of such calendar month (which amount shall, for the month of November, 2020, be determined based on Revenue of the Agnity Group for and in respect of the month of October, 2020), subject to reconciliation pursuant to Sections 2.4(b), 2.4(c) and 2.4(d); and |
(iii) | the final payment to be made under Section 2.4(a)(i) shall be made by the Corporation on October 31, 2020, which amount shall represent the Royalty Payment attributable to the month of October, 2020. The first payment to be made under Section 2.4(a)(ii) shall be made by the Corporation on November 30, 2020, which amount shall represent the Royalty Payment attributable to the month of November, 2020. |
(b) | Within 55 days following the end of the first, second and third fiscal quarters of the Corporation during each fiscal year of the Corporation, and within 100 days following the end of the fourth fiscal quarter of the Corporation of each fiscal year of the Corporation (the last day of each such 55 day and 75 day period being the Quarterly Determination Date), the Parties will determine: |
(i) | the aggregate royalties in respect of such fiscal quarter that would have been payable based on an application of the applicable Gross Sales Royalty to Revenue of the Agnity Group (without regard to any Minimum Monthly Amounts) for such fiscal quarter (or prorated for any partial fiscal quarter) using the financial statements of the Agnity Group in respect of such fiscal quarter (which in the case of the fourth fiscal quarter of the Corporation shall be the Annual Financial Statements) (the Pre-Adjusted Quarterly Royalties); and |
(ii) | whether the aggregate Minimum Monthly Amounts in respect of such fiscal quarter (if applicable) were greater than or less than the Pre-Adjusted Quarterly Royalties for such fiscal quarter (the greater of such amounts being the Confirmed Quarterly Royalties). |
(c) | If the actual Royalty Payments paid to the Purchaser in respect of a fiscal quarter were, in the aggregate, greater than the Confirmed Quarterly Royalties for such fiscal quarter, the Purchaser will pay to the Corporation the amount by which such actual Royalty Payments exceeded the Confirmed Quarterly Royalties within 20 Business Days following the Quarterly Determination Date. |
(d) | If the actual Royalty Payments paid to the Purchaser in respect of a fiscal quarter were, in the aggregate, less than the Confirmed Quarterly Royalties for such fiscal quarter, the Corporation will pay to the Purchaser the amount by which the Confirmed Quarterly Royalties exceeded such actual Royalty Payments within 20 Business Days following the Quarterly Determination Date; |
- 6 -
(e) | Notwithstanding anything else contained herein, the Parties may at any time elect to pay any amounts referenced in Sections 2.4(c) or 2.4(d) in such other manner as the Parties may agree. |
(f) | Any payment required to be made under this Agreement that is not paid within 30 days following the date on which it was originally due shall bear interest at a rate of 1.0% per month, compounded monthly. |
2.5 | Payment of Royalty Payments and Buyout Amounts |
All Royalty Payments and other amounts payable by the Corporation under or pursuant to this Agreement, including under Section 2.9 (Buyout Payments), plus all applicable Taxes thereon, if any, that the Purchaser is required by Law to collect from the Corporation in connection therewith, shall be made by wire transfer of immediately available funds to the Purchaser to an account designated in writing by the Purchaser on the date on which each such payment is due. The Corporation shall withhold from any Royalty Payment and Buyout Payment, and remit to the appropriate Governmental Authority, all Taxes that it is required to withhold that are levied thereon by any Governmental Authority, and the payment in each case of the applicable Royalty Payment or Buyout Payment net of any such withheld amount shall be deemed to satisfy the Corporations payment obligations hereunder, provided that the Corporation shall deliver to the Purchaser copies of the filed tax return reporting such payments and official receipts (or such other evidence of payment reasonably acceptable to the Purchaser) evidencing that such payments were in fact paid to the applicable Governmental Authority. Notwithstanding anything to the contrary, the Parties agree that any Taxes paid by the Corporation to any Governmental Authority on behalf of (or for the benefit of) the Purchaser will be deducted from any applicable Royalty Payment or Buyout Payment.
2.6 | Royalty Payments Following Termination |
The termination of this Agreement or the royalties payable hereunder shall not terminate the obligation of the Corporation to pay any Royalty Payment accrued prior to the date of termination. Upon termination of this Agreement or the royalties payable hereunder, the Parties will determine the aggregate royalties in respect of the portion of the fiscal year of the Corporation in which the termination occurs, and will make such adjustments to the amount of royalties paid or to be paid during such period, as may be necessary, in accordance with the terms of Section 2.4.
2.7 | Audit Right |
(a) | Upon not less than 10 days written notice to the Corporation, the Purchaser shall have the right to audit all books and records including all financial records) of the members of the Agnity Group (including those obtained from third parties). Any such audit shall be conducted during normal business hours by an accounting firm selected by the Purchaser at its cost. The members of the Agnity Group shall provide such accounting firm and the Purchaser with access to all pertinent books and records, subject to any confidentiality obligations owed to any third parties, and shall reasonably cooperate with such accounting firms efforts to conduct such audits. |
- 7 -
(b) | If any such audit reveals that there has been an underpayment of Royalty Payments due for the fiscal period being audited of more than I 0% of the amount of Royalty Payments which were actually due in respect of such fiscal period, the Corporation shall reimburse the Purchaser for the reasonable costs and expenses (including accountants fees) incurred by the Purchaser in connection with such audit. If the Purchaser claims that any such audit reveals an underpayment of Royalty Payments, the Purchaser will make the audit papers for the relevant period available to the Corporation. For greater certainty, if an audit reveals that there has been an underpayment of Royalty Payments, an Event of Default in respect of any such underpayment shall be deemed to occur only if such underpayment is not satisfied by the Corporation within 5 Business Days following the date on which the Corporation has been given written notice of such underpayment. |
2.8 | Dispute Mechanism |
If the Parties dispute the amount of one or more Royalty Payments or Buyout Payments (including: (i) the determination of such amounts following an audit conducted pursuant to Section 2.7; and (ii) the manner in which net equity value and net purchase price are determined pursuant to Section 2.9(a)(iv)(A)(2)C) (a Dispute), they shall each use commercially reasonable efforts to reach a negotiated resolution of the Dispute and shall exchange reasonable information with one another concerning the Dispute. If the Parties are unable to reach a negotiated resolution within 30 days from the commencement of negotiations to resolve the Dispute, then either Party may elect for the Dispute to be determined by an independent public accounting firm (the Independent Accountant) licensed to practice accounting in the United States of America selected by mutual agreement of the Parties, or in the absence of such agreement, KPMG LLP, and the Parties shall provide to the Independent Accountant their respective final figures in respect of the disputed amounts along with supporting documentation to substantiate their positions. one of the Parties will disclose to the Independent Accountant, and the Independent Accountant will not consider, for any purpose, any settlement offer made by a Party to the other. The determination of the Independent Accountant shall be final and binding upon the Parties, absent manifest error. Costs of the Independent Accountant shall be paid as determined by the Independent Accountant, and in the absence of such determination, each Party shall pay 50% of the Independent Accountants costs; provided, however, that each Party shall bear its own costs in presenting its arguments to the Independent Accountant. The Independent Accountant shall be deemed to act as an expert and not as an arbitrator. For greater certainty, in the event of a Dispute, and until such time as such Dispute is finally resolved in accordance with the terms of this Section 2.8, the Parties shall continue to be bound by all of the provisions of this Agreement in accordance with their terms (including the Gross Sales Royalty and Minimum Monthly Amount then in effect) notwithstanding the subject-matter of the Dispute.
- 8 -
2.9 | Buy-down Option and Change of Control Buyout Option |
(a) | Subject to Section 2.9(b): |
(i) | subject to Section 2.9(b), and in addition to the right granted under Section 2.9(a)(ii), at any time and from time to time during the period commencing on the date of this Agreement and ending on September 30, 2017, including without limitation concurrently with the completion of a Sale, the Corporation may by delivery of notice in writing to the Purchaser (a Note Principal Buyout Notice) purchase and extinguish up to $750,000 of the Aggregate Installment Amount (the Note Principal Buyout Option), upon payment to the Purchaser by wire transfer of immediately available funds of the amount of the Aggregate Installment Amount that the Corporation proposes to purchase (each a Note Principal Buyout Payment), and the applicable Gross Sales Royalty will be reduced proportionately contemporaneously with each Note Principal Buyout Payment as provided in Section 2.2(f) hereof; |
(ii) subject to Section 2.9(b), and in addition to the right granted under Section 2.9(a)(i), at any time following the date on which the Purchaser has received Royalty Payments under this Agreement that are, in the aggregate, equal to two times the then applicable Aggregate Installment Amount, the Corporation may by delivery of notice in writing to the Purchaser (a Buy-down Notice) purchase and extinguish 75% (but no more or less) of all amounts owing or to become owing to the Purchaser hereunder (but excluding any amounts which are or which may become owing under Section 2.12(c)), including the Aggregate Installment Amount, the Minimum Monthly Amount and the Gross Sales Royalty applicable thereto (such that, for greater certainty, the applicable Gross Sales Royalty and the applicable Minimum Monthly Amount will thereafter each be reduced by 75%, so that if the then applicable Gross Sales Royalty is 4.25%, it would become 1.0625%, and if the then applicable Minimum Monthly Amount is $41,667 it would become $10,416.75) (the Buy-down Option), upon payment to the Purchaser by wire transfer of immediately available funds on a date that is no later than the third Business Day following the date of the Buy-down Notice of an amount equal to the then applicable Aggregate Installment Amount multiplied by 0.75 (the Buy-down Payment);
(iii) | for greater certainty, the Corporation shall be entitled to exercise and complete the Note Principal Buyout Option and the Buy-down Option on multiple occasions, provided that, in the case of the Note Principal Buyout Option, the aggregate of all such exercises shall not exceed the $750,000 maximum referenced in Section 2.9(a)(i) and, in the case of the Buy-down Option, the aggregate of all such exercises shall not exceed the 75% threshold referenced in Section 2.9(a)(ii); and |
- 9 -
(iv) | subject to compliance with Sections 2.10(m) and 2.10(q), and in addition to the rights granted under Section 2.9(a)(i) and Section 2.9(a)(ii), if pursuant to a proposed Change of Control the acquirer under such transaction requires as a condition to the completion of such transaction that the Corporation purchase and extinguish all or some portion of the amounts owing or to become owing to the Purchaser hereunder (excluding any amounts which are or which may become owing under Section 2.12(c)), then contemporaneously with the completion of such proposed Change of Control, the Corporation may, by delivery of a written notice (a Change of Control Buyout Notice) to the Purchaser (which Change of Control Buyout Notice will contain a representation and warranty of the Corporation that the exercise and completion of the Change of Control Buyout Option is a condition precedent to the completion of the proposed Change of Control in favour of the acquirer), purchase and extinguish (effective as of the date of completion of the proposed Change of Control) such portion of the Gross Sales Royalty as is equal to the percentage of Revenue of the Agnity Group contributed by the member or members of the Agnity Group that are the subject of the Change of Control relative to the total Revenue of the Agnity Group, in each case based on the then most recent Interim Financial Statements (the Change of Control Buyout Option) upon payment to the Purchaser by wire transfer of immediately available funds within IO Business Days following the date of completion of the proposed Change of Control of an amount equal to: |
(A) | in the case of a Change of Control involving the sale of the members of the Agnity Group on a consolidated basis (such that following such sale the acquirer will own all or substantially all of the Business as carried on by the Agnity Group immediately prior to such sale), the greater of the following: |
(l) | an amount equal to two times the Aggregate Installment Amount as at the date of the Change of Control Buyout Notice; and |
(2) | an amount equal to A multiplied by B multiplied by C, where: |
A. | A is equal to the Aggregate Installment Amount as at the date of the Change of Control Buyout Notice divided by $20,000,000; |
B. | B is equal to 0.8; and |
C. | C is equal to the net equity value of the Agnity Group, or in the case of a proposed asset sale, the proposed net purchase price (expressed in United States dollars) of all or substantially all of the assets of the Business, in each case as determined based on the terms of the proposed Change of Control transaction or asset sale; or |
(B) | In the case of a Change of Control involving one or more members of the Agnity Group on a non-consolidated basis (such that following such sale the acquirer will own a distinct and severable division of the Business rather than all or substantially all of the Business), an amount equal to the result obtained from the following formula |
- 10 -
(DS/EV) X (AX B X EV)
Where:
DS = | the net equity value of the members of the Agnity Group that are subject to the Change of Control, or in the case of a proposed asset sale, the proposed net purchase price (expressed in United States dollars) of all or substantially all of the assets of the members of the Agnity Group that are subject to the Change of Control, in each case as determined based on the terms of the proposed Change of Control transaction or asset sale |
EV = | the net equity value of the Agnity Group on a consolidated basis as at the date of the Change of Control Buyout Notice (determined using the same principles used to determine DS) |
A = | the Aggregate Installment Amount as at the date of the Change of Control Buyout Notice divided by $20,000,000; |
B = | 0.8 |
If the proposed Change of Control is not completed within 10 Business Days following the date of the Change of Control Buyout Notice, the exercise by the Corporation of the Change of Control Buyout Option shall be deemed to be null and void and of no force or effect and this Section 2.9(a)(iv) shall thereafter continue to apply in accordance with its terms.
In the event that: (i) the Buy-down Option has previously been exercised and completed in accordance with the terms of this Agreement, then the payment under this Section 2.9(a)(iv) shall be reduced by 75%; or (ii) the Note Principal Buyout Option is exercised and completed concurrently or in connection with the exercise and completion of the Change of Control Buyout Option, the amount of the then total Note Principal Buyout Payments will be deemed to not form part of the Aggregate Installment Amount for the purposes of calculating the amount payable by the Corporation under this Section 2.9(a)(iv).
(b) | Notwithstanding anything else contained herein, the Corporations right to exercise the Note Principal Buyout Option, the Option Buy-down Option or the Change of Control Buyout Option shall immediately and forever cease effective as of the occurrence of an Event of Default or a Bankruptcy Occurrence that in each case is not cured to the satisfaction of the Purchaser, acting reasonably, within 21 days following the date of occurrence of the Event of Default or Bankruptcy Occurrence, as the case may be (which period shall, if the applicable Event of Default is the subject of dispute resolution under Section 2.8, be deemed to be stayed until such time as, and will only re-commence once, such dispute is finally resolved in accordance with Section 2.8). If an Event of Default has occurred, the Corporation shall not be permitted to exercise the Note Principal Buyout Option, the Option Buy-down Option or the Change of Control Buyout Option until such time as the Event of Default has been cured in accordance with the terms hereof; provided that if the applicable Event of Default is the subject of dispute resolution under Section 2.8, the applicable time period to exercise the Note Principal Buyout Option, the Option Buy-down Option or the Change of Control Buyout Option, as the case may be, shall be deemed to be stayed until such time as, and will re-commence once, such dispute is finally resolved in accordance with Section 2.8. |
- 11 -
2.10 | Acknowledgments and Obligations |
The Corporation acknowledges, covenants and agrees that at all times on and following the date hereof it will (and will cause the applicable members of the Agnity Group to):
(a) | operate the Business in good faith and in the ordinary course consistent with past practices, industry standards and best practices, and will use commercially reasonable efforts to operate the Business so as to maximize Revenue of the Agnity Group; |
(b) | not take any steps or actions, or omit or fail to take any steps or actions or enforce any right, the intent of which is to directly or indirectly reduce the calculation of or improperly characterize or account for, or which would reasonably result in or does result in any direct or indirect reduction in the calculation of or improper characterization or accounting for of, Revenue of the Agnity Group or any Royalty Payment; |
(c) | keep and maintain complete, true and materially accurate books and records of all transactions involving Revenue of the Agnity Group; |
(d) | not, without the prior written consent of the Purchaser (which consent will not be unreasonably withheld): (i) change the fiscal year end of any member of the Agnity Group; or (ii) in any way modify, amend or change the accounting practices of any member of the Agnity Group where the effect of such change in any way reduces, or would potentially have the effect of reducing, whether alone or in combination with or as a result of any other factor, the amount payable to the Purchaser hereunder, except for changes required under GAAP; |
(e) | provide to the Purchaser: (i) a monthly unaudited summary of Revenue of the Agnity Group; and (ii) a monthly unaudited management-prepared income statement and balance sheet of each member of the Agnity Group, in each case within 21 days after the last day of each calendar month. For greater certainty, all such information shall be printed directly from the Corporations accounting software with date and time stamps marked thereon; |
- 12 -
(f) | provide to the Purchaser unaudited management-prepared quarterly financial statements of each member of the Agnity Group within 45 days after the last day of each fiscal quarter of each such entity; |
(g) | provide to the Purchaser audited annual financial statements of each member of the Agnity Group within 90 days after the last day of each fiscal year of each such entity (which audit shall be performed by a firm of chartered accountants approved by the Purchaser in its sole discretion, acting reasonably), together with a written confirmation from the Corporations auditors (in a form acceptable to the Purchaser, in its sole discretion acting reasonably) regarding the authenticity of its audit report; |
(h) | provide to the Purchaser, contemporaneously with the reports provided pursuant to Sections 2.10(e), 2.10 (f) and 2.10(g), a certificate of a senior officer of the Corporation, dated as of the date of delivery of each such report, certifying, based on the knowledge of such officer having exercised reasonable diligence, that such reports: (i) are accurate and complete and do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the applicable report; and (ii) the financial information included in the reports fairly present in all material respects the financial condition, financial performance and cash flows of the members of the Agnity Group as of the date of and for the periods covered by the reports; |
(i) | provide to the Purchaser copies of all tax returns filed by each member of the Agnity Group promptly following the date on which such returns are filed; |
(j) | use the proceeds of each Installment in a manner that is consistent with an operating plan provided by the Corporation to the Purchaser, subject to the reasonable discretion of the members of the Agnity Group to use and allocate any portion of an Installment in a manner which is otherwise consistent with the proper exercise of the fiduciary duties of the directors of the applicable member of the Agnity Group; |
(k) | make all necessary filings required of the members of the Agnity Group under Law, obtain all necessary regulatory consents and approvals (if any) required of the members of the Agnity Group under Law and pay all filing fees required to be paid by the members of the Agnity Group under Law in connection with the Transaction; |
(l) | do all things necessary to maintain the corporate existence of each member of the Agnity Group, provided, however that this Section 2.10(1) shall not prevent the amalgamation, merger or wind-up of any member of the Agnity Group with or into another member of the Agnity Group; |
(m) | other than in connection with a transaction in respect of which the Corporation has exercised the Change of Control Buyout Option, not consolidate, amalgamate with, or merge with or into, or reorganize, reincorporate or reconstitute into or as another entity, or continue to any other jurisdiction, unless, at the time of such consolidation, amalgamation, merger, reorganization, reincorporation, reconstitution or continuance, the resulting, surviving or transferee entity in writing assumes in favour of the Purchaser all of the obligations of the Corporation and the Guarantors under this Agreement or as otherwise agreed by the Purchaser in writing; |
- 13 -
(n) | advise the Purchaser promptly of any material default or breach committed by any member of the Agnity Group under any agreement, document or instrument relating to any indebtedness for borrowed money owing to any Person (including any payment default), which breach or default continues for more than the applicable cure period, if any, with respect thereto; |
(o) | (i) maintain insurance upon the assets of each member of the Agnity Group comparable in amount, scope and coverage to that in effect on the date of this Agreement, subject to such changes as may be determined by the applicable member of the Agnity Group, having regard to normal commercial practices and market standards; (ii) not at any time do or omit to do anything, or cause anything to be done or omitted to be done, whereby any such insurance would, or would be likely to, be rendered void or voidable or suspended, impaired or defeated in whole or in part; (iii) notify the Purchaser of any termination, lapse or loss of any material coverage under such insurance no later than 10 days following the occurrence thereof; and (iv) rectify or otherwise cure any such termination, lapse or loss of coverage no later than 10 days following the occurrence thereof (with notice of such rectification or cure provided to the Purchaser within a reasonable period of time thereafter); |
(p) | not, without the prior written consent of the Purchaser, which consent will not be unreasonably withheld, in any way encumber or allow a security interest to attach to any material asset of any member of the Agnity Group where such encumbrance would, in the reasonable opinion of the Purchaser, directly or indirectly reduce the calculation of, or result in any direct or indirect reduction in the calculation of, Revenue of the Agnity Group or any Royalty Payment; |
(q) | not sell, transfer or otherwise dispose (whether to an arms length party or otherwise) of any material property or assets of any member of the Agnity Group (including, in the case of the Corporation, any Agnity Subsidiary) without the prior written consent of the Purchaser, which consent will not be unreasonably withheld; provided, in addition, that the Purchaser agrees that it will provide such consent if (A) contemporaneously with a sale, transfer or disposition of property or assets to an arms length third party buyer, the buyer enters into an agreement with the Purchaser in respect of such property or assets in a form and on terms similar to this Agreement or as is otherwise acceptable to the Purchaser in its sole discretion, acting reasonably, or (B) the Corporation has delivered a Change of Control Buy-out Notice in respect of such sale (including in the case of a Change of Control Buy-out involving only one member of the Agnity Group); |
(r) | be fully responsible for the full amount of any success fee, brokers fee, commission or similar fees which any Person claims is owing or payable to such Person (whether by any member of the Agnity Group or the Purchaser) in connection with the initiation, negotiation or consummation of the Transaction; |
- 14 -
(s) | advise the Purchaser promptly of any material adverse event or Material Adverse Effect that has occurred, or is reasonably likely to occur, in respect of any member of the Agnity Group, including any change to the board of directors or management of any member of the Agnity Group, any material adverse change to customer or client relationships of any member of the Agnity Group, or any material concern raised by the Corporations auditor or accountant in writing delivered to the Corporation regarding any member of the Agnity Group; |
(t) | on or before December 1, 2016, use reasonable efforts to reduce general and administrative expenses of the Agnity Group by at least $300,000 on an annualized basis in a manner satisfactory to the Purchaser, acting reasonably; |
(u) | on or before December 1, 2016, complete a Change of Control, financing, liquidation or other transaction involving Agnity Healthcare pursuant to which the Corporation either disposes of all of its interest in Agnity Healthcare or otherwise deals with its existing interest in Agnity Healthcare; provided, that, such date shall be extended to January 1, 2017 in the event that the Corporation has procured a term sheet with respect such Change of Control on or before December 1, 2016, and such term sheet is satisfactory to the Purchaser, acting reasonably; |
(v) | not, without the prior written consent of the Purchaser, which consent will not be unreasonably withheld, in any way increase the costs or expenses incurred, or obligations owing (including non-economic obligations), by any member of the Agnity Group to AGNITY India Technologies PVT Ltd. or any successor thereto or Affiliate thereof; and |
(w) | not, without the prior written consent of the Purchaser, which consent will not be unreasonably withheld, make any debt (whether convertible or otherwise) or equity investment in, loan, advance or contribute any funds to, subsidize or satisfy the debts or liabilities of, or use any funds or other assets of the Corporation (including any portion of any Installment) for the benefit or use of, any Insider (or any entity in which an Insider has an equity, debt or other form of economic interest), except for payments made to Insiders who are directors, officers, employees or contractors of a member of the Agnity Group in respect of bona fide services and/or in the ordinary course of business. |
2.11 | Conditions to Payment of Installments |
The Purchaser shall not pay any Installment to the Corporation unless and until each of the following conditions has been fulfilled, satisfied and performed in a manner completely satisfactory to the Purchaser in all respects (in the sole discretion of the Purchaser) on or before the date specified herein for each payment of an Installment:
(a) | the Disclosure Letter shall have been delivered to the Purchaser (and updated as necessary in connection with the payment of any Subsequent Installment); |
- 15 -
(b) | the Corporation shall have executed and delivered to the Purchaser each of the following documents: |
(i) | a certificate of status or good standing (or other applicable certificate of like form) issued by the applicable Governmental Authority dated on or about the date of payment of each Installment with respect to the legal existence and good standing of each member of the Agnity Group under the laws of the jurisdiction of incorporation or formation of each such entity; |
(ii) | a certificate of a senior officer of the Corporation, dated as of the date of payment of each Installment, certifying: |
(A) | the accuracy of an attached copy of the constating documents of each member of the Agnity Group, in each case together with all amendments thereto; |
(B) | the accuracy of an attached copy of the resolutions of the board of directors of the Corporation and the Guarantors with respect to the Transaction; |
(C) | that no Material Adverse Effect has occurred as of the date of payment of each Installment; |
(D) | that no Event of Default has occurred and is continuing and that no event or circumstance has occurred, and no condition exists, which would result, either immediately, or with the lapse of time or giving of notice or both, in the occurrence or existence of an Event of Default; and |
(iii) | an invoice of the Corporation in respect of the applicable Installment, and any applicable Taxes thereon, addressed to the Purchaser; |
(c) | the Purchaser shall have received such financial and other information in respect of the Business as may be reasonably required by the Purchaser (including the financial and other information specified in this Agreement); |
(d) | the Corporation and the Guarantors shall have received all third party consents, approvals or waivers required to be obtained pursuant to any Contract by which any member of the Agnity Group is bound and under which consent, approval or waiver from a third party is required as a result of the Corporation and the Guarantors entering into this Agreement or in connection with the completion of the Transaction; |
(e) | the Corporation and the Guarantors shall have, as applicable, executed and delivered such other documents, agreements, instruments, undertakings and assurances as the Purchaser or the Purchasers counsel (in each case, acting reasonably) may deem necessary or advisable in connection with, relating to or arising from, or to give effect to or support, this Agreement; |
- 16 -
(f) | the Corporation shall have delivered to the Purchaser all other materials and information reasonably requested by the Purchaser; and |
(g) | payment of the Installment shall have been approved by the Purchasers investment committee. |
Each of the conditions set forth in this Section 2.11 is for the exclusive benefit of the Purchaser and, unless waived in writing by the Purchaser, shall be fulfilled, satisfied and performed by the Corporation and the Guarantors.
2.12 | Event of Default and Bankruptcy Occurrence |
(a) | Upon the occurrence of: (i) an Event of Default; or (ii) a Bankruptcy Occurrence that in each case is not cured to the satisfaction of the Purchaser, acting reasonably, within 21 days following the date of occurrence of the Event of Default or Bankruptcy Occurrence, as the case may be (which period shall, if the applicable Event of Default is the subject of dispute resolution under Section 2.8, be deemed to be stayed until such time as, and will only re-commence once, such dispute is finally resolved in accordance with Section 2.8), the Aggregate Installment Amount will, at the Purchasers option and without notice to any member of the Agnity Group, be deemed to become immediately due and payable in a manner determined by the Purchaser, and in connection therewith the Purchaser may exercise any or all of the rights and remedies contained in this Agreement or otherwise afforded by law, in equity or otherwise in connection therewith. |
(b) | The Purchaser may waive default or any breach by the Corporation of any of the provisions contained in this Agreement. No waiver extends to a subsequent breach or default, whether or not the same as or similar to the breach or default waived, and no act or omission of the Purchaser extends to or is to be taken in any manner to affect any subsequent breach or default of the Corporation or the rights of the Purchaser resulting therefrom. Any such waiver must be in writing and signed by the Purchaser to be effective. |
(c) | The Corporation will pay or reimburse the Purchaser for any reasonable costs or expenses incurred by the Purchaser in collecting amounts owed to it by the Corporation hereunder. |
(d) | For greater certainty, this Agreement, and all covenants and obligations of the Corporation and the Guarantors hereunder, including the obligation to pay Royalty Payments, will continue in full force and effect, and will not be impaired in any way by, the occurrence of an Event of Default or a Bankruptcy Occurrence or the election by the Purchaser to have the Aggregate Installment Amount become immediately due and payable to the Purchaser, and all Royalty Payments due and owing hereunder shall continue to be paid to the Purchaser following the occurrence of an Event of Default or a Bankruptcy Occurrence in accordance with the terms of this Agreement in addition to, and not in substitution for, the repayment of the Aggregate Installment Amount. |
- 17 -
ARTICLE 3
REPRESENTATIONS AND WARRANTIES OF THE CORPORATION
The Corporation (on its own behalf and on behalf of each member of the Agnity Group) represents and warrants to the Purchaser as of the date of this Agreement (and confirmed as to accuracy by the execution and delivery by the Corporation on the date of payment of any Subsequent Installment of a bring-down certificate, which may contain updates and supplements to representations and warranties, in a form agreed upon by the Parties, each acting reasonably) as follows, and acknowledges that the Purchaser is entering into this Agreement and completing the Transaction in reliance upon such representations and warranties:
3.1 | Incorporation and Organization |
Each member of the Agnity Group is an entity incorporated, formed or established and validly subsisting under the laws of its jurisdiction of incorporation, formation or establishment, and is in good standing under such laws. Each member of the Agnity Group has the full power, authority and capacity:
(a) | to own or lease and operate its properties and assets; and |
(b) | to carry on its business as presently conducted. |
3.2 | Corporate Records |
The minute books of the members of the Agnity Group have been made available to the Purchaser or counsel to the Purchaser and contain all constating documents and resolutions, and such minute books contain, in all material respects, a complete and accurate record of all meetings and actions of directors (and committees of directors) and shareholders of, each such entity since the date of incorporation or formation thereof, and in all material respects accurately reflect all transactions referred to in such proceedings. The share ledgers and registers of each such entity are, in all material respects, complete and reflect all issuances, transfers, repurchases and cancellations of shares in the capital of each such entity.
3.3 | Subsidiaries |
Except as set out in Section 3.3 of the Disclosure Letter, no member of the Agnity Group owns or otherwise holds any legal or beneficial interest in any other Person. The Corporation confirms that a complete and accurate corporate organization chart showing all existing Agnity Subsidiaries has been provided to the Purchaser.
3.4 | Qualification in Foreign Jurisdictions |
either the nature of the Business nor the location or character of the assets owned or leased by the members of the Agnity Group requires any such entity to be registered, licensed or otherwise qualified as a foreign corporation in any jurisdiction other than any jurisdiction in which any such entity is duly registered, licensed or otherwise qualified for this purpose and other than any jurisdiction where the failure to be so registered, licensed or otherwise qualified would not have a Material Adverse Effect.
- 18 -
3.5 | Authorized and Issued Outstanding Capital |
(a) | The authorized and outstanding shares in the capital of each member of the Agnity Group are as set out in Section 3.5 of the Disclosure Letter. |
(b) | Other than as contemplated in this Agreement or the constating documents of any member of the Agnity Group or as set out in Section 3.5 of the Disclosure Letter, there are no outstanding options, warrants or other rights to subscribe for purchase or otherwise acquire from any member of the Agnity Group any: |
(i) | shares or any other equity securities of such entity; or |
(ii) | equity securities convertible into, exchangeable for, or representing the right to subscribe for, purchase or otherwise acquire, directly or indirectly, any shares or any other equity securities of such entity. |
(c) | Other than as contemplated in this Agreement or the constating documents of any member of the Agnity Group or as set out in Section 3.5 of the Disclosure Letter, no member of the Agnity Group: |
(i) | has any outstanding obligations, contractual or otherwise, to repurchase, redeem or otherwise acquire any shares or other equity securities in its capital; |
(ii) | is a party to or bound by, or has any knowledge of, any agreement or instrument relating to the voting of any of its securities. |
(d) | No Person has any pre-emptive rights in respect of any of the matters relating to the Transaction. |
3.6 | Corporate Authorization |
(a) | The execution and delivery of this Agreement and the consummation of the Transaction have been duly authorized by all necessary corporate action on the part of the Corporation and the Guarantors. |
(b) | This Agreement constitutes a valid and binding obligation of the Corporation and the Guarantors enforceable against each of them in accordance with its terms, except as enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the rights of creditors generally and except as limited by the application of equitable principles when equitable remedies are sought and except as rights to indemnity and contribution may be limited by Law. |
(c) | The execution of, or the performance of obligations under, this Agreement by the Corporation and the Guarantors will not result in a breach or violation of a Contract to which any member of the Agnity Group is party, a breach of the charter or by-laws of the Corporation, a breach of Law or authorization by a Governmental Authority to which any member of the Agnity Group is bound, in any case that would with the notice or passage of time result in a Material Adverse Effect or would create a Lien on any material asset of any member of the Agnity Group. |
- 19 -
3.7 | No Governmental or Third Party Consents |
Other than those which have already been obtained, no consent, approval, authorization or declaration of and no filing or registration with, any Governmental Authority or other party is required to be made or obtained by the Corporation which, if not made or obtained, would with the notice or passage of time result in a Material Adverse Effect in connection with:
(a) | the execution and delivery of this Agreement; or |
(b) | the performance by the Corporation and the Guarantors of their respective obligations under this Agreement. |
3.8 | Financial Statements |
The Financial Statements have been prepared in accordance with GAAP, consistent with past practice, and the Financial Statements present fairly the assets, liabilities (whether secured, absolute, contingent or otherwise) and the financial condition of the members of the Agnity Group for the periods covered by the Financial Statements except that the Interim Financial Statements do not contain footnotes and are subject to normal year-end audit adjustments in accordance with GAAP and past practice.
3.9 | Absence of Certain Changes |
Except as otherwise described in this Agreement or as set out in Section 3.9 of the Disclosure Letter, since the date of the most recent Interim Financial Statements the Business has been carried on in the ordinary course of business and no Material Adverse Effect has occurred.
3.10 | Properties, Leases, Etc. |
(a) | o member of the Agnity Group owns any real property. |
(b) | Each member of the Agnity Group has: |
(i) | good and marketable title to all of the assets and properties owned by it; |
(ii) | title to the lessee interest in all assets and properties leased by it as lessee; and |
(iii) | full right to hold and use all of the assets used in or necessary to the Business subject to the terms of any agreement relating to those assets, |
in each case free and clear of Liens except Liens incurred in the ordinary course of the Business or as otherwise disclosed in Section 3.10 of the Disclosure Letter.
- 20 -
3.11 | Indebtedness |
Section 3.11 of the Disclosure Letter sets out all accounts payable of the Agnity Group as of September 30, 2016, including amounts payable to Insiders (except for amounts owing to Insiders who are employees in respect of salary for current pay periods). Except as set out in Section 3.11 of the Disclosure Letter, no member of the Agnity Group is in default with respect to any outstanding material indebtedness or any Contract relating to outstanding material indebtedness. Except as set out in Section 3.11 of the Disclosure Letter, no indebtedness or any Contract relating to indebtedness purports to limit the issuance of any securities by the Corporation or the payment of any royalty or other distribution by any member of the Agnity Group. The Corporation confirms that complete and accurate copies of all Contracts (including all amendments, supplements, waivers, and consents) relating to any material indebtedness of the members of the Agnity Group have been provided to the Purchaser.
3.12 | Absence of Undisclosed Liabilities |
Except as set out in Section 3.12 of the Disclosure Letter or the Financial Statements, none of the members of the Agnity Group have any material liabilities, guarantees, pledges or obligations, whether accrued, absolute, contingent or otherwise (including liabilities as guarantor or otherwise with respect to obligations of others) and whether due or to become due, except those accruing in the ordinary course of the Business or those which, individually or in the aggregate, would not have a Material Adverse Effect.
3.13 | Tax Matters |
Except as set out in Section 3.13 of the Disclosure Letter:
(a) | no member of the Agnity Group has any liability, obligation or commitment, actual or contingent, for the payment of any Tax, except such as have arisen in the usual and ordinary course of the Business; |
(b) | no member of the Agnity Group is in any arrears with respect to any required withholdings or instalment payments of any Tax nor has it filed any waiver for a taxation year under any legislation imposing Tax on it; |
(c) | each member of the Agnity Group has filed within the times and within the manner prescribed by law, all federal, provincial, state, local and foreign Tax Returns and reports that are required to be filed by or with respect to it, all such Tax Returns are true, correct and complete in all material respects, and do not, in any material respect, understate the taxable income or liability for Taxes of such entity for the periods covered by such returns, no Tax Return has been amended, and the tax liability of such entity for previous taxation periods is as indicated in its Tax Returns; |
(d) | each member of the Agnity Group has withheld from payments made to its officers, directors, employees, debtholders and shareholders the amount of all Taxes, including income tax, federal or provincial pension and medical plan contributions, unemployment insurance contributions and other deductions required to be withheld from such payments, and has paid them to the proper receiving officers or authorities (or made adequate reserves or provisions for the payment thereof); |
- 21 -
(e) | there is no unresolved assessment, reassessment, action, suit, proceeding, audit, investigation or claim in progress, pending or, to the knowledge of the Corporation, threatened with respect to Taxes of any member of the Agnity Group and, in particular, there are no currently outstanding reassessment or written enquiries that have been issued to, or raised in respect of, any member of the Agnity Group relating to any Taxes; and |
(t) | no member of the Agnity Group is a party to, is bound by, or has any obligation under, any tax sharing agreement, tax indemnification agreement or similar Contract. |
3.14 | Litigation |
Except as set out in Section 3.14 of the Disclosure Letter, no litigation, arbitration, action, suit, proceeding or investigation (whether conducted by or before any judicial or regulatory body, arbitrator or other Person) is pending or, to the knowledge of the Corporation, threatened or contemplated, against any member of the Agnity Group or, to the knowledge of the Corporation, any Insider, nor is there any basis therefor known to the Corporation in which a claimant would have a reasonable likelihood of success as against any member of the Agnity Group or any Insider.
3.15 | Employment Contracts |
(a) | There are currently no material disagreements or other difficulties with any member of the Agnity Groups senior employees or senior independent contractors. To the knowledge of the Corporation, no officer or key employee of any member of the Agnity Group or key independent contractor of any member of the Agnity Group has any present intention of terminating his or her employment with or services to such entity, nor does any member of the Agnity Group have any present intention of terminating the employment or engagement of any such Person. |
(b) | There are no complaints against any member of the Agnity Group before any government employment standards branch, tribunal or human rights tribunal, and no member of the Agnity Group has received notice of any such complaint. There are no outstanding decisions or settlements or pending settlements under any employment standards legislation that place any obligation upon any member of the Agnity Group to do or to refrain from doing any act. |
(c) | o member of the Agnity Group is delinquent in payments to any of its employees, consultants or independent contractors for any wages, salaries, commissions, bonuses or other direct compensation for any service performed for it to the date of this Agreement or amounts required to be reimbursed to such employees, consultants or independent contractors, and all such amounts have been properly accrued in the books and records of the members of the Agnity Group. |
- 22 -
(d) | Each member of the Agnity Group has complied with all Laws related to employment, including those related to wages, hours, worker classification, collective bargaining, and the payment and withholding of Taxes and other sums as required by law, except where non-compliance would not result in a Material Adverse Effect. |
(e) | Except as set out in Section 3.15 of the Disclosure Letter, no member of the Agnity Group has, since the date of the Interim Financial Statements, terminated the employment of any senior officer or senior employee. |
3.16 | Material Contracts |
The Corporation has made available to the Purchaser for inspection correct and complete copies (or written summaries of the material terms of oral agreements or understandings) of each material Contract of each member of the Agnity Group. Each such Contract is a valid, binding and enforceable obligation of the applicable member of the Agnity Group and, to the knowledge of the Corporation, of the other party or parties thereto, and is in full force and effect. No member of the Agnity Group nor, to the knowledge of the Corporation, any other party, is, or is considered by any other party to be, in breach of any term of any such Contract (nor, to the knowledge of the Corporation, is there any basis for any claim of breach, including as a result of the execution and delivery of this Agreement or the completion of the Transaction), except for any breaches that individually or in the aggregate would not have a Material Adverse Effect.
3.17 | Insiders |
Except as set forth in Section 3.17 of the Disclosure Letter, there are no Contracts between any member of the Agnity Group and any Insider or with any Person in which an Insider has an interest, other than Contracts of employment and employment-related agreements and covenants entered into in the ordinary course of the Business and the Employee IP Agreements. Except as set out in Section 3.17 of the Disclosure Letter, no member of the Agnity Group has made any payment or loan to, or borrowed any money from or is otherwise indebted to, any Insider, except for payments made to Insiders who are directors, officers, employees or contractors of a member of the Agnity Group in respect of bona fide services.
3.18 | Business Intellectual Property |
(a) | Section 3.18 of the Disclosure Letter contains a complete and accurate list of all Business IP existing as of the date hereof, except for Commercial Software Licenses, and specifies, for each item, whether the Business IP is Owned IP or Licensed IP, and in the case of Licensed IP, sets forth all contracts entered into in connection with the Licensed IP (except for Commercial Software Licenses). |
(b) | The Business IP, together with Commercial Software Licences, constitutes substantially all of the Intellectual Property necessary to conduct fully the Business as it is currently conducted. |
- 23 -
3.19 | Intellectual Property Rights |
(a) | Except as set out in Section 3.19(a) of the Disclosure Letter, the Agnity Group owns all right, title and interest in and to the Owned IP existing as of the date hereof free and clear of any Liens and, except for any non-exclusive end user licenses granted to customers of the Business in the ordinary course of Business, and has exclusive rights (and is not contractually obligated to pay any compensation to any other Person in respect of the exercise of such rights) to the use of such Owned IP or the material covered by such Owned IP. The Owned IP existing as of the date hereof does not contain, embody or use, or require for its full and proper operation, any Intellectual Property or Technology, except the Licensed IP and any Commercial Software Licenses, owned by any other Person. |
(b) | Each Contract entered into in connection with the Licensed IP existing as of the date hereof is valid, subsisting and in good standing, and there is no material default by any member of the Agnity Group under any such Contract nor is there, to the knowledge of the Corporation, any material default by the other parties to such Contract. The applicable member of the Agnity Group has the right to sub-license, or to re-sell sub-licences, for the use of the Licensed IP existing as of the date hereof that is currently incorporated in or distributed with, or that the applicable member of the Agnity Group has contemplated incorporating in or distributing with, the Agnity Groups products to distributors, resellers and end-users of such products. |
(c) | To the knowledge of the Corporation, none of the Owned IP existing as of the date hereof nor any service rendered by the Agnity Group, nor any product currently or proposed to be developed, manufactured, produced or used by the Agnity Group, infringes upon any of the Intellectual Property, Technology or moral rights owned or held by any other Person, and no member of the Agnity Group or any of its directors, officers or employees has ever received any charge, complaint, claim, demand or notice alleging any interference, infringement, misappropriation or violation with respect to any Business IP existing as of the date hereof (including any claim that any member of the Agnity Group or such other Persons must license or refrain from using any Intellectual Property or Technology of a third party), nor does the Corporation have knowledge of any valid grounds for any bona fide claims. |
(d) | To the knowledge of the Corporation, there is no unauthorized use, infringement or misappropriation of any Owned IP existing as of the date hereof by any other Person. No member of the Agnity Group has agreed with any Person not to sue or otherwise enforce any legal rights with respect to any of such Owned IP. |
(e) | Each member of the Agnity Group has taken all commercially reasonable steps (including measures to protect secrecy and confidentiality and obtaining waivers of moral rights) to protect the Agnity Groups right, title and interest in and to all Owned IP existing as of the date hereof. All agents and representatives of the members of the Agnity Group who have or have had access to confidential or proprietary information of the Agnity Group relating to the Business IP existing as of the date hereof have a legal obligation of confidentiality to the Agnity Group with respect to such information, except where the absence of which would not have a Material Adverse Effect. |
- 24 -
(f) | All of the Owned IP existing as of the date hereof was developed by full-time employees and contractors of one or more members of the Agnity Group during the time they were employed or engaged with such entity as software, information technology or hardware developers (the Developers). All of the Developers and other employees and contractors who have or have had access to confidential or proprietary information relating to such Owned IP have duly executed and delivered Employee IP Agreements in substantially the same form as set forth in Section 3.l 9(f) of the Disclosure Letter to the applicable member of the Agnity Group on or before the date of commencement of his or her employment with such entity in the form provided to the Purchaser. o member of the Agnity Group has any knowledge of any material breach of any of the Employee IP Agreements. |
(g) | Except as set out in Section 3.19(g) of the Disclosure Letter, no royalty or other amounts are required to be paid by any member of the Agnity Group in connection with the continued use or exploitation by the Agnity Group of any Intellectual Property used in the operation of the Business. |
3.20 | Insurance |
Section 3.20 of the Disclosure Letter lists the policies of insurance owned or held by the members of the Agnity Group. All such policies:
(a) | are, and at all times since the respective start dates of such policies have been, in full force and effect; |
(b) | are sufficient for compliance in all material respects by the members of the Agnity Group with all agreements to which any such entity is a party; |
(c) | provide that they will remain in full force and effect through the respective expiry dates thereof; and |
(d) | will not terminate or lapse or otherwise be affected in any way by reason of the completion of the Transaction. |
3.21 | Brokers |
Except as disclosed in Section 3.21 of the Disclosure Letter: (a) no finder, broker, agent or other intermediary has acted for or on behalf of any member of the Agnity Group in connection with the initiation, negotiation or consummation of the Transaction; and (b) no success fee, brokers fee, commission or similar fees will be payable by any member of the Agnity Group to any Person in connection with the initiation, negotiation or consummation of the Transaction.
- 25 -
3.22 | No Sale Agreements |
Except as disclosed in Section 3.22 of the Disclosure Letter, there are no Contracts, or any right or privilege capable of becoming a Contract, for the purchase of the Business or any of the material assets of any member of the Agnity Group. Except as disclosed in Section 3.22 of the Disclosure Letter, no member of the Agnity Group currently maintains any discussions, conditions or proceedings with respect to the sale, merger, consolidation, liquidation or reorganization of any such entity.
3.23 | Compliance with Other Instruments, Laws, Etc. |
Each member of the Agnity Group has complied, and is in compliance, with:
(a) | all Laws applicable to it and the Business, except for any non-compliance that, individually or in the aggregate, has not had and could not reasonably be expected to have a Material Adverse Effect; and |
(b) | its constating documents. |
3.24 | Agreements Restricting Business |
Except as disclosed in Section 3.24 of the Disclosure Letter, no member of the Agnity Group is a party to any agreement or arrangement that restricts the freedom of such entity to carry on the Business, including any Contract that contains covenants by any member of the Agnity Group not to compete in any line of business competitive with or similar to the Business with any other Person.
3.25 | Absence of Questionable Payments |
To the knowledge of the Corporation, no member of the Agnity Group or, to the knowledge of the Corporation, any director, officer, agent or employee of any of the foregoing or any other Person acting on behalf of any of the foregoing, has used any corporate or other funds for unlawful contributions, payments, gifts or entertainment, or made any unlawful expenditures relating to political activity to government officials or others or established or maintained any unlawful or unrecorded funds in connection with the Business. No member of the Agnity Group or, to the knowledge of the Corporation, any director, officer, agent or employee of any of the foregoing or any other Person acting on behalf of any of the foregoing, has accepted or received any unlawful contributions, payments, gifts or expenditures in connection with the Business.
3.26 | Change of Control |
Except as disclosed in Section 3.26 of the Disclosure Letter, no member of the Agnity Group has approved, is contemplating, considering or has held discussions in respect of, has entered into any Contract in respect of, or has any knowledge of:
(a) | a proposed Change of Control or similar transaction involving such entity; or |
(b) | any Contract, or any right or privilege capable of becoming a Contract, for the purchase, sale, transfer or other disposition of any material property or assets or any interest therein owned directly or indirectly by such entity (including any of the outstanding shares of any Agnity Subsidiary). |
- 26 -
3.27 | Disclosure |
(a) | No representation or warranty by the Corporation in this Agreement or in the Disclosure Letter contains or will contain any untrue statement of a material fact or omits or will omit to state a material fact required to be stated in this Agreement or necessary to make the statements contained in this Agreement not false or misleading. |
(b) | To the knowledge of the Corporation, there is no fact or circumstance relating specifically to the Business or the members of the Agnity Group that could reasonably be expected to result in a Material Adverse Effect and that is not disclosed in the Disclosure Letter. |
The Corporation has made available to the Purchaser or its counsel all information reasonably available to the Corporation and the Guarantors that the Purchaser (or its counsel) has requested.
ARTICLE 4
REPRESENTATIONS AND WARRANTIES OF THE PURCHASER
The Purchaser represents and warrants to the Corporation as of the date of this Agreement as follows, and acknowledges that the representations and warranties contained in this Agreement are made by it with the intent that they may be relied upon by the Corporation.
4.1 | Incorporation and Organization |
The Purchaser is a corporation incorporated and validly subsisting under the laws of the Province of British Columbia, and is in good standing under such laws.
4.2 | Corporate Authorization |
(a) | The execution and delivery of this Agreement and the consummation of the Transaction have been duly authorized by all necessary corporate action on the part of the Purchaser. |
(b) | This Agreement constitutes, a valid and binding obligation of the Purchaser enforceable against it in accordance with its terms, except as enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the rights of creditors generally and except as limited by the application of equitable principles when equitable remedies are sought and except as rights to indemnity and contribution may be limited by Law. |
(c) | The execution of, or the performance of obligations under, this Agreement by the Purchaser will not result in a breach or violation of a Contract to which the Purchaser is party, a breach of the Purchasers charter or by-laws, a breach of Law or authorization by a Governmental Authority to which the Purchaser is bound, in either case that would with the notice or passage of time result in a Material Adverse Effect or would create a Lien on any material asset of the Purchaser. |
- 27 -
4.3 | Purchasing for Investment Purposes |
The Purchaser is acquiring the interest granted to it herein for investment purposes only and not with a view to the resale or distribution of any portion of such interest.
4.4 | Capital Resources |
The Purchaser has sufficient liquid capital resources to pay the Aggregate Investment Amount and to consummate the Transaction.
4.5 | Purchase as Principal |
The Purchaser is acquiring the interest granted to it herein as principal for its own account, and not on behalf of or for the benefit of any other Person.
ARTICLES
SURVIVAL AND INDEMNIFICATION
5.1 | Survival |
Subject to the limitations contained in this Agreement, all representations and warranties contained in this Agreement on the part of each of the Parties will survive the date hereof for a period of two (2) years following the date of this Agreement.
5.2 | Indemnification Obligations |
(a) | All covenants, representations and warranties made in this Agreement by the Corporation and the Guarantors are deemed to have been relied on by the Purchaser, notwithstanding any investigation made by or on behalf of the Purchaser. Subject to the limitations set forth in Section 5.2(b) and subject to Section 5.2(c), the members of the Agnity Group (the Indemnitors), for each of which the Corporation acts as agent hereunder, will jointly and severally indemnify, defend and hold harmless the Purchaser, and each of the Purchasers officers, directors, employees, agents, advisors, representatives and affiliates, and the respective successors, assigns, heirs, executors, administrators and legal and personal representatives of each of the foregoing (each, an lndemnitee), from and against all Direct Damages incurred or suffered by any of them in any capacity and resulting from or relating to the occurrence of a Non-Monetary Event of Default. |
(b) | The obligations of the Indemnitors under Section 5.2(a) are subject to the following limitations: |
(i) | except for the matters referred to in paragraphs (ii) and (iii) hereof, the obligations of the Indemnitors under Section 5.2(a) will terminate on the date that is 2 years following the date of this Agreement, except with respect to bona fide claims by any Indemnitee set forth in written notices given by them to the Corporation prior to such date; |
- 28 -
(ii) | the obligations of the lndemnitors in respect of any claim relating to Tax matters, including any claim arising out of Section 3.12, will terminate on the date that is 90 days after the relevant Governmental Authorities are no longer entitled to assess or reassess liability for Taxes (other than interest, penalties, fines, additions to Tax or other additional amounts) against the applicable member of the Agnity Group, having regard to any waivers given by any such entity in respect of any taxation year, except with respect to bona fide claims by any Indemnitee set forth in written notices given by them to the Corporation prior to such date; |
(iii) | the obligations of the Indemnitors in respect of any claim based upon fraud or intentional misrepresentation shall survive indefinitely; and |
(iv) | the liability of the Indemnitors under Section 5.2(a), whether alone or in the aggregate, shall be limited to an amount equal to the Aggregate Installment Amount. |
(c) | The Indemnitors, for each of which the Corporation acts as agent hereunder, will jointly and severally indemnify, defend and hold harmless the Indemnitees from and against all Direct Damages incurred or suffered by any of them in any capacity and resulting from or relating to: |
(i) | an Event of Default; |
(ii) | a Bankruptcy Occurrence; or |
(iii) | a breach by the Corporation or any of the Guarantors of Section 6.2 or Section 6.8. |
The rights of indemnity under this Section 5.2(c) shall not be subject to any monetary limitation and shall be in addition to, and not in substitution for, all of the rights and remedies of the Indemnitees otherwise afforded to the Indemnitees by law, equity or otherwise in respect of the occurrence of an Event of Default, a Bankruptcy Occurrence or a breach by the Corporation or any of the Guarantors of Section 6.2 or Section 6.8, including all rights and remedies of the Purchaser under Section 2.12.
ARTICLE 6
GENERAL
6.1 | Notices |
Any notice given in connection with this Agreement must be in writing and is sufficiently given if delivered (whether in person, by courier service or other personal method of delivery), or if transmitted by electronic means:
(a) | in the case of a notice to the Corporation or any of the Guarantors at: |
- 29 -
42808 Christy Street, Suite 201
Fremont, CA 94538 USA
Attention: Sanjeev Chawla
Email: sanjeev.chawla@agnity.com
(b) | in the case of a notice to the Purchaser at: |
220 Bay Street, Suite 5000
Toronto, Ontario MSJ 2W4
Attention: William R. Tharp
Email: bill@GrenvilleSRC.com
Any notice delivered or transmitted to a Party in accordance with the foregoing is deemed given and received on the day it is delivered or transmitted if it is delivered or transmitted on a Business Day prior to 5:00 p.m. local time in the place of delivery or receipt. If the notice is delivered or transmitted after 5:00 p.m. local time or if such day is not a Business Day, then the notice is deemed to have been given and received on the next Business Day. Any Party may, from time to time, change its physical address or email address by giving notice to the other Parties in accordance with the provisions of this Section 6.1.
6.2 | Announcements |
Except as otherwise required by Law (including in order to comply with continuous disclosure or other requirements under securities Laws), following the date hereof, the Corporation may make reasonable disclosure of the completion and nature of the Transaction only with the prior written consent of the Purchaser, such consent not to be unreasonably withheld or delayed, and, except as otherwise required by Law (including in order to comply with continuous disclosure or other requirements under securities Laws), the Purchaser may make reasonable disclosure of the completion and nature of the Transaction only with the prior written consent of the Corporation, such consent not to be unreasonably withheld or delayed. The Corporation and the Guarantors hereby consent to the reasonable disclosure by the Purchaser of the completion and nature of the Transaction to Governmental Authorities, the Purchasers shareholders and to any other Person in connection with any financing, offering, business combination or similar transaction proposed to be undertaken by the Purchaser. The Corporation and the Guarantors acknowledge that the Purchaser may be required, in accordance with applicable securities laws, to publicly disclose the Transaction and to file a copy of this Agreement on SEDAR, and the Purchaser agrees that in such case it shall make such redactions to this Agreement as are permitted under Section 12.2(3) of National Instrument 51-102 (NI 51-102) (subject to compliance by the Purchaser with the remaining provisions of Section 12.2 of NI 51-102) with the prior consultation of the Corporation. The Purchaser hereby consents to the reasonable disclosure by the Corporation and the Guarantors of the completion and nature of the Transaction to Governmental Authorities, the respective shareholders of the Corporation and the Guarantors and to any other Person in connection with any financing, offering, franchising, business combination or similar transaction proposed to be undertaken by any member of the Agnity Group.
6.3 | Facsimile/Adobe Acrobat and Counterparts |
This Agreement may be executed via facsimile or scanned Adobe Acrobat (Portable Document Format or PDF) or TIFF document and in any number of counterparts each of which shall be deemed to be an original and all of which when taken together shall be deemed to constitute one and the same instrument and it shall not be necessary in making proof of this Agreement to produce more than one counterpart.
- 30 -
6.4 | Further Assurances |
The Parties shall with reasonable diligence do all such things and provide all such assurances as may be required or desirable to consummate the Transaction and each Party shall provide such further documents or instruments as may be required or be desired by any other Party to effect the purpose of this Agreement and to carry out the provisions of this Agreement, whether before or after Closing.
6.5 | Severability |
In case any one or more of the provisions contained in this Agreement is for any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be reformed and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law.
6.6 | Delays or Omissions |
No delay or omission to exercise any right, power, or remedy accruing to any Party under this Agreement upon any breach or default of any other Party under this Agreement shall impair any such right, power, or remedy of such non-breaching or non-defaulting Party, nor shall it be construed to be a waiver of or acquiescence to any such breach or default, or to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All remedies, whether under this Agreement or by law or otherwise afforded to any Party, shall be cumulative and not alternative.
6.7 | Acknowledgment re Drafting |
Each Party acknowledges and agrees that the Parties have participated jointly in the negotiation and drafting of this Agreement and, therefore, in the event that any ambiguity or a question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties and no presumption or burden of proof shall arise favouring or disfavouring any Party by virtue of the authorship of any provision hereof.
6.8 | Confidentiality |
Each Party acknowledges that it has had access to and will in the future receive confidential and proprietary information concerning the other Parties (the Confidential Information), the disclosure of which would be detrimental to the interests of the other Parties. Accordingly, each Party covenants and agrees, subject to Section 6.2, to keep the Confidential Information in strict confidence and not disclose any of such Confidential Information to any Person or use or attempt to use such Confidential Information. Notwithstanding the foregoing, no Party will have liability for any Confidential Information that is:
- 31 -
(a) | already in the public domain or comes into the public domain without any breach of this Agreement; |
(b) | required to be disclosed pursuant to Law or pursuant to any regulatory or judicial authority having jurisdiction over such Party; or |
(c) | made to a professional advisor of such Party, in which event such party shall ensure that the recipient is aware of and agrees to comply with the terms of this Section 6.8 as if a party to this Agreement. |
6.9 | Assignment |
This Agreement shall enure to the benefit of and be binding upon the Parties and their respective successors and permitted assigns; provided, however, that:
(a) | the Purchaser may, without the consent of the Corporation or the Guarantors, assign its rights and obligations or encumber its interest (including by way of security for any indebtedness of the Purchaser and its Affiliates) under this Agreement, in whole or in part, to any Person; and |
(b) | none of the Corporation or the Guarantors may assign any of its rights under this Agreement without the prior written consent of the Purchaser (such consent not to be unreasonably withheld by the Purchaser), and any such purported assignment without such prior written consent is void. |
For greater certainty, unless terminated, reduced or extinguished pursuant to the terms of this Agreement, the Gross Sales Royalty shall survive, and shall not in any way be extinguished or impaired by, any: (i) Change of Control of any member of the Agnity Group; or (ii) any transfer by operation of Law or otherwise of this Agreement by the Corporation or any of the Guarantors.
6.10 | Payment of Purchaser Expenses |
The Corporation will pay all of the reasonable legal fees and other reasonable out-of-pocket expenses incurred by the Purchaser in connection with the Transaction and the various agreements and documents referred to in this Agreement, up to a maximum amount of $15,000 (plus all disbursements incurred by counsel to the Purchaser and all applicable Taxes on any of the foregoing amounts), which amounts will, if applicable, be deducted from any Installment advanced to the Corporation.
6.11 | Force Majeure |
o Party shall be liable for the failure to comply with any of its obligations under this Agreement to the extent, and for the period, that such failure results from Force Majeure. The Party claiming a Force Majeure shall make all reasonable efforts, including all reasonable expenditures, necessary to cure, mitigate or remedy the effects of a Force Majeure.
- 32 -
6.12 | Tax Cooperation |
The Parties shall (and, if requested to do so, shall cause their respective Affiliates to): (i) use commercially reasonable efforts to assist the other Parties in preparing for or defending against any audit, investigation, claim, dispute or controversy relating to Taxes regarding the Gross Sales Royalty or the Transaction; and (ii) make available to the other Parties and to any taxing authority as reasonably requested all information, records and documents relating to the Gross Sales Royalty or the Transaction; (iii) furnish the other Parties with timely notice of, and copies of all correspondence received from any taxing authority in connection with, any audit, investigation, claim, dispute or controversy relating to Taxes regarding the Gross Sales Royalty or the Transaction; and (iv) use commercially reasonable efforts to assist the other Parties in the proper compliance with its Tax filing and reporting obligations relating to the Gross Sales Royalty or the Transaction.
6.13 | Maximum Permitted Rate |
Under no circumstances shall the Purchaser be entitled to receive nor shall it in fact receive a payment or partial payment (whether in the form of Royalty Payments, Buyout Payments or otherwise) under or in relation to this Agreement at a rate that is prohibited under Laws. Accordingly, notwithstanding anything herein or elsewhere contained, if and to the extent that under any circumstances the amounts received or to be received by the Purchaser pursuant to this Agreement or any agreement or arrangement collateral hereto entered into in consequence or implementation hereof would, but for this Section 6.13, be a rate that is prohibited under Laws, then the effective annual rate, as so determined, received or to be received by the Purchaser shall be and be deemed to be adjusted to a rate that is one whole percentage point less than the lowest effective annual rate that is so prohibited (the Adjusted Rate); and, if the Purchaser has received a payment or partial payment which would, but for this Section 6.13, be so prohibited then any amount or amounts so received by the Purchaser in excess of the lowest effective annual rate that is so prohibited shall and shall be deemed to have comprised a credit to be applied to subsequent payments on account of other amounts due to the Purchaser at the adjusted rate.
6.14 | Guarantee |
The Guarantors jointly and severally unconditionally and irrevocably guarantee in favour of the Purchaser the punctual performance by the Corporation of each and every covenant and agreement of the Corporation pursuant to this Agreement, including all payment obligations of the Corporation. The Guarantors jointly and severally covenant in favour of the Purchaser to pay any amount when due under or in connection with this Agreement immediately on demand by the Purchaser as if the Guarantors were principal obligors. The obligations of the Guarantors under this Section 6.14 will not be affected by any act, omission or thing which, but for this Section 6.14, would reduce, release or prejudice any of their obligations under this Section 6.14, whether or not known to any Guarantor, including any amendment or waiver of any provision of this Agreement.
[Signature Page Follows]
Grenvil/e/Agnity Royalty Agreement Signature Page
- 33 -
IN WITNESS WHEREOF, each party has duly executed this Agreement
Agnity Global, Inc. |
\s\ Sanjeen Chawla |
Name: Sanjeen Chawla |
Title: CEO |
Agnity Communications, Inc. |
\s\ Sanjeen Chawla |
Name: Sanjeen Chawla |
Title: CEO |
Agnity Healthcare, Inc. |
\s\ Sanjeen Chawla |
Name: Sanjeen Chawla |
Title: CEO |
SPINACOM, Inc. |
\s\ Sanjeen Chawla |
Name: Sanjeen Chawla |
Title: CEO |
Grenville Strategic Royalty Corp. |
\s\ Steve Parry |
Name: Steve Parry |
Title: CEO |
SCHEDULE A
DEFINED TERMS
Whenever used in this Agreement, the following words and terms have the following meanings:
Additional Royalty Interest has the meaning given to it in the ate.
Adjusted Rate has the meaning given to it in Section 6.13.
Affiliate has the meaning given to it in National Instrument 45-106 - Prospectus and Registration Exemptions.
Aggregate Installment Amount means, as of a specified date, the aggregate of all Installments actually paid to the Corporation as of such date.
Aggregate Note Amount has the meaning given to it in the recitals to this Agreement.
Agnity Group means, collectively, the Corporation and each of the Agnity Subsidiaries.
Agnity Subsidiaries means collectively: (a) each Guarantor; and (b) each direct or indirect subsidiary, affiliate or investee of the Corporation or any Guarantor (whether wholly, partially or not at all owned, directly or indirectly, by the Corporation or any Guarantor and whether or not controlled by the Corporation or any Guarantor, as the case may be) incorporated, acquired or established after the date hereof (including any direct or indirect interest held by any member of the Agnity Group in any joint venture, partnership or similar entity or structure), and Agnity Subsidiary means any one of the aforementioned entities.
Agreement means this amended and restated royalty purchase agreement, including all schedules and all amendments or restatements, and references to Article or Section mean the specified Article or Section of this Agreement.
Annual Financial Statements means, as at any given date, the financial statements of the Corporation and each other applicable member of the Agnity Group for the then most recently completed financial year of each such entity.
Bankruptcy Occurrence means the occurrence of any of the following:
(a) | if an order is made or an effective resolution passed for the winding-up or liquidation of any member of the Agnity Group, or if a petition is filed for the winding-up of any member of the Agnity Group; |
(b) | if any member of the Agnity Group commits an act of bankruptcy, makes a general assignment for the benefit of its creditors, ceases to carry on the Business or becomes insolvent within the meaning of applicable legislation of any applicable jurisdiction; |
(c) | if a bankruptcy petition is filed or presented against any member of the Agnity Group, or if any proceedings with respect to any member of the Agnity Group are commenced under any applicable legislation of any applicable jurisdiction providing protection for the benefit of the applicable member of the Agnity Group; or if an execution, sequestration, or any other process of any court becomes enforceable against any member of the Agnity Group or if a distress or analogous process is levied upon any part of the property of any member of the Agnity Group; or |
(d) | any trustee in bankruptcy, interim receiver, receiver, receiver and manager, custodian, sequestrator, administrator, monitor or liquidator of any other Person with similar powers is appointed in respect of any member of the Agnity Group or any of the assets or property of any member of the Agnity Group. |
Business means the business currently carried on by the Agnity Group or as carried on at any relevant time.
Business Day means a day, other than a Saturday or Sunday, on which the principal commercial banks located in Fremont, California and Toronto, Ontario are open for business during normal banking hours.
Business IP means the Owned IP and the Licensed IP.
Buy-down Notice has the meaning given to it in Section 2.9(a)(ii).
Buy-down Option has the meaning given to it in Section 2.9(a)(ii).
Buy-down Payment has the meaning given to it in Section 2.9(a)(ii).
Buyout Payments has the meaning given to it in Section 2.5.
Change of Control means, unless otherwise determined by the Purchaser to be a transaction that would violate Section 2.10(b), any of the following: (a) a sale or other transfer of all or substantially all of the assets of a member of the Agnity Group; or (b) the acquisition of a member of the Agnity Group by another entity by means of merger, arrangement, share purchase (whether from the relevant member of the Agnity Group or from the holders of shares in the capital of member of the Agnity Group, as the case may be), share exchange, consolidation, reorganization, amalgamation, arrangement, take-over bid, reverse take-over or other business combination or transaction or series of related transactions; provided that a Change of Control shall not include (i) a merger effected exclusively for the purpose of changing the domicile of any member of the Agnity Group, or (ii) any transaction in which one or more of the Insiders or Affiliates of the Corporation immediately prior to the transaction own 50% or more of the voting power of the surviving entity or the acquirer of the assets of the Corporation following the transaction.
Change of Control Buyout Notice has the meaning given to it in Section 2.9(a)(iv).
Change of Control Buyout Option has the meaning given to it in Section 2.9(a)(iv).
Closing means the completion of the Transaction, which shall be deemed to occur on the date on which the last Installment is fully paid to the Corporation.
Commercial Software Licenses means shrink-wrap, web-wrap, click-wrap or other similar generic licenses for commercially available software available to the public.
Confidential Information has the meaning given to it in Section 6.8.
Confirmed Quarterly Royalties has the meaning given to it in Section 2.4(b)(ii).
Contract means any written or oral agreement, contract, understanding, arrangement, instrument, note, guarantee, indemnity, warranty, deed, assignment, power of attorney, commitment, covenant or undertaking of any nature.
Corporation means Agnity Global, Inc., and includes any assignee thereof pursuant to an assignment made in accordance with Section 6.9(b).
Communications means Agnity Communications, Inc., and includes any assignee thereof pursuant to an assignment made in accordance with Section 6.9(b).
Developers has the meaning given to it in Section 3.19(f).
Direct Damages means all damages and losses of any kind excluding Indirect Damages.
Disclosure Letter means the Disclosure Letter delivered by the Corporation to the Purchaser on the date hereof, as the same may be updated as of the date on which any Subsequent Installment is paid to the Corporation.
Dispute has the meaning given to it in Section 2.8.
Employee IP Agreements means agreements relating to proprietary information and assignment of inventions to a member of the Agnity Group by employees and consultants of such entity.
Event of Default means the occurrence of any of the following:
(a) | any failure by the Corporation to pay in full when due any Royalty Payment, Buyout Payment or any other amount owing under this Agreement or arising in as a result of or relating to the Transaction, including any amount owing under Section 2.12(c); |
(b) | any failure by a Guarantor to satisfy any of its obligations under Section 6.14; or |
(c) | any default by any member of the Agnity Group in the observance or performance of any of the Specified Covenants. |
Financial Statements means, collectively, the Annual Financial Statements and the Interim Financial Statements.
Force Majeure means any event or circumstance that prevents the affected Party from performing its obligations under this Agreement and is beyond the reasonable control of the affected Party, but:
(a) | is not due to the fault or negligence of the affected Party or those for whom it is responsible at law; |
(b) | does not arise by reason of any act or omission by the Party (or those for whom it is responsible at law) claiming Force Majeure in breach of the provisions of this Agreement; and |
(c) | does not arise by reason of the lack or insufficiency of funds or failure to make payment of monies. |
GAAP means generally accepted accounting principles, as promulgated by the United States Financial Accounting Standards Board, or the equivalent thereof for and in respect of any other applicable jurisdiction.
Governmental Authority means any government, regulatory authority, governmental department, agency, commission, bureau, official, minister, Crown corporation, court, board, tribunal, governmental or administrative dispute settlement panel or body or other law, rule or regulation-making entity:
(a) | having or purporting to have jurisdiction on behalf of any nation, province, territory, state or other geographic or political subdivision thereof; or |
(b) | exercising, or entitled or purporting to exercise any administrative, executive, judicial, legislative, policy, regulatory or taxing authority or power. |
Gross Sales Royalty has the meaning given to it in Section 2.2.
Guarantors means Communications, Healthcare, and Agnity, and Guarantor means any one of them.
Healthcare means Agnity Healthcare, Inc., and includes any assignee thereof pursuant to an assignment made in accordance with Section 6.9(b).
Independent Accountant has the meaning given to it in Section 2.8.
lndemnitee has the meaning given to it in Section 5.2.(a).
Indemnitors has the meaning given to it in Section 5.2(a).
Indirect Damages means all indirect, consequential, special, incidental, punitive and aggravated damages and losses, loss of profits and diminution of value.
Initial Agreement has the meaning given to it in the recitals to this Agreement.
Initial Installment has the meaning given to it in Section 2.1(a)(i).
Insiders means:
(a) | directors, officers, shareholders, members, security holders or employees of a member of the Agnity Group; and |
(b) | any other Person not dealing at arms length with any member of the Agnity Group or any Affiliate or related party of any member of the Agnity Group or of any Person referred to in paragraph (a) hereof. |
Installments means, collectively, the Initial Installment and all Subsequent Installments, and individually means any one of them.
Intellectual Property means any or all of the following and all proprietary intellectual property and other rights in, arising out of or associated with:
(a) | all patents and utility models and applications therefore and all provisionals, re-issuances, continuations, continuations-in-part, divisions, rev1s1ons, supplementary protection certificates, extensions and re-examinations thereof and all equivalent or similar rights anywhere in the world in inventions and discoveries, including invention disclosures; |
(b) | all registered and unregistered trade-marks, service marks, trade names, trade dress, logos, business, corporate and product names and slogans and registrations, and applications for registration thereof; |
(c) | all copyrights in copyrightable works, and all other rights of authorship, worldwide, and all applications, registrations and renewals in connection therewith; |
(d) | all maskworks, maskwork registrations and applications therefor, and any equivalent or similar rights in semiconductor masks, layouts, architectures or topologies; and |
(e) | all World Wide Web addresses, domain names and sites and applications and registrations therefor. |
Interest has the meaning given to it in the recitals to this Agreement.
Interim Financial Statements means, as at any given date, the unaudited management-prepared financial statements of the Corporation and each other applicable member of the Agnity Group for the then most recently completed fiscal quarter of each such entity.
Laws means applicable laws (including common law), statutes, codes, by-laws, rules, regulations, orders, ordinances, protocols, codes, guidelines, treaties, policies, notices, directions, decrees, judgments, awards or requirements, in each case of any Governmental Authority.
Licensed IP means all Intellectual Property and Technology that any member of the Agnity Group uses or has a right to use, including all Intellectual Property and Technology that any member of the Agnity Group uses or has a right to use at any time after the date hereof, in the conduct of the Business under a Contract with another Person.
Liens means any lien, hypothec, mortgage, security interest, charge, encumbrance, pledge, option, pre-emptive right, or transfer restriction other than, in the case of references to securities, any transfer restriction arising under applicable securities Laws solely by reason of the fact that such securities were issued pursuant to exemptions from registration or prospectus requirements under such securities Laws.
Material Adverse Effect means any effect, change, event, occurrence or development with respect to the Agnity Group or the Business, taken as a whole and as a going concern, that is or is reasonably likely to be materially adverse to the results of the Business or the Agnity Groups affairs, properties, assets, liabilities or condition (financial or otherwise), operations or capital, or that is materially adverse to the completion of the Transaction.
Minimum Monthly Amount has the meaning given to it in Section 2.3(a).
NI 51-102 has the meaning given to it in Section 6.2.
Non-Monetary Event of Default means the breach by the Corporation or any of the Guarantors of any of the representations, warranties or covenants of any such Party under this Agreement other than the Specified Covenants.
Note has the meaning given to it in the recitals to this Agreement.
Note Principal Buyout Notice has the meaning given to it in Section 2.9(a)(i).
Note Principal Buyout Option has the meaning given to it in Section 2.9(a)(i).
Note Principal Buyout Payment has the meaning given to it in Section 2.9(a)(i).
Owned IP means all Intellectual Property and Technology that any member of the Agnity Group owns, including all Intellectual Property and Technology owned by any member of the Agnity Group at any time after the date hereof.
Parties means the Corporation, the Guarantors and the Purchaser, and Party means either one of them.
Person means any individual, sole proprietorship, partnership, firm, entity, unincorporated association, unincorporated syndicate, unincorporated organization, trust, body corporate or Governmental Authority, and where the context requires, any of the foregoing when they are acting as trustee, executor, administrator or other legal representative.
Pre-Adjusted Quarterly Royalties has the meaning given to it in Section 2.4(b)(i).
Principal Amount has the meaning given to it in the recitals to this Agreement.
Purchaser means Grenville Strategic Royalty Corp., and any assignee thereof pursuant to an assignment made in accordance with Section 6.9(a).
Quarterly Determination Date has the meaning given to it in Section 2.4(a).
Revenue of the Agnity Group means, in respect of any period commencing on or after the date hereof and without duplication, all revenue of any kind directly or indirectly actually received by the members of the Agnity Group (which, in respect of any non-wholly owned Agnity Subsidiary, shall be the percentage of such Agnity Subsidiarys revenue actually received during such period that is equal to the direct or indirect ownership percentage of the Corporation of such Agnity Subsidiary) during such period on account of or in connection with all products and services sold or otherwise provided by the members of the Agnity Group, including all royalties, license fees, lease fees, service fees, subscription fees and other forms of compensation actually invoiced and received by a member of the Agnity Group (including amounts received in connection with the settlement of disputes or the proceeds of litigation and amounts received in connection with the sale of any assets of any member of the Agnity Group, including any sale of securities of any Agnity Subsidiary held by another member of the Agnity Group, that in each case does not otherwise result in the exercise of, and the completion of the transaction contemplated by, the Change of Control Buyout Option); but excludes:
(a) | any amount received by a member of the Agnity Group in the form of a grant or other form of funding (including funding for research purposes), incentive, loan, advance, exemption, tax reduction, tax credit, subsidy or similar benefit from any Governmental Authority, institution or organization; |
(b) | any amount received by a member of the Agnity Group which is required by contract or Law to be paid by such entity: (i) to agents or resellers of such entity; or (ii) to third parties on account of shipping, duties or customs charges; |
(c) | any amount received by a member of the Agnity Group from another member of the Agnity Group; and |
(d) | any amount received by a member of the Agnity Group which constitutes Taxes payable by a Person in connection with goods or services provided by the member of the Agnity Group to such Person. |
Royalty Payment has the meaning given to it in Section 2.2 (and, for greater certainty, includes all Minimum Monthly Amounts).
Sale means the completion by Agnity Communications, or the stockholders thereof, on or before September 30, 2017 of a Change of Control of Agnity Communications where Novacap TMT IV, L.P. or Constellation Software Inc., or in each case an Affiliate thereof, is the acquirer of Agnity Communications.
Specified Covenants means those covenants set out m Sections 2.10(a), 2.10(b), 2.10(c), 2.l0(d), 2.l0(e), 2.10(f), 2.10(g), 2.10(h), 2.10(i), 2.10(1), 2.10(m), 2.10(o), 2. 10(p), 2.10(q), 2.10(r), 2.10(s), 2.10(t), 2.10(u), 2.10(v) and 2.10(w).
Spinacom means Spinacom, Inc. (formerly Agnity. Inc.), and includes any assignee thereof pursuant to an assignment made in accordance with Section 6.9(b).
Subsequent Installment has the meaning given to it in Section 2.1(a)(i).
subsidiary has the meaning given to it in National Instrument 45-106Prospectus and Registration Exemptions.
Tax or Taxes means all taxes, assessments, charges, duties, fees, levies, or other governmental charges, including all federal, provincial, state, local, foreign and other income, corporation, franchise, profits, capital gains, estimated, sales (including HST), use, transfer, registration, value added, excise, natural resources, severance, stamp, occupation, premium, environmental, customs, duties, imposts, immovable property, personal property, capital stock, unemployment, disability, payroll, license, employee, deficiency assessments, withholding and other taxes, assessments, charges, duties, fees, levies or other governmental charges (whether payable directly or by withholding and whether or not requiring the filing of a Tax Return), and any interest, penalties, or additions to tax in respect of the foregoing and includes any liability for such amounts as a result either of being a member of a combined, consolidated, unitary or affiliated group or of a contractual obligation to indemnify any Person or other entity.
Tax Return means any return, declaration, report, claim for refund, information return or other document (including any related or supporting estimates, elections, schedules, statements or information) filed or required to be filed in connection with the determination, assessment or collection of any Tax or the administration of any Laws relating to any Tax.
Technology means:
(a) | works of authorship including computer programs, source code and executable code, whether embodied in software, firmware or otherwise, documentation, designs, methods, techniques, processes, files, industrial models, schematics, specifications, net lists, build lists, records and data; |
(b) | inventions (whether or not patentable), improvements, enhancements and modifications; |
(c) | proprietary and confidential business and technical information, including technical data, trade secrets, ideas, research and development and know how; and |
(d) | databases, data compilations and collections and technical data. |
Transaction means the transactions contemplated in this Agreement.
Exhibit 23.3
KPMG LLP
205 5th Avenue SW
Suite 3100
Calgary AB T2P 4B9
Tel (403) 691-8000
Fax (403) 691-8008
www.kpmg.ca
Consent of Independent Registered Public Accounting Firm
The Board of Directors of mCloud Technologies Corp.
We consent to the use of our report dated April 29, 2022, on the consolidated financial statements of mCloud Technologies Corp., which comprise the consolidated statements of financial position as of December 31, 2021 and December 31, 2020, the related consolidated statements of loss and comprehensive loss, changes in equity and cash flows for each of the years in the three-year period ended December 31, 2021, and the related notes, which is included herein and to the reference to our firm under the heading Experts in the prospectus included in the registration statement on Amendment No. 5 to Form F-1 dated August 9, 2022 of mCloud Technologies Corp.
/s/ KPMG LLP
Chartered Professional Accountants
August 9, 2022
Calgary, Canada
Exhibit 107
Calculation of Filing Fee Tables
FORM F-1
(Form Type)
mCloud Technologies Corp.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
CALCULATION OF REGISTRATION FEE
Security Type |
Security Class Title |
Fee or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price (1) |
Fee Rate |
Amount of Registration Fee | |||||||
Newly Registered Securities | ||||||||||||||
Fees to Be Paid | Equity | Series A Preferred Shares, no par value per share (2) |
Rule 457(o) | | $28,750,000 | $0.0000927 | $2,665.13 | |||||||
Equity | Warrants to purchase Common Shares (3) |
Rule 457(g) | | | | | ||||||||
Equity | Common Shares, no par value per share, underlying the Series A Preferred Shares (4) (5) | Rule 457(i) | | | | | ||||||||
Equity | Common Shares, no par value per share, underlying the Warrants (5)(6) |
Rule 457(i) | | $49,162,500 | $0.0000927 | $4,557.36 | ||||||||
Total Offering Amount: | $77,912,500 | $7,222.49 | ||||||||||||
Total Fees Previously Paid | $5,829.97 | |||||||||||||
Total Fee Offsets | | |||||||||||||
Net Fees Due: | $1,392.52 |
(1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933. |
(2) | Includes additional Series A Preferred Shares and/or Warrants to purchase Common Shares (and the Common Shares issuable thereunder) representing 15% of the number of Series A Preferred Shares and the number of Warrants to purchase Common Shares which may be offered to the public, that the underwriter has the option to purchase. |
(3) | No fee required in accordance with Rule 457(g) under the Securities Act. |
(4) | No registration fee required pursuant to Rule 457(i) under the Securities Act. |
(5) | Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions. |
(6) | Estimated solely for purpose of calculating the registration fee pursuant to Rule 457(i) under the Securities Act. There will be issued 9.00 Warrants to purchase one Common Share for every one Series A Preferred Share offered. The Warrants are exercisable at a per-share price equal to $4.75. Includes 15% of the Warrants to purchase Common Shares which may be offered to the public, that the underwriter has the option to purchase. |
NHR9WQ
M22\@]0_CMPB8JAQ]L4I!'80W-N!@\.VWA#19D IN1$3(438X)&+5*V"+A09C
M*2+"/\_=D8,P>.4T#.WJ@&$C=J50Y165-RB(%# !:P,@DL44_/4$&*#$RNQ#?4%3%0 Y1+[0_$
M-=HJ=+Y?FFGFM.YN [1ML);$@$F24R!MQ6V".1,ZCS.@SUS/LI*6*IRH4Z;,
M5JB21.8G89'?'6>-Z4,B5ID-:I_4K?H*D)G6*Q@E(N+DG\ "GRAW_(JHG_>1HG]XN2M>JNQQ_BT
M_P#]+=_G&(\E=LC_ K;_P"IL_S3\?%L;VB/Z7_5&U])LM_J2/S9_#,?,FK_
M *P[]^/P1$-7,640^;U?9[0U$*4!(&R)@I2;C$=]C 8-@,!@,!@ 'F HD V
M_N@*(AOJDIII2@M24E0,YRMG$_&=PE&)6$B1$X"(CVB._*!=]QWY2^U#?MX;
MZF*$JO ,2)6I)FDD'HCL5TV8>JF8['=XRYV9S4J]3L=OKR]DVLM4Z^10&-IJ
ME>*W=SMT43KL2W(-F\X%5;85!0[LH\QR[\ZU_K<?1MF@9"RX<8FE1 4)B<
MD6SEMV;;(Z/H/2Z-6U);JGRCAK $U2O%]L; U-HE# 7^2^8T>4
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M4$+0 $>2"DI_%)(D9"T2((EU2OYL9N\T*3.MJ 6L('$$G96C9/:(N5)*5%)V&(F4 I=Q$O@WX\-"ZA
M*<2IQ #P13%
$JGY29W61#5?-@ZDJM/U3
M%"*8Y$I)D'<7&PJ959U$\.?!E[Z6+HE&X,08R#%&.*UC\DM[]%KS5RV"3,R*
MQ.Y%9RLX*?S5)95)'E!;80W, B&_J:WW1.B*72.DF]+J6'P@K)6$! .-2E>3
M-4I ROMOC1];:H>U?J2IS\(X''#8P%6,IP-I1Y4DSGAG<)3E&+X0P8EAJ$M4
M,2Q+3A;/:Y.T'6%@E'>:*21BB9H0B*RHJD3*&W,8=S>IV:Q/+SERC0=%5Y?Z
M2*BFJGRXH!'#E,89>4J=D@>Y&8UWKQ>M
9&--)/!,0ZK5S<(O)KIFJ[3+YP142K;B*>P\H7R'RES'5&J
M4AW'Q0 4SQI*5)O;(\I*9 V&XV1V5OGE7(8]"53)*2,)-MQF#[_8)_88LN/.
MKZ)Q92YO%M.P1'1>.+,XLI['$JY,NBEI73M5
H]BZ;M'2$C(TZQ,(YTSD)%O%QIBKN
M8E(JOGTF]:M$#"82.%52)D*)A(&L57Y_I]VL4[Z91J?!"5=87I).&4K")&=Q
MD#.P1?4^FL^#(0U35P1.?D)V@ GRMM\MABVSE(N\"^FHNRU&TU^3K<8G8+(Q
MF*Y.1CF!@W2[=-O.3C-^P:+1L$Z?NDR&<*@DB90Y3<^_'5?UWIIX"H:JJ-16
M3-0783T81(]P718NY-G="M*/1ZH*V!8ENNDHVRVF)$Z7='+^#A&5*NCF3MT.
M$M5H1I69=26M$&HDY5]]*^V;QAW,K$BW:JF*NT3 ]PJ%FZ9GOE='4\/E(^8Q(!PZ6,<
M F OE9$M(=H[F2!.7ERB8/E(N91[.EC&OQCVG[&M03V0LC4)IS#,I_>L^;
M%-/;5K??Y;2#ON?I(D/\I'S$3;GZ6,;;CV &1[1]C6IVNR#D,CZ1F.8I7.R2
M6+1WT;XBKMH5SA!:RVCP 6S+M_1)R) ^4CYA'C]ZQC@/4'(MJ_-"M[:D/9"R
M4"8S#,9?>L>;$X[9E7*W+Z*?=>_216_*/WER19A,/B]O7D2
M]OC,'YVE%V1,@> <=S',4K3N2Q+V41:O]M6K<3Z.